gener
review
made
munchausen
syndrom
andor
surgic
addict
patient
emihasi
made
psychiatr
patholog
treatment
mean
psychoheravi
one
cdse
report
correspond
number
coombia
number
bl
worldwid
medic
literatur
present
oldest
one
exist
case
characteristio
surgic
addict
unneccesari
abdo
min
sgical
prooedur
perform
unexist
ill
neg
oih
boratori
xray
test
patient
mental
condit
pictur
chronic
depress
exarceb
stress
enviroment
familiar
long
evolut
ill
almost
patient
lifetim
good
gener
condit
spite
year
confirm
munchusen
syndrom
perman
psychotherapi
support
assist
symptomat
medica
constitu
treatment
given
type
patient
parenter
hyperaliment
ph
current
use
nutrit
support
varieti
clinic
situat
includ
pancreat
sinc
prevent
pancreat
stimul
principl
treatment
pancreat
studi
undertaken
determin
effect
ph
rest
secretinstimul
pancreat
exocrin
function
five
patient
abdomin
complaint
without
pancreat
diseas
studi
follow
secretin
stimul
carri
secretin
boot
dose
ukg
bodi
weight
studi
ukg
bodi
weight
other
follow
min
postsecretin
observ
anoth
hour
collect
duoden
juic
allow
pancreat
secret
return
rest
level
next
ph
administ
two
hour
infus
consist
modifi
protein
hydrolys
glucos
administ
rate
mlhr
secretin
stimul
repeat
continu
ph
duoden
juic
urin
collect
throughout
studi
blood
sampl
drawn
begin
period
end
studi
sampl
duoden
juic
examin
volum
bicarbon
total
protein
amylas
bilirubin
blood
examin
glucos
bun
electrolyt
amylas
osmol
urin
amylas
ph
depress
pancreat
secretori
flow
mean
rest
level
path
mean
bi
rubin
output
rose
ph
bicarbon
amylas
total
protein
output
affect
low
dose
secretin
stimulatioph
significantli
affect
mean
bilirubin
output
howev
patient
receiv
higher
secretin
dose
bilirubin
output
rose
consist
effect
volum
bicarbon
total
protein
output
note
studi
suggest
ph
increas
bilirubin
secret
adequ
secretin
stimul
probabl
explain
gall
bladder
contract
sinc
ident
dose
secretin
use
two
period
consist
chang
volum
respons
ph
seen
would
appear
ph
stimul
pancreat
secret
condit
studi
use
acut
pancreat
would
probabl
contradict
possibl
purpos
studi
observ
peristalt
activ
oropharynx
use
dl
antonel
glass
gastroenterolog
advantag
offer
characterist
peristalt
complex
twenti
patient
normal
patient
variou
esophag
diseas
studi
measur
chang
upper
high
pressur
zone
incisor
teeth
follow
deglutit
two
serial
dl
use
demonstr
wave
propag
proxim
open
second
dl
level
distal
open
first
dl
standard
lead
proxim
open
first
dl
pharynx
peristalt
complex
last
second
found
use
dl
demonstr
dl
complex
resembl
peristalt
wave
found
mouth
patient
junction
mouth
oropharynx
usual
cm
incisor
teeth
motor
complex
seen
standard
differenti
lead
durat
rang
second
standard
lead
complex
posit
wave
notch
peak
dl
complex
appear
peristalt
wave
continu
sequenc
patient
first
portion
junction
complex
transmit
pharynx
wherea
second
portion
complex
move
pharynx
remain
patient
first
portion
junction
wave
propag
pharynx
correl
underli
esophag
diseas
portion
wave
transmit
locat
junction
complex
may
repres
transit
point
first
voluntari
stage
deglutit
second
reflex
peristalt
stage
deglutit
swallow
act
patient
would
thu
consist
voluntari
stage
mouth
pressur
gradient
move
abor
toward
faucial
area
point
first
wave
follow
typic
peristalt
wave
give
rise
long
junction
complex
peristalt
part
wave
transmit
pharynx
voluntari
portion
wave
transmit
transmiss
first
portion
wave
patient
explain
present
data
assess
cellmedi
immun
respons
inflammatori
bowel
diseas
vitro
cultur
wash
peripher
blood
lymphocyt
obtain
patient
crohn
diseas
small
larg
intestin
nonspecif
ulcer
coliti
healthi
individu
similar
sex
age
distribut
cultur
contain
x
lymphocyt
suspend
ml
eagl
medium
supplement
pool
normal
human
serum
group
ab
rh
neg
perform
presenc
either
salin
control
cultur
increas
amount
phytohemagglutinin
conconavalin
pokewe
mitogen
result
dna
synthesi
measur
incorpor
tritiat
thymidin
incub
three
day
assess
duplic
cultur
mean
result
group
subject
compar
dose
mitogen
lymphocyt
stimul
phytohemagglutinin
depress
significantli
patient
crohn
diseas
contrast
healthi
subject
p
certain
concentr
thu
phenomenon
seen
cultur
contain
microgram
microgram
phytohemagglutinin
lymphocyt
respons
conconavalin
pokewe
mitogen
depress
crohn
diseas
group
signific
degre
ulcer
coliti
mean
lymphocyt
respons
three
mitogen
impair
significantli
result
suggest
defect
cellular
immun
crohn
diseas
independ
serum
factor
possibl
affect
certain
lymphocyt
popul
defect
might
import
host
reactiv
unidentifi
agent
condit
coagul
defect
suspect
certain
categori
massiv
g
bleed
routin
lab
test
fail
reveal
consist
abnorm
recent
observ
abnorm
low
platelet
adhes
mean
group
patient
massiv
g
bleed
follow
trauma
sepsi
significantli
lower
mean
normal
individu
p
similarli
signific
reduct
platelet
adhes
note
patient
bleed
follow
intak
aspirin
histori
alcohol
cirrhosi
esophag
varic
platelet
count
howev
critic
reduc
except
patient
sepsi
cirrhosi
contrast
patient
bleed
chronic
gastroduoden
ulcer
slight
reduct
platelet
adhes
rang
eight
patient
trauma
sepsi
platelet
dysfunct
correct
continu
bleed
despit
correct
procedur
die
patient
platelet
dysfunct
correct
transfus
fresh
blood
platelet
frozen
plasma
bleed
stop
six
surviv
two
die
recurr
sepsi
later
similarli
patient
histori
aspirin
intak
alcohol
chronic
gastroduoden
ulcer
esophag
varic
btn
platelet
adhes
improv
spontan
correct
bleed
stop
one
correct
oper
perform
elect
later
patient
chronic
gastroduoden
ulcer
esophag
varic
reduct
platelet
adhes
essenti
initi
hemostasi
provid
plausibl
explan
persist
sever
massiv
g
bleed
recommend
correct
platelet
dysfunct
unnecessari
riski
oper
may
avoid
patient
massiv
g
bleed
follow
sepsi
aspirin
alcohol
gastroesophag
oper
intervent
esophag
varic
chronic
peptic
ulcer
may
postpon
favor
time
hope
new
approach
would
result
substanti
decreas
mortal
morbid
massiv
g
bleed
preval
macroamylasemia
barrow
je
berk
l
fridhandl
depart
medicin
univ
calif
irvin
calif
studi
report
date
socal
macrocmylasemia
concern
patient
select
studi
persist
hypercmylasemia
determ
ine
frequenc
macroanylasemia
popul
larg
newli
describ
rapid
screen
method
macroamylasemia
clin
chem
use
examin
randomli
select
serum
sampl
obtain
three
group
hospit
patient
varieti
disord
presum
normal
person
repres
blood
bank
donor
small
group
volunt
newborn
studi
mean
umbil
ical
cord
blood
sampl
macroamylas
detect
initi
excmin
serum
nine
hospit
patient
two
nine
patient
larg
compan
longer
present
second
sampl
taken
within
month
first
one
one
normal
subject
exhibit
macrocmylas
sera
none
cord
blood
sampl
contain
macrcmolecular
amylas
form
find
suggest
macroamylasemia
probabl
much
frequent
suspect
data
also
indic
macroamylasemia
may
transient
phenomenon
macroamylas
compan
may
present
serum
whose
total
cmylas
activ
within
normal
limit
sever
investig
report
fluid
transport
across
intestin
wall
isoosmot
mucos
solut
mucos
solut
hyperton
isoosmot
transport
fluid
occur
irrespect
substanc
use
increas
osmol
mucos
solut
present
studi
investig
mechan
isoosmot
transport
occur
osmol
mucos
solut
increas
substanc
differ
molecular
radii
evert
hamster
small
intestin
incub
either
isoton
krebshenseleit
solut
contain
glucos
mosmkg
one
hyperton
mosmkg
mucos
solut
use
hyperton
mucos
solut
prepar
addit
follow
substanc
molecularcradii
isoton
ution
mannitol
q
x
erythritol
urea
ethylen
glycol
formamid
substanc
refer
ad
solut
order
collect
transport
fluid
without
dilut
seros
side
intestin
bath
result
show
transport
fluid
isoosmot
mucos
solut
concentr
glucos
yl
na
fluid
transport
hyperton
mucos
solut
decreas
inearli
decreas
molecular
radiu
ad
solut
rl
fi
p
oool
p
oool
neg
relat
concentr
ad
olut
transport
fluid
molecular
radii
p
oool
data
indic
osmol
mucos
solut
increas
addit
poorli
permeabl
substanc
mannitol
erythritol
transport
fluid
becom
isoosmot
mucos
solut
increas
concentr
glucos
na
osmol
mucos
solut
increas
substanc
smaller
molecular
radii
urea
ethylen
glycol
formamid
transport
fluid
becom
isoosmot
mucos
solut
due
presenc
ad
substanc
glucagon
known
inhibit
gastric
secretori
respons
food
exogen
gastrin
effect
glucagon
endogen
gastrin
releas
unknown
studi
effect
intraven
glucagon
serum
gastrin
respons
meal
heidenhain
pouch
dog
duoden
ulcer
patient
gastrin
measur
radioimmunoassay
method
man
blood
sampl
taken
basal
measur
gastrin
basal
acid
output
measur
hour
standard
meal
given
test
day
mg
glucagon
infus
hour
multipl
serum
sampl
taken
gastrin
measur
studi
dog
ident
except
dose
glucagon
doubl
heidenhain
pouch
acid
output
measur
minut
interv
result
averog
basal
serum
gastrin
concentr
picogram
pgml
duoden
ulcer
potient
pgml
dog
man
increas
gastrin
concentr
minut
eat
increas
minut
glucagon
given
gastrin
rose
minut
minut
fallen
basal
level
dog
increas
gastrin
concentr
minut
eat
increos
minut
glucagon
caus
highli
signific
diminut
respons
food
increas
minut
increas
minut
averag
heidenhain
pouch
output
first
hour
eat
meq
respons
nearli
abolish
glucagon
meq
glucogon
infus
halt
acid
output
rose
control
level
conclus
studi
provid
direct
evid
glucagon
suppress
releas
gastrin
man
dog
thu
glucagon
like
secretin
appear
capobl
interf
releas
gastrin
action
gastrin
poriet
ce
ii
healthi
adult
low
lactas
level
lll
unit
develop
symptom
ga
cramp
diarrhea
amount
lactos
found
oz
serv
mi
ik
other
note
symptom
quart
mi
ik
variat
respons
differ
amount
lactos
studi
assayproven
lll
subject
fed
gm
lactos
electrolyt
solut
seventyf
percent
symptomat
gm
less
equival
oz
mi
iktwentyf
percent
symptom
gm
less
lactos
equival
oral
load
glucosegalactos
sucros
caus
symptom
lll
subject
correl
minimum
dosag
lactos
caus
symptom
degre
lactas
defici
six
lll
subject
control
intub
polyvinyl
triplelumen
tube
fed
peg
gm
marker
gm
lactos
electrlyt
solut
simi
lar
mi
ik
specimen
aspir
duodenum
midjejunum
ileum
lll
subject
control
fold
dilut
occur
stomach
fluid
becam
isosmot
within
duodenum
howev
na
significantli
higher
k
lower
duodenum
bf
lll
subject
control
lll
subject
decreas
net
fluid
absorpt
jejunum
littl
gm
lactos
net
fluid
product
jejunum
ileum
gm
glucos
solut
mm
ad
lactos
net
fluid
product
jejunum
significantli
decreas
p
ooi
feed
lactos
meal
increas
amount
toler
lll
subject
conclus
person
low
lactas
level
awar
symptom
ingest
lactos
equival
oz
mi
ik
gm
physiolog
derang
fluid
absorpt
upper
smal
bowel
occur
ittl
gm
lactos
glucos
ad
lactos
lessen
small
intestin
fluid
respons
undigest
lactos
lactos
taken
mea
li
betterto
erat
person
low
actas
eve
evalu
role
antacid
atropin
therapi
gastroesophag
reflux
postcib
state
studi
perform
subject
histolog
demonstr
esophag
control
subject
without
esophag
radiolog
demonstr
slide
hiatal
hernia
occurr
gastroesophag
reflux
determin
continu
monitor
intraesophag
pkwith
ph
electrod
place
cm
proxim
lower
esophag
sphincter
patient
esophag
none
control
show
fall
esophag
ph
within
one
hour
test
meal
antacid
significantli
increas
refluxfre
interv
test
meal
pretreat
atropin
prolong
period
even
effect
antacid
anticholinerg
therapi
mark
patient
clinic
histolog
evid
esophag
without
endoscop
chang
mild
esophag
subject
advanc
esophag
endoscop
evid
ulcer
strictur
format
sever
esophag
prolong
refluxfre
interv
antacid
atropin
therapi
show
signific
correl
rest
lower
esophag
sphincter
pressur
two
differ
pattern
reflux
note
prolong
reflux
character
fall
ph
persist
minut
longer
brief
reflux
fall
ph
last
minut
less
prolong
reflux
usual
seen
patient
sever
esophag
frequent
associ
manometr
abnorm
distal
esophagu
neither
antacid
atropin
therapi
modifi
pattern
reflux
patient
conclud
antacid
atropin
benefici
prolong
refluxfre
period
postcib
state
effect
mark
patient
mild
esophag
moder
impair
sphincter
compet
howev
agent
may
limit
valu
treatment
advanc
esophag
mark
impair
lower
esophag
sphincter
pressur
ventricular
respons
atrial
tachycardia
result
mark
diminut
superior
mesenter
arteri
blood
veloc
peak
level
reduc
control
valu
depend
preced
cycl
length
r
p
ventricular
tachycardia
superior
mesenter
arteri
blood
veloc
decreas
markedli
beat
result
forward
flow
paroxysm
tachyarrhythmia
follow
blood
veloc
overshoot
resumpt
sinu
rhythm
short
diastol
fill
period
reduc
stroke
output
increas
mesenter
vascular
resist
account
alter
conclud
aggress
approach
institut
treatment
arrhythmia
patient
suspect
mesenter
vascular
insuffici
doppler
ultrason
cathet
flowmet
system
valuabl
techniqu
character
superior
mesenter
arteri
blood
veloc
cardiac
arrhythmia
purpos
paper
present
hypothesi
cholerh
enteropathi
factor
pathogenesi
diarrhea
death
due
acut
chronic
radiat
enter
examin
effect
cholestyramin
prevent
treatment
acut
syndrom
sullivan
shown
acut
experi
intestin
absorpt
bile
salt
radiat
rat
diminish
therefor
like
cholerh
enteropathi
occur
abdomin
radiat
play
role
product
acut
radiat
syndrom
would
explain
deleteri
effect
bile
acut
radiat
diarrhea
note
jackson
entenman
sullivan
archambeau
excess
loss
sodium
stool
radiat
observ
jackson
similarli
patient
chronic
radiat
ileiti
bile
salt
malabsorpt
cramp
diarrhea
case
may
also
manifest
cholerh
enteropathi
preliminari
acut
experi
rat
suggest
pretreat
cholestyramin
reduc
incid
diarrhea
death
abdomin
radiat
comparison
rat
given
radiat
alon
rat
given
gm
cholestyramin
daili
day
prior
abdomin
radiat
rad
develop
diarrhea
die
compar
equal
number
rat
given
radiat
alon
diarrhea
die
rat
succumb
radiat
dose
increas
rad
whether
cholestyramin
pretreat
given
cholestyramin
therapi
consid
patient
acut
chronic
radiat
enter
diarrhea
control
symptomat
therapi
alon
discoveri
levi
gatmaitan
aria
two
hepat
cytoplasm
protein
fraction
appear
import
transfer
bilirubin
bromosulfophthalein
plasma
hepat
cell
may
provid
better
understand
physiochem
factor
determin
excretori
pathway
radiograph
contrast
materi
protein
design
z
present
tissu
preferenti
extract
bilirubin
bromosulfophthalein
plasma
sinc
found
liver
except
presenc
z
small
intestin
mucosa
addit
role
elimin
bilirubin
bromosulfophthalein
bile
protein
may
also
import
hepat
excret
biliari
contrast
materi
evalu
influenc
z
pathway
excret
radiograph
contrast
agent
sephadex
gel
filtrat
experi
perform
rat
liver
supernat
determin
affin
variou
radiograph
contrast
materi
protein
vitro
result
show
iopano
acid
iodipamid
two
cholecystograph
contrast
media
bind
z
protein
iothalam
repres
urograph
contrast
agent
affin
protein
indic
protein
may
import
determin
pathway
excret
contrast
materi
knowledg
type
import
futur
develop
less
toxic
organ
specif
contrast
materi
use
clinic
radiolog
g
bevan
depart
medicin
center
health
scienc
lo
angel
california
vitro
lymphocyt
transform
impair
patient
chronic
liver
diseas
impair
like
result
diseas
process
factor
respons
wlknown
order
examin
possibl
bile
salt
may
influenc
transform
lymphocyt
nonnal
donor
incub
tc
medium
phytohemagglutinin
presenc
vari
concentr
bile
salt
cholic
deoxychol
chenodeoxychol
lithochol
acid
taurin
glycin
salt
acid
except
lithochol
acid
ml
methanol
solut
mixtur
substanc
equal
concentr
individu
acid
alon
ad
lymphocyt
cultur
give
final
concentr
medium
rang
mgioo
ml
blast
transform
lymphocyt
assess
abil
incorpor
tritiat
thymidin
ad
cultur
media
hr
harvest
cell
amount
tritium
incorpor
measur
either
autoradiographi
bile
acid
mixtur
liquid
scintil
count
individu
bile
acid
tritium
incorpor
significantli
differ
control
concentr
bile
salt
less
mgioo
ml
increas
concentr
level
result
diminish
rate
thymidin
incorpor
mgioo
ml
transform
complet
inhibit
although
morpholog
appear
untranaform
cell
normal
exclud
trypan
blue
stain
normal
trihydroxi
bile
acid
significantli
less
effect
inhibit
transform
dihydroxi
bile
acid
differ
found
free
conjug
bile
acid
conclud
bile
salt
concentr
similar
found
serum
patient
chronic
liver
diseas
impair
lymphocyt
transform
vitro
increas
excret
dival
cation
calcium
ca
magnesium
mg
steatorrhea
previous
attribut
format
insolubl
ca
mg
soap
fatti
acid
howev
correl
total
fat
total
ca
excret
stool
role
soap
play
unclear
fecal
ca
soap
measur
patient
total
ca
mg
total
unesterifi
fecal
fatti
acid
measur
thu
correl
total
unesterifi
fecal
fatti
acid
total
ca
mg
soap
could
made
measur
hr
fecal
excret
total
fat
total
unesterifi
fatti
acid
ca
mg
soap
also
measur
daili
fecal
excret
ca
mg
atom
absorpt
spectroscopi
control
ca
mg
fat
diet
normal
subject
patient
pancreat
insuffici
patient
small
bowel
mucos
diseas
studi
data
summar
follow
total
fat
tot
l
ca
mg
excret
correl
patient
pancreat
insuffici
excret
ca
mg
mucos
diseas
even
though
total
fat
excret
much
higher
latter
group
howev
one
plot
valu
total
fatti
acid
excret
per
day
versu
percentag
total
ca
mg
excret
soap
straight
least
squar
regress
line
ob
histolog
similar
differ
behavior
make
surgic
manag
difficult
carcinoid
tumor
islet
cell
tumor
occur
duodenum
carcinoid
tumor
metastas
islet
cell
tumor
produc
gastric
hypersecret
peptic
ulcer
diseas
lifeendang
carcinoid
tumor
duodenum
region
lymph
node
metastas
best
treat
radic
pancreaticoduodenectomi
wherea
oper
may
suffic
control
ulcer
diseas
patient
islet
cell
tumor
associ
either
metastas
islet
cell
tumor
latter
patient
total
gastrectomi
advis
experi
two
patient
islet
cell
tumor
duodenum
associ
gastric
hypersecret
one
patient
malign
carcinoid
tumor
duodenum
follow
postop
year
respect
individu
oper
procedur
perform
base
presenc
absenc
gastric
hypersecret
presenc
region
lymph
node
metastas
absenc
gastric
hypersecret
presenc
region
lymph
node
metastas
dictat
need
radic
pancreaticoduodenectomi
presenc
gastric
hypersecret
justifi
total
gastrectomi
howev
one
patient
larg
duoden
islet
cell
tumor
anoth
patient
isol
ectop
islet
cell
tumor
near
duodenum
ulcer
diseas
follow
partial
gastrectomi
need
total
gastrectomi
patient
singl
isol
islet
cell
tumor
remov
determin
later
basi
radioimmunoassay
level
serum
gastrin
effect
halogen
anesthet
halothan
rat
liver
previous
damag
either
carbon
tetrachlorid
e
coli
endotoxin
contrast
diethyl
ether
control
microsom
detoxif
hexabarbit
reduc
percent
carbon
tetrachlorid
unaffect
endotoxin
halothan
caus
percent
reduct
hexabarbit
metabol
carbon
tetrachlorid
treat
rat
effect
endotoxin
treat
rat
ether
depress
hexabarbit
metabol
carbon
tetrachlorid
treat
rat
result
demonstr
halogen
hydrocarbon
anesthet
directli
toxic
action
rat
liver
action
could
demonstr
normal
control
anim
may
signific
choic
anesthet
patient
demonstr
impair
liver
function
observ
made
frequent
diarrhea
ensu
patient
follow
oral
administr
certain
antibiot
mechan
antibioticinduc
diarrhea
effect
man
unknown
studi
done
experiment
anim
see
whether
antibiot
elicit
gastrointestin
symptom
major
side
effect
induc
disaccharidas
defici
wellrecogn
caus
diarrhea
dd
defici
small
intestin
mucosa
man
intoler
sever
oral
ingest
notabl
gliadin
cow
milk
protein
neomycin
four
antibiot
chosen
studi
neomycin
ne
erythromycin
er
ampicillin
cephaloglycin
ce
grouppair
healthi
grow
charl
river
spraguedawley
rat
fed
ground
chow
mix
antibiot
dosag
latter
calcul
weightrel
basi
commensur
therapeut
dose
man
antibiot
administ
period
day
necontain
feed
partial
reject
first
day
time
chang
feed
habit
weight
gain
similar
group
chang
end
day
signific
group
diarrhea
occur
anim
group
sacrific
jejun
mucos
lactas
sucras
maltas
activ
measur
dahlqvist
analyt
biochem
result
show
follow
ne
er
produc
signific
chang
activ
ce
produc
unexpect
increas
lactas
activ
p
slight
signific
increas
sucras
maltas
activ
druginduc
chang
dd
activ
could
relat
chang
villu
height
epitheli
cell
mass
ce
treat
anim
differ
treat
control
anim
signific
patholog
epitheli
chang
discern
antibiot
treat
anim
although
data
obtain
anim
alway
util
explain
pathophysiolog
human
diseas
result
suggest
mechan
direct
cellular
injuri
respons
antibioticinduc
diarrhea
postul
disrupt
normal
gastric
mucos
barrier
consequ
destruct
tight
junction
surfac
epitheli
cell
increas
effect
pore
area
mucos
permeabl
valid
hypothesi
requir
part
demonstr
absorpt
gastric
mucosa
lipid
insolubl
substanc
larg
molecular
radiu
stomach
normal
permeabl
present
studi
absorpt
phenolsulfonphthalein
psp
mw
mol
radiu
canin
fundic
pouch
topic
applic
urea
agent
known
disrupt
barrier
determin
use
test
solut
consist
mml
hcl
nml
nacl
ml
psp
mmml
peg
associ
alter
net
flux
h
na
k
cl
h
also
assess
mean
psp
absorpt
prior
urea
instil
minutesloo
cm
mucos
area
follow
urea
mean
psp
absorpt
minutesloo
cm
mucos
area
associ
ionic
water
flux
rate
minutesloo
mucos
area
pouch
gain
pouch
loss
result
suggest
follow
urea
applic
mucos
permeabl
increas
increas
effect
pore
area
may
respons
recommend
psp
use
volum
marker
studieo
integr
gastric
mucos
barrier
assess
bozymski
scott
pharr
dept
univ
north
carolina
sch
medicin
chapel
hill
north
carolina
effort
made
defin
clearli
role
esophagu
speech
process
post
laryngectomi
patient
particularli
respect
intralumin
gastric
esophag
pressur
especi
sphincter
area
determin
import
factor
relat
intellig
test
speech
profici
patient
pronunci
random
word
standard
speech
test
tape
record
ten
judg
unaccustom
esophag
speech
listen
tape
attempt
choos
four
similar
sound
word
word
patient
actual
read
intellig
calcul
follow
formula
number
word
correctli
chosen
judg
x
test
word
esophag
gastric
pressur
measur
use
tripl
lumen
constantli
perfus
cathet
later
open
cm
apart
pressur
stomach
variou
level
esophagu
upper
esophag
sphincter
ue
lower
esophag
sphincter
le
record
cathet
withdrawn
stomach
pharynx
trace
analyz
intellig
correl
intralumin
pressur
stomach
throughout
esophagu
sphincter
pharynx
pressur
stomach
esophagu
good
speaker
averag
compar
poor
speak
group
analyz
use
two
tail
test
good
speaker
found
lower
pressur
compar
poor
speak
group
p
ol
pressur
compar
level
alway
higher
poor
speak
group
differ
statist
signific
certain
level
esophagu
rest
speak
stomach
speak
paramet
relat
intellig
also
studi
indic
younger
patient
speech
lesson
spoke
intellig
correl
pressur
speak
abil
patient
peter
brightasar
henri
j
binder
yale
univers
new
connecticut
relationship
ohfa
diarrhea
often
accompani
steatorrhea
recent
suggest
hofmann
jci
part
base
presenc
hydroxi
fatti
acid
ricinoleicacid
ra
castor
oil
increas
fecal
orfa
patient
diarrhea
steatorrhea
determin
effect
ra
net
water
elerrolyt
transport
l
peqg
dri
wtmin
vivo
perfus
techniqu
use
c
peg
nonabsorb
marker
employ
rat
colon
water
na
cl
absorb
control
isoton
salin
solut
anim
l
peq
peq
respect
contrast
signific
net
secret
water
na
cl
pi
peq
peq
respect
anim
caus
mm
ra
solut
solubil
na
taurochol
tc
salin
solut
mm
tc
alon
decreas
absorpt
histolog
examin
ra
perfus
colon
demonstr
uniform
deplet
goblet
cell
mucou
without
histolog
chang
ra
induc
secret
partial
revers
hour
salin
perfus
measur
net
secret
induc
ra
secondari
absorpt
marker
sinc
recoveri
c
peg
similar
salin
ra
perfus
anim
vs
ra
caus
signific
decreas
intralumin
potenti
differ
pd
lumen
neg
compar
control
addit
perf
us
ion
unidirect
movement
na
determin
na
salin
perfus
na
insorpt
peq
exsorpt
peq
ra
induc
secret
insorpt
decreas
significantli
peq
p
ool
exsorpt
increas
slightli
peq
anoth
seri
perfus
demonstr
oleic
acid
differ
ra
absenc
hydroxi
oh
group
produc
secret
thu
conclud
effect
ohfa
na
absorpt
relat
group
studi
demonstr
ra
caus
net
secret
water
na
cl
rat
colon
mechan
net
secret
consist
inhibit
na
insorpt
interpret
support
unidirect
na
flux
data
decreas
intralumin
pd
diarrhea
observ
patient
steatorrhea
may
caus
ohfa
two
year
ago
int
roduc
concept
artifici
gut
system
selfadministr
parenter
nutrient
believ
artifici
gut
system
patient
sever
ch
ronic
bcwel
diseas
artifici
kidney
patient
endstag
kidney
diseas
artifici
gut
system
consist
follcm
compon
use
one
rout
circulatori
access
silast
indwel
cuf
right
atrial
cathet
p
roven
remaik
free
cojjq
licat
includ
sepsi
b
creation
av
fistula
wrist
infusicn
larg
dilat
vein
c
infus
th
rough
sidearm
place
standard
av
shunt
ilethod
provid
access
area
high
blood
flcm
dilut
hyperton
solut
small
portabl
pump
cont
rol
infus
rate
nutrient
solut
special
bottl
contain
facilit
mix
patient
hoil
aa
alarm
devic
warn
bottl
nearli
ty
eight
patient
complet
train
establish
home
patient
gain
weight
continucu
infus
abl
iieintain
desir
weight
int
nnittent
overnight
infus
complic
directli
attribut
ilethod
minor
gener
handl
patient
hoil
one
unexpect
find
hepatomegali
mild
enzym
elev
bsp
retent
patient
larg
fatti
liver
derronstr
autopsi
two
p
roblem
revers
torarili
discontinu
infus
nutrient
solut
advantag
long
term
home
parenter
nutrit
chronic
malnourish
patient
avoid
repeat
hospit
cost
great
imp
patient
independ
gener
state
wellb
improveli
gast
rointestin
syjlq
tomatolog
p
robabl
imp
roveli
underli
diseas
p
rocess
increas
net
absorpt
water
sodium
glucos
demonstr
remnant
massiv
gut
resect
chang
unidirect
flux
caus
net
chang
known
accordingli
vivo
ileal
perfus
done
pairf
sham
oper
jejunectomizedat
four
week
surgeri
net
water
sodium
glucos
absorpt
unidirect
sodium
flux
determin
measur
chang
peg
glucos
sodium
perfus
jejunectomi
caus
increas
water
absorpt
increas
sodium
absorpt
addit
glucos
perfus
increas
absorpt
even
p
valu
less
increas
net
sodium
absorpt
due
entir
increas
insorpt
sinc
exsorpt
unchang
find
suggest
increas
activ
transport
sodium
mucosa
serosa
remnant
hypothesi
confirm
studi
similar
remnant
uss
chamber
show
signific
increas
potenti
differ
millivolt
control
millivolt
experiment
short
circuit
current
across
membran
data
repres
first
direct
demonstr
increas
unidirect
activ
transport
adapt
gut
remnant
compar
pig
experiment
infect
specif
corona
viru
age
day
matchf
litter
mate
profus
diarrhea
occur
within
hour
infect
charac
teriz
massiv
elec
trolyt
water
loss
alkalin
sugar
free
stool
normal
fat
content
stool
hour
infect
control
pig
weigh
vs
g
contain
vs
meq
na
vs
meq
k
vs
meq
clrespect
light
electron
microscopi
scan
transmiss
show
structur
abnorm
mucosa
proxim
jejunum
proxim
jejunum
activ
na
k
sensit
mgatpas
vs
unitsmg
protein
mgatpas
vs
unitsmg
protein
lactas
vs
unitsg
protein
significantli
less
infect
pig
control
wherea
adenyl
cyclas
activ
unchang
diarrhea
character
perfus
specif
cm
segment
proxim
jejunum
mid
jejunum
distal
ileum
total
colon
use
tripl
lumen
tube
polyethylen
glycol
nonabsorb
marker
infect
pig
signific
chang
occur
proxim
jejunum
net
flux
lumen
water
cm
vs
cm
na
cm
vs
cm
cl
cm
vs
cm
increas
compar
data
pig
immedi
infect
unidirect
flux
na
lumen
use
increas
significantli
segment
suspens
epitheli
cell
isol
perfus
segment
infect
pig
significantli
greater
total
efflux
rate
constant
vs
hrl
cell
control
diarrhea
tge
appear
result
net
flux
electrolyt
water
lumen
diseas
small
bowel
suspect
massiv
increas
unidirect
movement
na
lumen
import
caus
abnorm
gastric
hypersecretori
state
character
human
duoden
ulcer
diseas
might
due
either
increas
stimul
decreas
inhibit
normal
stimul
assess
possibl
inhibitor
mechan
patient
chronic
duoden
ulcer
diseas
studi
patient
effect
iv
salin
control
iv
secretin
boot
unitskg
divid
dose
duoden
perfus
n
hcl
brothstimul
gastric
acid
secret
evalu
gastric
acid
concentr
test
titrat
ph
free
acid
ph
total
acid
significantli
inhibit
test
p
either
secretin
duoden
perfus
total
acid
decreas
similarli
neither
amount
naoh
requir
titrat
ph
combin
acid
volum
gastric
juic
differ
significantli
indic
neutral
reflux
alkalin
duoden
content
respons
observ
effect
furthermor
elimin
period
greater
reflux
assess
use
nonabsorb
marker
duoden
perfus
fail
alter
effect
duoden
perfus
inhibitori
effect
duoden
perfus
acid
significantli
less
mark
p
secretin
decreas
effect
might
due
greater
variabl
respons
duoden
perfus
secretin
analysi
varianc
could
demonstr
signific
patient
variat
without
identifi
poorlyrespond
subgroup
result
studi
indic
failur
endorgan
gastric
mucosa
respons
secretin
appear
playa
role
hypersecret
duoden
ulcer
rel
failur
releas
either
secretin
inhibitor
substanc
might
contribut
factor
vagal
control
canin
gastric
electr
mechan
activ
j
carrigg
kohatsu
stanford
u
va
hospit
dept
surgeri
palo
alto
ca
order
separ
local
food
distent
vagal
effect
feed
dog
prepar
follow
manner
stomach
vagi
intact
transect
distal
esophagogastr
junction
distal
end
close
proxim
end
anastomos
jejunum
dog
later
instrumen
stainless
steel
electrod
implant
gastric
wall
extralumin
strain
gage
record
electr
slow
wave
mechan
activ
record
obtain
fast
follow
feed
iv
insulin
feed
insulin
stimul
follow
test
transthorac
vagotomi
perform
test
repeat
electr
mechan
record
analyz
rate
chang
mechan
amplitud
chang
prevagotomi
fast
slow
wave
regular
rate
cpm
mechan
activ
vari
pattern
weak
omnipres
rhythmic
contract
usual
bodi
pattern
period
contract
follow
burst
contract
usual
antrum
insulin
hypoglycemia
produc
signific
increas
electr
rate
fast
within
minut
contract
decreas
ceas
minut
immedi
follow
insulin
inject
follow
rhythmic
strong
contract
greater
fast
follow
feed
half
test
slow
wave
becam
irregular
rate
decreas
minut
within
minut
postfeed
signific
increas
rate
fast
contract
becam
weaker
absent
minut
feed
follow
rhythmic
strong
contract
inhibit
contract
feed
great
enough
inhibit
strongli
contract
stomach
hypoglycem
anim
postvagotomi
fast
slow
wave
irregular
dog
contract
weaker
less
frequent
insulin
feed
produc
electr
mechan
chang
conclud
vagu
nerv
multipl
effect
gastric
electr
mechan
activ
vagal
stimul
may
increas
slow
wave
frequenc
decreas
slow
wave
frequenc
increas
frequenc
amplitud
contract
decreas
frequenc
amplitud
contract
abolish
contract
patient
partial
gastrectomi
simpl
gastric
achlorhydria
may
low
serum
level
despit
adequ
amount
intrins
factor
normal
biz
absorpt
test
find
prompt
investig
metabol
gastric
acid
secret
subject
variou
clinic
disord
normal
absorpt
serum
euglena
gracili
assay
absorpt
plasma
absorpt
test
gastric
acid
secret
histalogw
stimul
measur
studi
ionic
flux
across
canin
gastric
mucosa
util
close
system
instil
withdraw
acid
solut
antral
fundic
pouch
experi
design
measur
ionic
flux
across
gastric
mucosa
intact
canin
stomach
perfus
techniqu
devis
establish
steadi
state
obviat
need
calcul
pylor
loss
method
measur
residu
pool
fluid
stomach
use
indic
initi
valid
calibr
cylind
laporotomi
two
dog
perfus
tube
posit
cardia
collect
tube
pyloru
tube
introduc
peror
second
collect
tube
place
immedi
distal
pyloru
introduc
transduoden
perfus
system
demonstr
recoveri
indic
pylor
loss
cervic
esophagostomi
creat
separ
group
dog
polyethylen
perfus
collect
tube
posit
fluroscop
cardia
pyloru
respect
isoton
n
label
ilc
continu
perfus
collect
rate
ccmin
min
period
absorpt
h
ion
dog
sem
min
na
entri
min
dog
h
absorpt
v
min
na
entri
min
littl
fluid
entri
use
methylen
blue
perfus
enabl
us
trace
area
gastric
mucosa
perfus
sacrific
anim
absolut
h
loss
na
gain
greater
found
pouch
experi
reflect
greater
surfac
area
mucosa
avail
ionic
flux
techniqu
provid
physiolog
mean
evalu
gastric
mucos
barrier
intact
canin
stomach
gastroenterolog
normal
salin
introduc
mlmin
caecum
addit
measur
electrolyt
transport
water
movement
transit
time
volum
colon
continu
record
potenti
differ
pd
intralumin
pressur
caecum
done
two
addit
studi
electromyogram
caecum
also
record
suction
silver
electrod
qualiti
electr
contact
observ
continu
record
imped
potenti
differ
increas
markedli
introduct
sodium
chlorid
colon
lumen
reach
steadi
state
variat
time
still
consider
maximum
rang
variat
mv
mean
ise
variat
small
amplitud
pd
coincid
electromyogram
experiment
condit
analysi
curv
show
good
correl
p
averag
time
potenti
true
mean
potenti
tmp
tmp
mv
lumen
neg
respect
blood
evid
correl
tmp
pressur
variat
absorpt
na
cl
water
secret
k
transit
time
colon
volum
within
normal
rang
correl
sodium
absorpt
entir
colon
tmp
caecum
p
present
studi
provid
tool
studi
colon
physiolog
take
account
sever
paramet
simultan
demonstr
complex
phenomena
occur
colon
perfus
particular
suggest
caution
exercis
interpret
pd
measur
human
colon
ethanol
dose
gmkg
solut
administ
daili
esophagostomi
except
saturday
sunday
dog
receiv
well
balanc
diet
quantiti
daili
daili
administr
ethanol
start
preethanol
period
mean
maxim
acid
output
mao
stomach
respons
histamin
meq
dog
studi
end
first
month
daili
ethanol
administr
mao
increas
mean
mean
mao
remain
increas
similar
level
month
mean
maxim
acid
concentr
howev
chang
neither
mean
mao
mean
maxim
acid
concentr
chang
control
dog
order
explain
increas
mao
follow
daili
ethanol
administr
pariet
cell
mass
fcm
size
pariet
cell
determin
dog
includ
control
dog
healthi
dog
mean
pcm
x
dog
receiv
ethanol
month
pcm
x
mean
diamet
pariet
cell
u
healthi
dog
u
ethanol
treat
dog
chang
observ
zymogen
cell
alcohol
fed
dog
electronmicroscop
examin
fine
secretori
tubul
alcohol
fed
dog
reveal
appar
increas
number
although
tubul
lumen
collaps
mitochondria
appear
nearli
doubl
size
rel
control
anim
mitochondria
bleb
other
ruptur
christa
adjac
zymogen
cell
mucou
cell
contain
normal
mitochondria
organel
observ
suggest
strongli
increas
mao
result
daili
excess
ethanol
intak
dog
attribut
hypertrophi
pariet
cell
extent
increas
total
pariet
cell
mass
data
suggest
ingest
larg
dose
ethanol
nutrit
replet
dog
may
causal
relat
hyperplasia
toxic
chang
observ
pariet
cell
observ
previous
cholecystokinin
cck
stimul
small
intestin
motil
secretin
inhibit
cck
stimul
intestin
motil
man
observ
prompt
us
use
hormon
radiograph
examin
small
intestin
small
intestin
examin
ounc
barium
sulfat
mixtur
infus
distal
duodenum
proxim
jejunum
rehfuss
tube
intraven
administr
cck
dose
one
ivi
dog
unitkg
barium
column
follow
fluoroscop
spot
film
taken
cineradiographi
perform
also
select
patient
sixti
five
studi
perform
subject
transit
time
upper
jejunum
ileocec
junction
less
minut
subject
varieti
small
bowel
disord
examin
use
cck
reveal
abnorm
radiograph
find
either
convent
small
bowel
examin
fail
demonstr
abnorm
find
equivoc
moreov
examin
use
cck
demonstr
detail
mucos
abnorm
clearer
delin
extent
diseas
bowel
abl
differenti
stenosi
spasm
secretin
use
inhibit
motil
one
desir
examin
specif
segment
bowel
thoroughli
secretin
use
hypoton
duodenographi
also
subject
advantag
secretin
anticholinerg
hypoton
duodenographi
prompt
inhibitori
action
rel
short
durat
inhibitori
action
usual
minut
known
side
effect
contraind
radiograph
examin
small
bowel
use
two
hormon
reveal
small
bowel
diseas
strongli
suspect
clinic
convent
examin
show
abnorm
radiograph
find
equivoc
one
desir
thorough
examin
small
bowel
alreadi
shown
abnorm
consciou
dog
gastric
fistula
effect
ctermin
octapeptid
cck
octapeptid
balloonstimul
antral
motil
studi
constant
intraven
infus
octapeptid
minut
dose
ugkghr
dog
experi
ere
perform
dose
level
mean
percentag
chang
motor
activ
produc
differ
dose
octapeptid
follow
dose
ugkghr
data
indic
maxim
effect
dose
octapeptid
inhibit
ugkghr
amplitud
index
markedli
affect
paramet
indic
octapeptid
caus
partial
inhibit
instead
complet
inhibit
produc
secretin
chey
et
ai
j
physiol
dose
octapeptid
increas
beyond
ugkghr
inhibitori
effect
much
less
produc
dose
ugkghr
order
investig
effect
octapeptid
unstimul
stomach
anesthet
dog
sensit
minitransduc
place
antral
wall
pylor
sphincter
motil
two
area
record
respons
continu
intraven
administr
salin
alon
octapeptid
dose
ugkghr
dose
level
ugkghr
motil
antrum
pylor
sphincter
increas
control
motil
obtain
salin
infus
observ
indic
ctermin
octapeptid
cck
stimul
motor
activ
antrum
pylor
sphincter
unstimul
stomach
octapeptid
hand
caus
partial
inhibit
antral
motil
stimul
balloon
diphenylhydantoin
dph
use
treat
spastic
colon
patient
present
studi
design
see
dph
would
alter
phasic
motor
activ
contractil
state
insitu
segment
ascend
colon
termin
ileum
pentobarbit
anesthet
dog
contractil
state
indic
complianc
intestin
j
dig
di
flaccid
balloon
connect
pressur
transduc
introduc
segment
ileum
gm
colon
gm
pressur
determin
variou
balloon
volum
ml
colon
ml
ileum
complianc
calcul
divid
chang
volum
chang
pressur
complianc
segment
reach
steadi
valu
dph
mg
iv
given
follow
hour
later
neostigmin
n
mg
iv
b
n
given
follow
dph
thu
wall
termin
ileum
ascend
colon
becam
compliant
follow
dph
regardless
whether
wall
rest
condit
made
less
compliant
n
studi
also
show
n
decreas
complianc
ileum
colon
made
compliant
dph
addit
dph
also
abolish
attenu
phasic
motor
activ
colon
occur
spontan
follow
distens
deflat
lumen
phasic
activ
ileum
consist
affect
dph
dph
also
inhibit
increas
motor
activ
colon
induc
iv
infus
studi
thu
indic
intraven
infus
dph
dosag
use
decreas
contractil
state
ileum
colon
make
distens
also
decreas
phasic
activ
colon
action
colon
appear
longer
stronger
ileum
sought
local
effect
probabl
lax
compon
castor
oil
ricinol
acid
electromyogram
circular
muscl
colon
colon
taken
adult
barbiturateanesthet
cat
open
along
antimesenter
border
pin
flat
tabl
stainless
steel
mesh
mucosa
put
bath
kreb
solut
gass
remov
mucosa
expos
circular
muscl
cm
ileocec
valv
silversilv
chlorid
glass
pore
electrod
align
mm
apart
put
expos
muscl
long
axi
colon
electr
potenti
differ
electrod
common
silversilv
chlorid
refer
electrod
record
separ
ac
amplifi
inkwrit
polygraph
experi
record
made
minut
minut
addit
either
sodium
ricinol
sodium
oleat
make
bath
concentr
salt
experi
concentr
control
experi
noth
ad
bath
record
read
interv
determin
proport
time
phase
lock
slow
wave
throughout
region
studi
frequenc
appar
veloc
slow
wave
ricinol
reduc
phase
lock
slow
wave
effect
increas
concentr
p
ratio
time
phase
lock
first
minut
period
time
phase
lock
second
period
fatti
acid
oleat
increas
phase
lock
less
significantli
p
correspond
ratio
oleat
fatti
acid
neither
fatti
acid
chang
slow
wave
frequenc
appar
veloc
ricinol
appear
increas
number
pacemak
within
region
studi
mechan
local
probabl
relat
hydroxyl
fatti
acid
resembl
chang
slow
wave
associ
spontan
castor
oilinduc
diarrhea
unanesthet
restrain
rat
absorb
intraduoden
infus
triglycerid
rate
depend
infus
rate
clearli
defin
maxima
invivo
mechan
present
notlown
steadi
state
infus
trioleinc
maxim
uptak
rate
lipidc
per
unit
weight
intestin
differ
greatli
differ
region
rat
intestin
lumen
unabsorb
c
hydrolyz
extent
region
beyond
first
axim
rate
infus
thereaft
percentag
distribut
lumin
c
fatti
acid
mono
diand
triglycerid
resembl
close
system
equilibrium
lipas
excess
triglycerid
substrat
product
remov
ie
mucos
uptak
lipolyt
product
therefor
control
lipolysi
throughout
intesihn
lumen
system
steadi
state
maxim
trioleinc
infus
prolong
hour
total
mucos
concentr
lipidl
increas
despit
constant
rate
mucos
uptak
indic
presenc
intramucos
reaction
whgse
averag
rate
slower
intestin
uptak
rate
intestin
tissu
lipidl
c
concentr
differ
differ
region
steadi
state
maxim
absorpt
c
concentr
rel
low
proxim
termin
small
intestin
increas
ie
infus
period
extend
hour
transport
time
lipidc
therefor
less
hour
region
third
quarter
small
intestin
prolong
e
steadi
state
infus
hour
result
increas
tissu
lipidl
c
level
serial
measur
clinic
biochem
serolog
histopatholog
chang
determin
patient
hepat
acut
episod
week
thereaft
assess
relat
find
prognosi
presenc
haa
patient
associ
greater
predict
histolog
find
acut
viral
hepat
strikingli
abnorm
biochem
test
hepatocellular
function
parallel
increas
haa
titer
decreas
serum
level
featur
initi
ill
correl
prognosi
week
patient
judg
recov
complet
four
patient
went
develop
chronic
aggress
hepat
cah
show
either
persist
haa
serum
beyond
week
presenc
le
cell
serum
acut
stage
hepat
without
haa
patient
cah
treat
prednison
littl
evid
clinic
improv
two
patient
haa
cah
haa
titer
either
increas
remain
unchang
steroid
patient
die
within
six
month
onset
acut
ill
patient
le
cell
telescop
clinic
cours
cah
lost
le
cell
steroid
therapi
one
die
within
six
week
observ
studi
support
conclus
initi
clinic
biochem
serolog
histopatholog
chang
patient
acut
hepat
bear
relationship
ultim
prognosi
patient
haa
persist
beyond
week
acut
ill
le
cell
onset
ill
develop
cah
latter
group
cours
diseas
acceler
achalasia
long
regard
rel
uniform
function
impair
manometri
initi
demonstr
lower
esophag
sphincter
le
achalasia
normal
pressur
absent
relax
case
liie
rsport
vari
le
hypertens
incomplet
relax
case
studi
perfus
manometri
addit
physiolog
variat
note
subsequ
led
studi
patient
defin
variat
implic
clinic
radiolog
manometr
apprais
obtain
roanometri
ell
rapid
perfus
use
lcm
space
radial
orient
fix
cathet
open
test
betamethacholin
done
subject
posit
though
variabla
degre
le
pressur
significantli
higher
normal
subject
le
pressur
wae
normal
lower
normal
patient
mild
atyp
symptom
radiographi
minim
absent
le
narrow
holdup
barium
bodi
esophagua
dilat
overal
group
differ
le
swallow
respons
relax
awallow
incomplet
relax
occur
completa
relax
occur
ehow
variat
tha
axial
extant
aperiatalsi
amplitud
wave
iiihila
entir
aperistalt
subject
peristalsi
present
uppsr
sever
cm
dietal
eever
cm
small
number
other
wave
amplitud
low
absent
normal
excess
progress
describ
manometr
impair
th
le
andor
insignific
subject
followup
studi
stabl
physiolog
divers
impli
causitiv
factor
must
vari
intens
occur
on
point
time
ganglion
cell
nsurotrop
viral
infect
recent
hypothesizsd
caus
diseas
differ
degre
loa
agyrophil
neuron
supervisori
motor
control
agyrophob
neuron
cholinerg
musclsfir
besn
idsntifisd
vari
sever
extent
viral
infsction
fallout
nsuron
typss
consist
rang
admixtur
cardiospasm
achalasia
cholinerg
supsrssnsit
aperistalsi
describ
fdr
disord
esdphag
contractu
function
experiment
work
concern
effect
antacid
prepar
done
fast
subject
subject
fed
unusu
test
meal
subsequ
sampl
stric
content
perform
multipl
nasogastr
intub
may
stimul
gastric
acid
secret
corn
ph
endoradio
capsul
successor
heidelberg
capsul
permit
constant
intragastr
ph
monitor
without
gastric
intub
gastric
stimul
fifteen
normal
volunt
subject
studi
usual
american
breakfast
consist
two
scrambl
egg
two
piec
butter
toast
one
cup
coffe
one
small
glass
orang
juic
ie
g
carbohydr
g
protein
g
fat
total
calori
one
hour
finish
breakfast
patient
swallow
precalibr
corn
ph
capsul
baselin
ph
valu
ph
ph
consist
obtain
subject
swallow
cc
aluminummagnesium
hydroxid
prepar
intragastr
ph
level
rose
time
interv
ingest
antacid
subsequ
fall
intragastr
ph
ph
record
studi
perform
differ
day
use
cc
antacid
prepar
analysi
durat
effect
ie
mainten
intragastr
ph
greater
three
amount
antacid
medic
show
normal
patient
cc
aluminummagnesium
hydroxid
prepar
effect
dose
cc
cc
ca
rbenoxolon
triterpenoid
acceler
heal
ing
gastric
ulcer
ambul
patient
sinc
bi
ie
reflux
stomach
may
import
pathogenesi
gastric
ulcer
examin
whether
carbenoxolon
prevent
ucosa
l
damag
normal
fol
lo
contat
bi
ie
three
dog
heidenhain
po
uch
use
flux
hand
na
pouch
measur
three
consecut
minut
period
contact
either
mm
solut
human
bi
ie
simi
lar
control
solut
without
bile
standard
acid
solut
use
period
back
diffus
h
gain
na
pouch
increas
period
bi
ie
p
howev
pouch
previousl
repar
mgm
ca
rbenoxolon
period
day
back
diffus
h
reduc
exposur
bi
ie
p
na
gain
prepar
unprepar
pouch
experi
repeat
four
time
dog
result
examin
analysi
varianc
two
anim
experi
repeat
prepar
pouch
one
hour
day
test
result
simi
lar
prolong
pouch
prepar
carbenoxolon
increas
product
vi
ibl
ucu
pouch
si
nce
carbenoxolon
excret
high
concentr
bi
ie
effect
solut
human
bi
ie
obtain
ttube
patient
receiv
car
benoxolon
wa
examin
two
dog
bi
ie
equal
damag
unprepar
pouch
despit
carbenoxolon
content
arbenoxolon
direct
action
mucosa
reduc
back
diffus
h
across
gastric
mucosa
contact
bi
ie
chang
na
movement
uninfluenc
drug
studi
potenti
pathogenet
role
lah
activ
uc
determin
spectrophotometr
optim
assay
condit
kinet
properti
specif
activ
lah
activ
acid
phosphatas
ap
sglucuronidas
sg
arylsulfatas
nonlysosom
marker
alkalin
phosphatas
alkp
colon
mucosa
control
subject
uc
patient
specif
activ
mucos
ap
alkp
significantli
increas
p
respect
wherea
sg
activ
significantli
decreas
uc
p
histolog
normal
colon
mucosa
uc
patient
normal
lah
activ
differ
due
chang
bind
activ
particul
cellular
fraction
differ
kinet
properti
dissoci
inhibitor
stimul
activ
ap
activ
vari
invers
sg
patient
patient
although
mean
alkp
activ
increas
uc
mucosa
signific
neg
correl
r
exist
ap
alkp
patient
addit
lphenylalanin
inhibit
alkp
activ
significantli
less
uc
normal
mucosa
suggest
heterogen
increas
mucos
alkp
activ
lah
activ
isol
circul
lymphocyt
uc
normal
patient
assay
condit
optim
colon
tissu
demonstr
signific
activ
incub
normal
colon
mucosa
lymphocyt
isol
patient
uc
reproduc
lah
differ
note
uc
mucosa
compar
incub
normal
mucosa
normal
lymphocyt
conclus
lah
activ
colon
mucosa
uc
patient
differ
significantli
normal
although
individu
lah
activ
vari
lah
profil
consist
patient
patient
chang
mucos
lah
activ
uc
confin
diseas
bowel
due
lymphocyt
inflammatori
exud
sensit
lymphocyt
uc
patient
promptli
reproduc
lah
chang
detect
uc
normal
colon
suggest
lah
chang
may
occur
earli
concomit
cytopathogenet
chang
ge
lah
chang
appear
divorc
chang
nonlysosomalkp
shown
bile
secret
depend
upon
efflux
bile
salt
liver
littl
known
kinet
hepat
bile
salt
transport
studi
transport
sodium
taurochol
tc
stabl
hepatoma
cell
maintain
growth
medium
cell
incub
presenc
x
tc
c
influx
reach
steadi
state
within
minut
wherea
c
influx
proceed
exponenti
requir
hour
achiev
steadi
state
cell
first
satur
tc
preincub
high
concentr
unlabel
tc
x
expos
trace
amount
x
influx
gradual
requir
hour
c
hour
c
reach
steadi
state
efflux
cell
c
presenc
high
low
concentr
tc
medium
exponenti
hour
contrast
efflux
complet
elimin
cell
incub
c
conclud
influx
tc
passiv
process
efflux
tc
activ
process
complet
inhibit
c
efflux
appear
energi
depend
rate
limit
transport
sodium
taurochol
liver
cell
twentytwo
patient
studi
esophag
perfus
within
day
follow
esophagoscopi
use
acidpepsin
solut
n
hydrochlor
acid
contrast
salin
placebo
solut
sixteen
definit
esophag
document
photographi
four
normal
esophagu
normal
stomach
normal
esophagu
superfici
gastriti
gastric
mucosa
cardioesophag
junction
random
number
determin
use
placebo
perfus
acid
perfus
first
half
test
solut
unknown
physician
patient
second
half
test
employ
altern
solut
respons
salin
placebo
solut
provid
baselin
comparison
physician
subsequ
abl
assess
esophag
symptom
relat
acid
perfus
result
doubleblind
perfus
studi
identifi
presenc
esophag
posit
test
neg
diseas
present
test
posit
presenc
inflam
gastric
mucosa
cardioesophag
junction
recognit
signific
heartburn
good
correl
induc
symptom
spontan
symptom
suggest
mucos
compon
exist
symptom
complex
best
correl
exist
object
evid
mucos
inflamm
doubleblind
perfus
test
influenc
suggest
physician
elimin
techniqu
meaning
result
thu
achiev
report
cea
posit
approxim
patient
carcinoma
pancrea
approxim
select
patient
sever
alcohol
liver
diseas
done
cea
assay
method
thomson
eta
serum
patient
acut
andor
chronic
pancreat
alcohol
nonalcohol
sixteen
posit
alcohol
group
nine
clinic
andor
laboratori
evid
liver
diseas
four
malnourish
also
debilit
respect
pancreat
insuffici
diabet
complic
peptic
ulcer
six
year
age
neither
occult
gastrointestin
cancer
liver
diseas
account
cea
posit
patient
neither
chronic
pancreat
alon
sever
acut
episod
amylas
elev
reduc
serum
albumin
correl
cea
posit
cautiou
interpret
cea
posit
patient
alcohol
pancreat
warrant
ileal
condui
use
urinari
bladder
man
provid
unusu
opportun
follow
morpholog
c
funct
onal
chang
occur
segment
small
intestin
environ
mod
ifi
function
chang
present
studi
tritiat
thymidin
administ
patient
termin
bladder
car
cinoma
ileal
conduit
construct
nine
month
previous
biopsi
conduit
obtain
fo
r
interv
hour
dual
purpos
defin
cell
prolifer
tissu
well
describ
wide
spectrum
histolog
c
chang
seen
individu
patient
vari
degre
atrophi
present
area
blunt
broaden
villi
lay
adj
acent
area
complet
devoid
villi
label
mitosi
cur
reveal
phase
approxim
hour
gl
phase
greater
hour
replac
time
atroph
area
mucosa
base
label
index
hour
cell
per
crypt
hour
three
day
estim
replac
time
base
observ
mitot
c
frequ
nci
hour
day
histolog
kinet
inform
obtain
compar
normal
human
ileum
colon
well
clini
cal
condit
ion
character
atrophi
small
intestin
mucosa
serum
gastric
cancer
juic
appear
strong
domin
precipitin
line
doubl
diffus
agar
gel
immunodiffus
immunoelectrophoresi
preval
gastric
cancer
antigen
gca
other
share
noncanc
juic
conspicu
immun
serua
absorb
noncanc
juic
absorpt
normalhuman
plasma
gca
appear
sharp
singl
line
electrophoret
mobil
greater
gold
cea
gca
immunolog
reactiv
carbohydrat
moieti
differ
blood
group
substanc
isol
gastric
secret
highli
purifi
state
phenolethanol
extract
antigen
materi
detect
tumor
appear
secret
correspond
precipitin
line
disappear
immun
serum
absorb
gastric
cancer
juic
thu
establish
pathognomon
signific
detect
gca
may
crucial
earli
diagnosi
gastric
cancer
particularli
younger
patient
still
salvag
free
hcl
gastric
analysi
sept
investig
accord
similar
protocol
patient
age
found
less
three
defec
per
week
high
residu
diet
day
known
etiolog
abnorm
colon
perfus
gdevroed
gastroenterolog
perform
subject
age
control
isoton
solut
determin
transport
water
electrolyt
transit
time
volum
colon
group
constip
suect
longer
mean
transit
time
mlmin
vs
min
p
ol
x
se
mlmin
vs
min
p
perfus
greater
colon
volum
ml
ml
vs
ml
p
greater
absorpt
sodium
chlorid
rich
solut
sodium
water
p
proportion
absorpt
per
minut
contact
colon
mucosa
less
constip
swallow
radioopaqu
marker
retain
longer
colon
diseas
group
day
vs
p
diagnost
purpos
patient
undergon
anorect
myotomi
extend
cm
proxim
dentat
line
patient
neuron
abnorm
one
neuron
close
proxim
line
resect
defec
per
week
high
residu
diet
pool
postop
day
one
patient
mean
colon
transit
time
perfus
decreas
ml
mlmin
myotomi
retent
day
marker
decreas
colon
transport
water
electrolyt
differ
p
ool
control
patient
absorpt
return
normal
rang
h
mlmin
na
qmin
cl
peqmin
ml
mlmin
na
qmin
cl
qmin
ml
conclus
increas
absorpt
idiopath
constip
secondari
outlet
obstruct
possibl
select
patient
myotomi
simpl
object
clinic
protocol
difficult
distinguish
short
segment
hirschsprung
idiopath
constip
classic
diagnost
tool
report
incid
cea
posit
colon
cancer
vari
wide
seri
seri
use
method
thomson
et
al
perform
assay
patient
proven
colon
cancer
test
posit
patient
whose
tumor
consid
resect
oper
consid
resect
preoper
cea
level
correl
surgic
patholog
find
concentr
cea
sera
individu
patient
markedli
influenc
extent
primari
tumor
presenc
absenc
metastas
follow
extent
tumor
noo
ea
posit
cea
local
bowel
wall
extend
pericol
tissu
without
region
lymph
node
invas
metastat
distant
tissu
cea
level
ngml
greater
greater
duplic
tube
conclud
high
preoper
serum
cea
ngml
greater
correl
dissemin
tumor
impli
reduc
likelihood
cur
resect
neg
preoper
cea
correl
local
tumor
impli
cur
resect
incid
posit
depend
upon
rel
proport
earli
advanc
cancer
two
miniatur
schnauzer
one
fox
terrier
one
german
shepherd
socal
achalasia
studi
anim
fast
unrestrain
esophag
motor
activ
record
multilumen
sideopen
polyvinyl
cathet
assembl
continu
perfus
water
rate
mlmin
cine
fluoroscopi
instil
barium
esophagu
also
perform
disord
dog
exhibit
differ
compar
human
disord
symptom
invari
appear
shortli
birth
disord
dog
involv
striat
muscl
rather
smooth
muscl
present
motor
activ
seen
lower
esophagu
absent
upper
motor
acti
vi
ty
usual
peristalt
bodi
motor
activ
lower
esophag
sphincter
le
relax
complet
swallow
close
sphincter
contract
sequenc
contract
esophag
bodi
bodi
esophagu
show
hypersensit
sc
mecholyl
given
dose
mgkg
featur
note
frequent
failur
swallow
produc
bodi
motor
activ
relax
le
swallow
follow
balloon
distens
esophagu
absenc
bodi
motor
activ
normal
activ
upper
esophag
sphincter
find
suggest
achalasia
dog
differ
human
may
repres
congenit
immatur
least
motor
innerv
portion
esophag
bodi
studi
also
provid
evid
le
relax
bodi
rotor
activ
separ
entiti
believ
valid
draw
analog
chronic
activ
hepat
inflammatori
bowel
diseas
ibd
extens
search
presenc
viral
invas
warrant
ibd
epithelium
examin
detail
electron
microscopi
ibd
perform
indepth
analysi
histolog
area
colon
ibd
surgic
punch
biopsi
obtain
patient
crohn
diseas
colon
patient
ulcer
coliti
control
surgic
specimen
colon
obtain
patient
without
ibd
specimen
prepar
routin
method
electron
micrograph
obtain
vari
magnif
epithelium
unimpress
remark
promin
multi
vesicular
bodi
mvb
plasma
cell
promin
contain
endoplasm
reticulum
er
massiv
distend
secretori
product
wedg
ganglion
cell
cluster
smooth
muscl
cell
area
normal
found
capillari
endothelia
uniformli
normal
strike
membran
chang
smooth
muscl
consist
presenc
myelin
figur
replac
cytoplasm
smooth
er
presenc
great
number
mvb
condens
dens
bodi
neural
fiber
show
promin
neurotubul
increas
number
neurofila
centriol
promin
cell
element
mitochondri
dens
bodi
promin
unusu
appear
mast
cell
promin
fibrin
deposit
frequent
within
lamina
propria
presenc
elast
tissu
free
bacteria
found
within
submucosa
singl
biopsi
specimen
studi
effect
increas
intraabdomin
pressur
esophag
motor
function
subject
manometr
cathet
consist
fuse
tube
id
rom
tip
cm
apart
infus
wi
th
water
mlmin
differ
type
modal
studi
wet
allow
ws
ml
ater
bolu
dri
swallm
os
infus
fluid
aspir
dri
dri
ds
esophag
suction
abdomin
compress
ac
pressur
cuff
increment
rom
hg
caus
rom
hg
increas
intragastr
pressur
rom
hg
intragastr
pressur
rose
hg
lower
esophag
sphincter
le
pressur
rose
rom
hg
u
esophag
sphincter
ue
pressur
rose
rom
hg
ac
caus
le
move
id
cm
proxim
ue
le
relax
pressur
fell
level
intrathorac
intragastr
pressur
respect
durat
le
relax
ws
significantli
greater
sec
os
sec
durat
le
relax
increas
sec
ws
contrast
sec
os
distal
esophagu
peristalsi
associ
lith
ws
greater
amplitud
complex
durat
slmer
speed
os
intermedi
valu
obtain
os
ws
os
grade
increas
pressur
result
progress
increas
pressur
complex
durat
slow
speed
distal
esophagu
effect
os
neglig
studi
demonstr
increas
intraabdomin
pressur
result
augment
le
ue
rest
pressur
prolong
sphincter
relax
hen
bolu
present
associ
prolong
slming
peristalt
wave
distal
esophagu
ws
os
os
al
though
unknmm
mechan
effect
probabl
mediat
neural
reflex
arc
perhap
initi
esophag
stretch
abdomin
pressur
receptor
llagnitud
respons
may
relat
bolu
volum
case
hen
bolu
presen
esophagu
perform
vlork
move
bolu
pressur
caviti
thorax
caviti
higher
pressur
abdomen
pre
sure
gradient
beaeen
caviti
increas
ac
quantit
chang
peristalt
variabl
distal
esophagu
proport
gradient
studi
e
valuat
variabl
affect
fidel
manometr
record
polyvin
yl
tube
id
mm
side
hole
use
invitro
model
modifi
pope
test
pressur
complex
vari
amplitud
mmhg
durat
sec
infus
rate
ir
also
vari
ml
mi
n
result
studi
done
esophag
specimen
indic
pressur
record
accuraci
vers
relat
pressur
amplitud
test
directli
relat
durat
pressur
complex
directli
relat
ir
exampl
ir
mlmin
accur
record
pressur
wave
mmhg
amp
sec
dur
wherea
ir
mlmin
need
accur
record
pressur
complex
mmhg
amp
l
sec
duro
esophag
pressur
complex
record
hu
man
subject
use
ir
mlmin
distal
fourfifth
esophagu
record
pressur
plateau
ir
ml
min
proxim
esophagu
record
pressur
kept
ir
increas
ml
min
pressur
amplitud
rang
mmhg
distal
twothird
esophagu
pressur
trough
mmhg
exist
level
aortic
arch
mean
plitud
mmhg
record
proxim
esophagu
durat
peristalt
complex
averag
sec
proxim
esophagu
compar
sec
rest
esophagu
peristalt
pressur
complex
also
record
simulta
neousl
ident
level
infus
cathet
tip
subminiatur
strain
gage
mo
del
probe
honeywel
biomed
pressur
amplitud
record
strain
gage
affect
var
ying
ir
adjac
cathet
tip
show
esophag
pressur
profil
record
opentip
cathet
n
fuse
rapid
rate
studi
indic
peristalt
pressur
amplitud
highest
n
proxim
esophagu
ir
mlmin
permit
accur
record
pressur
amplitud
distal
fourfifth
esophagu
wherea
ir
mlmin
necessari
proxim
esophagu
strain
gage
probe
suitabl
high
fidel
record
pressur
rapid
infus
manometr
techniqu
due
result
gag
feasibl
record
pharyng
pressur
subject
record
pharyng
motil
use
strain
gage
record
system
model
probe
hone
lell
biomed
probe
consist
silicon
semiconductor
mount
cm
apart
within
sila
tic
tube
three
cathet
id
mm
ier
tie
sila
tic
tube
sidehol
record
tip
cathet
level
one
strain
gage
nasal
passag
record
assembl
esophagu
cath
ter
ier
infus
th
water
mlmin
esophag
peristalsi
via
record
assembl
vlithdrawn
cm
increment
upper
esophag
sphincter
ue
pharynx
tio
dri
swallool
ere
obtain
station
infus
cathet
discontinu
tip
enter
pharynx
ue
pressur
record
model
hobe
mm
hg
differ
significantli
record
infus
cath
ter
mm
hg
durat
ue
relax
ho
ever
record
strain
gage
less
sec
record
infus
cathet
sec
ue
augment
amplitud
consider
higher
vs
mm
hg
pharyng
pressur
profil
reveal
peristalt
pressur
amplitud
rang
mm
hg
hypopharynx
pressur
trough
mm
hg
oropharynx
amplitud
mm
hg
velopharyng
channel
uninfus
cathet
record
pressur
mm
hg
atmospher
pressur
exist
nasal
canal
durat
pharyng
peristalt
complex
decreas
abor
measur
sec
velopharyng
channel
sec
hypopharynx
peristalt
wave
speed
rang
cmsec
compar
esophag
peri
talsi
peak
peri
tal
tic
amplitud
pharynx
sub
tantial
higher
durat
peristalt
complex
shorter
wave
speed
much
faster
strain
gage
probe
suitabl
method
accur
measur
peak
pressur
transient
gener
pharyng
peristalsi
believ
accur
determin
pharyng
peristalt
variabl
iill
result
precis
character
normal
pharyng
function
better
evalu
pharyng
motil
disord
ulcerogen
effect
exogen
administ
serotonin
led
investig
possibl
role
amin
pathogenesi
acut
stress
ulcer
stress
restraint
cold
induc
ulcer
studi
rat
glandular
stomach
assay
serotonin
fluorometr
also
two
enzym
involv
format
catabol
serotonin
decarboxylas
monoamin
oxidas
although
gastric
activ
enzym
differ
stress
unstress
rat
concentr
sepotonin
significantli
higher
stomach
stress
rat
gig
compar
control
rat
gg
vagotomi
offer
appreci
protect
restraintinduc
ulcer
effect
serotonin
concentr
stomad
either
stress
control
rat
neither
antiserotonin
compound
methysergid
cinanserin
inhibitor
serotonin
biosynthesi
pchlorophenylalanin
protect
rat
stress
ulcer
although
pchlorophenylalanin
lower
serotonin
concentr
stomach
thu
although
serotonin
concentr
appar
increas
stomach
stress
rat
concentr
seem
relat
sever
stress
ulcer
gastric
ulcer
also
induc
rat
mean
hydrocortison
administr
steroid
ulcer
differ
gastric
serotonin
rat
compar
untreat
control
vagotomi
howev
offer
mark
protect
steroid
ulcer
contrast
effect
restraint
induc
ulcer
data
suggest
differ
pathogenet
mechan
steroid
induc
ulcer
compar
restraint
cold
induc
ulcer
neither
involv
serotonin
present
studi
evid
provid
stimul
effect
histamin
gastric
acid
secret
mediat
cyclic
monophosph
cyclic
amp
male
wistar
rat
g
b
w
content
cyclic
amp
unstimul
gastric
mucosa
nmole
g
wet
wt
obtain
isotop
dilut
procedur
purif
cyclic
nucleotid
subsequ
determin
enzymat
cycl
gastric
acid
output
determin
ing
lai
perfus
rat
stomach
prepar
shown
increas
increas
dose
histamin
diphosph
hdp
given
subcutan
dose
mg
hdp
kg
rise
acid
secret
correl
dosedepend
increas
cyclic
amp
content
gastric
mucosa
correl
coeffici
ro
degre
freedom
order
elicit
tempor
correl
effect
hdp
gastric
mucos
level
cyclic
amp
secretori
respons
hdp
mgkg
applic
rapidli
intraven
inject
subsequ
cyclic
amp
level
gastric
mucosa
increas
within
minut
preced
secretori
reaction
adrenalectom
rat
subcutan
administ
hdp
produc
minor
rise
gastric
acid
output
cyclic
amp
content
gastric
mucosa
wherea
hdp
fulli
stimul
anim
replac
therapi
dexamethason
rat
intact
adren
dexamethason
enhanc
histaminestimul
gastric
secret
cyclic
amp
product
accord
result
histamin
suggest
stimul
gastric
secret
via
increas
format
cyclic
amp
render
possibl
permiss
role
glucocorticoid
studi
support
grant
deutsch
forschungsgemeinschaft
bad
godesberg
west
germani
stifel
fb
et
al
activ
transport
mcmanu
jpa
isselbach
k
j
gastroenterolog
well
establish
howev
effect
dietari
manipul
intestin
dipeptidas
activ
unknown
decreas
activ
certain
jejun
dipeptidas
presenc
normal
small
bowel
morpholog
observ
undernutrit
kumar
v
chase
hp
clinr
purpos
present
studi
determin
whether
intestin
mucos
dipeptidas
glycylprolin
hydrolas
regul
specif
intralumin
substrat
intraduoden
canula
insert
via
gastrostomi
group
male
spragu
dawley
rat
weigh
anim
restrain
bollman
cage
infus
either
glycylprolin
mixtur
glycin
prolin
rate
mlhr
hour
ten
control
anim
infus
intraduoden
physiolog
electrolyt
solut
hour
anim
sacrif
scrape
intestin
mucosa
obtain
upper
jejunum
lower
ileum
activ
mucos
dipeptidas
glycylprolin
valylprolin
hydrolas
measur
method
josefsson
lindberg
express
umg
protein
jejun
glycylprolin
hydrolas
activ
mean
sem
glycylprolin
group
significantli
greater
eitherth
electrolyt
glycin
nd
prolin
group
p
adapt
chang
appear
mark
ileum
anim
infus
intact
dipeptid
mean
ileal
glycylprolin
hydrolas
activ
compar
electrolyt
p
amino
acid
p
ool
group
respectivelyther
statist
differ
valylprolin
hydrolas
activ
either
group
data
would
suggest
intestin
glycylprolin
hydrolas
activ
regul
specif
intralumin
substrat
vagal
stimul
man
use
insulininduc
hypoglycemia
evok
variabl
respons
serum
gastrin
level
worker
conclud
stimulu
result
signific
gastrin
releas
latter
hypothesi
howev
ignor
inhibit
gastrin
releas
antral
acidif
well
nongastrin
mediat
stimul
gastric
acid
product
insulin
hypoglycemia
investig
effect
antral
ph
gastrin
releas
studi
serum
gastrin
respons
insulin
induc
hypoglycemia
normal
subject
patient
pernici
anemia
evalu
effect
serum
gastrin
level
antral
acidif
achlorhydr
patient
antacid
normal
subject
normal
subject
insulin
induc
hypoglycemia
produc
mean
increas
serum
gastrin
picogram
per
ml
pgml
administr
antacid
suffici
maintain
antral
ph
result
serum
gastrin
elev
pgml
addit
insulin
hypoglycemia
produc
elev
pgml
patient
pernici
anemia
show
increas
pgml
follow
insulin
administr
antral
acidif
produc
prompt
decreas
serum
gastrin
gastrin
respons
hypoglycemia
complet
abolish
conclus
vagal
stimul
potent
stimulu
gastrin
releas
man
releas
may
abol
ish
antral
acidif
differ
antral
ph
may
explain
variabl
respons
normal
subject
patient
duoden
ulcer
studi
esophag
manometri
preoper
month
later
vagotomi
either
pyloroplasti
gastroenterostomi
pe
rform
polya
p
rtial
gastrectomi
without
vagotomi
use
nonperfus
water
fill
open
tip
int
diam
rom
mean
maximum
pressur
intragastr
cm
h
zone
elev
pressur
zep
cm
long
differ
mean
maximum
intragastr
pressur
opentip
unchang
follow
vagotomi
draina
reduc
significantli
partial
astrectomi
cm
h
p
zep
shorten
group
cm
cm
p
paramet
also
significantli
differ
measur
balloon
mean
intragastr
pressur
opentip
increas
group
postop
cm
h
p
manometr
find
suggest
gastroesophag
sphincter
impair
follow
vagotomi
drainag
oper
techniqu
increas
incid
hiatal
hernia
follow
either
type
oper
attempt
made
measur
reflux
follow
partial
gastrectomi
like
due
weak
sphincter
hiatal
hernia
low
pressur
follow
partial
gastrectomi
may
due
remov
antrum
produc
gastrin
ulcer
coliti
uc
mucos
diseas
unknown
etiolog
epitheli
cell
renew
may
alter
investig
report
increas
wherea
other
describ
decreas
epitheli
cell
prolifer
uc
use
shortterm
hr
vitro
dna
label
method
describ
studi
epitheli
cell
renew
uc
normal
rectal
mucosa
use
organ
cultur
method
shown
maintain
mucos
viabil
continu
epitheli
cell
renew
small
intestin
least
hr
j
clin
invest
suction
rectal
biopsi
obtain
patient
uc
normal
incub
biopsi
subject
hcontain
medium
hr
specimen
remov
cultur
specimen
allow
continu
cultur
isotopefre
medium
addit
hr
light
electron
microscopi
reveal
excel
preserv
mucos
architectur
epitheli
cell
morpholog
hr
cultur
quantit
epitheli
cell
renew
radioautograph
l
section
eponembed
tissu
prepar
hr
cultur
mean
epitheli
cell
lower
crypt
label
label
index
uc
wherea
mean
label
normal
moreov
twice
mani
label
epitheli
cell
seen
upper
crypt
uc
normal
occasion
surfac
epitheli
cell
label
hr
uc
section
wherea
surfac
epitheli
cell
label
normal
hr
label
cell
upper
crypt
increas
cellscrypt
label
surfac
cell
uc
compar
label
cellscrypt
label
surfac
cellssect
normal
studi
indic
human
rectal
biopsi
remain
viabl
vitro
organ
cultur
least
hr
epitheli
cell
prolifer
migrat
acceler
ulcer
coliti
document
twofold
increas
label
index
hr
migrat
mani
label
cell
upper
crypt
absorpt
surfac
hr
cultur
organ
cultur
may
appli
studi
metabol
process
ulcer
coliti
rectal
mucos
diseas
mysiolog
characterist
human
pylor
sfhincter
robert
fisher
sidney
cohen
hospit
univers
pennsylvania
va
hospit
hrlla
pa
gener
accept
human
pyloru
independ
sphincter
properti
howev
conclus
base
upon
manometr
studi
perfon
method
consid
insensit
defin
p
ysiolog
characterist
human
pyloru
infus
opentip
cathet
slowli
withdrawn
duodenum
stomach
normal
subject
mucosa
skin
kcl
potenti
differ
pd
monitor
precis
local
gastroduoden
junction
basal
state
high
pressur
zone
em
mean
se
length
detect
zone
pressur
ddll
hg
intraabdomin
pressur
close
associ
pd
chang
declin
pylor
pressur
preced
antral
peristalsi
duoden
acidif
oln
hcl
meq
hour
significantli
increas
pylor
pressur
ddll
hg
p
ool
salin
perfus
caus
signific
chang
use
phenol
red
marker
renux
duoden
infus
stomach
perfus
salin
compar
duodenogastr
renux
acidif
elev
pylor
pressur
associ
decreas
pylor
renux
endogen
hormon
releas
duoden
instil
oliv
oil
caus
increas
ddll
hg
p
amino
acid
infus
produc
increas
ddll
hg
p
ol
final
intraven
administr
cholecystokinin
secretin
produc
signific
elev
pylor
pressur
respons
cholecystokinin
infus
loukghr
pylor
pressur
increas
ddll
hg
p
respons
secretin
loukghr
pressur
increas
ddll
hg
p
elev
pylor
pressur
respons
individu
exogen
hormon
administr
less
caus
endogen
hormon
releas
studi
indic
human
pyloru
associ
zone
elev
pressur
relax
preced
antral
peristalsi
high
pressur
zone
increas
tone
respons
endogen
hormon
releas
exogen
hormon
administr
increas
pylor
pressur
diminish
duodenogastr
renux
data
conclud
lruman
pyloru
function
hormonallyregul
siolog
sphincter
previou
studi
indic
perman
mucos
damag
respons
transport
chang
acid
test
solut
introduc
human
jejunum
determin
import
proton
amino
acid
side
chain
mechan
reduc
absorpt
intestin
absorpt
rate
free
amino
acid
long
leucin
short
glycin
side
chain
investig
presenc
absenc
excess
h
lumen
util
constant
situ
perfus
techniqu
test
solut
contain
mm
leucin
mm
nacl
ph
either
infus
jejun
segment
separ
occas
test
solut
contain
mm
glycin
mm
nacl
ph
either
infus
segment
mean
intralumin
phi
infus
neutral
acid
test
solut
respect
acidif
modestli
decreas
leucin
absorpt
rate
umolesmincm
sever
reduc
glycin
absorpt
rate
umolesmincm
p
sinc
enzymat
digest
markedli
retard
acid
milieu
follow
studi
perform
determin
whether
jejun
disappear
rate
glycylleucin
glycylglycin
also
alter
intralumin
ph
consider
reduc
glycylleucin
excel
glycylglycin
poor
substrat
membranebound
enzym
concentr
dipeptid
solut
mm
ph
test
solut
well
chang
intralumin
ph
similar
free
amino
acid
studi
acidif
intralumin
fluid
decreas
disappear
rate
glycylleucin
so
glycylglycin
umolesmincm
howev
consider
glycin
absorpt
umol
mincm
acidifi
glycylglycin
solut
data
indic
introduct
posit
charg
side
chain
may
account
reduc
rate
disappear
free
amino
acid
dipeptid
human
intestin
acid
milieu
profound
reduct
absorpt
rate
glycin
rate
could
consider
increas
present
glycin
dipeptid
instead
free
form
intestin
mucosa
intestin
surfac
glycoprotein
mucu
may
elabor
secret
respons
extern
stimuli
stimuli
present
unknown
sinc
cyclic
amp
mediat
mani
hormon
action
studi
initi
determin
whether
stimuli
known
rais
intracellular
cyclic
amp
level
would
affect
intestin
glycoprotein
synthesi
intestin
slice
incub
min
modifi
kreb
medium
uc
glucosamin
glycoprotein
synthesi
estim
radioact
incorpor
acid
precipit
protein
incorpor
enhanc
theophyllin
isoproterenol
epinephrin
combin
either
isoproterenol
epinephrin
theophyllin
result
greatli
increas
incorpor
isop
theoph
epineph
theoph
suggest
maxim
intracellular
cyclic
amp
level
attain
simultan
stimul
adenyl
cyclas
inhibit
phosphodiesteras
dibutyryl
camp
stimul
incorpor
compar
level
cycloheximid
complet
abolish
stimulatori
effect
isoproterenol
theophyllin
subcellular
fraction
intestin
slice
incub
dibutyryl
camp
show
synthesi
cellular
glycoprotein
fraction
stimul
equal
intestin
glycoprotein
synthesi
therefor
respond
p
adrenerg
stimuli
mediat
camp
glycocalyx
mucu
secret
may
subject
rapid
hormon
modif
four
subsequ
die
five
ten
year
followup
studi
avail
ten
patient
known
cystic
fibrosi
sinc
infanc
three
diseas
discov
age
nutrit
rang
poor
fair
pulmonari
involv
rang
mild
sever
gross
steatorrhea
four
essenti
normal
fecal
fat
fecal
nitrogen
pancreat
replac
effect
nutrit
metabol
balanc
discuss
intraduoden
enzym
level
follow
pancreat
replac
discuss
cours
diseas
pancreat
pulmonari
aspect
discuss
irrit
colon
syndrom
includ
varieti
colon
disturb
occurrinq
absenc
organ
diseas
addit
colon
motor
dysfunct
clinic
studi
suggest
irrit
syndrom
may
also
encompass
disord
qastric
small
bowel
motor
function
twelv
intralumin
oressur
studi
oerform
five
male
one
femal
oatient
patient
select
typic
clinic
criteria
irrit
colon
syndrom
lonq
histori
intermitt
recurr
abdomin
cramp
andor
diarrhea
normal
ohys
examin
sigmoidoscopi
barium
enema
examin
gi
small
bowel
xray
intralumin
pressur
studi
oerform
assembl
three
oolyvinyl
tube
havinq
mm
oval
apertur
throuqh
intralumin
pressur
record
apertur
cm
apart
pressur
sanborn
transduc
polyviso
record
studi
nerform
includ
basal
studi
overniqht
fast
b
qastric
sb
reactiv
inqest
standard
element
low
residu
liquid
diet
c
qastric
sb
reactiv
mg
prostigmin
sc
result
compar
orevi
studi
normal
patient
result
demonstr
mark
increas
total
basal
activ
patient
studi
type
iii
activ
siqnificantli
greater
normal
patient
follow
ingest
standard
element
low
residu
diet
irrit
bowel
patient
show
greater
reactiv
predomin
type
wave
mark
pharmacolog
hyperreact
prostigmin
dramat
increas
type
iii
activ
sb
type
ii
activ
stomach
note
suqgest
irrit
bowel
syndrom
univers
affect
gastrointestin
tract
hyperreact
gastric
small
bowel
motor
function
part
syndrom
current
lsc
requir
nullifi
transmur
electr
potenti
differ
jejunum
strip
musculari
observ
previous
less
isc
strip
ileum
suggest
quantit
qualit
differ
ion
transport
exist
two
segment
intestin
present
studi
isotop
na
cl
flux
measur
simultan
across
shortcircuit
strip
jejunum
obtain
distal
ligament
treitz
mount
lucit
chamber
side
tissu
bath
ringer
solut
result
given
mean
eqhr
cm
se
mucos
seros
flux
j
na
less
jsm
result
secretori
net
flux
jnet
p
nlo
net
cl
transport
neglig
nlo
bidirect
na
flux
measur
two
flux
period
control
tissu
indic
jm
jsm
jnet
chang
significantli
nlo
follow
baselin
flux
period
show
net
na
secret
glucos
mm
ad
mucos
bath
solut
jm
increas
p
jsm
chang
p
jnet
neglig
p
nlo
increas
jm
chang
jnet
significantli
differ
increas
isc
glucos
p
theophyllin
mm
ad
seros
bath
solut
caus
transient
increas
isc
alter
net
na
p
net
cl
p
flux
nlo
chang
occur
net
flux
control
tissu
nlo
secret
na
neglig
net
cl
transport
across
proxim
jejunum
contrast
previou
observ
absorpt
ion
across
termin
ileum
studi
ident
condit
effect
glucos
na
flux
isc
jejunum
suggest
two
independ
opposit
direct
na
transport
process
presenc
neglig
net
na
transport
one
na
transport
process
howev
coupl
metabolit
transport
contrast
neglig
effect
jejunum
theophyllin
shown
previous
stimul
secret
na
cl
across
ileum
report
near
physiolog
dose
pancreat
glucagon
gl
decreas
net
na
h
absorpt
well
flow
veloc
hu
man
jejunum
steadyst
perfuslon
view
recent
report
scienc
gl
caus
mark
incres
secret
canin
small
bowel
question
aros
whether
observ
decreas
net
absorpt
studi
actual
due
increas
intestin
secret
hypothesi
evalu
slow
marker
intestin
perfus
isoton
peg
plu
dmannitol
infus
mlmin
ligament
treitz
sampl
jejunum
ileum
everi
min
data
obtain
fro
normal
subject
hour
perfus
hour
control
period
gmin
gl
given
intraven
hour
sampl
continu
co
vitamin
bl
dyedilut
curv
obtain
intraven
gl
infus
gl
nad
effect
flow
rate
mlmin
composit
fast
intestin
content
ric
jejunum
ileu
contrast
flow
veloc
cmmin
ric
decreas
cmmin
jeju
num
cmmin
ileum
calcul
volum
ric
contain
small
intestin
increas
fold
ml
ml
gl
infus
chang
similar
observ
effect
parenter
atropin
studi
method
result
support
hypothesi
glinduc
decreas
net
absorpt
due
increas
intestin
secret
rather
suggest
glucagon
interfer
absorpt
mechan
directli
patient
diagnos
past
two
year
adenocarcinoma
stomach
lesion
origin
includ
cardioesophag
junction
sever
cytolog
endoscop
biopsi
fail
prove
etiolog
esophag
stenosi
discov
laparotomi
esophag
manometri
perform
preoper
eight
patient
fundal
adenocarcinoma
perfus
cathet
side
open
cm
apart
glass
ph
electrod
attach
distal
cathet
use
result
two
studi
normal
six
patient
entir
aperistalt
swallow
wave
diminish
amplitud
two
sphincter
pressur
increas
two
markedli
diminish
two
assembl
tube
could
enter
stomach
mecholyl
test
perform
three
patient
posit
three
six
patient
manometri
test
suggest
patient
strictur
might
malign
one
patient
appar
benign
strictur
aperistalt
swallow
wave
low
amplitud
neg
mecholyl
test
adenocarcinoma
cardioesophag
junction
common
lesion
preoper
diagnosi
may
suggest
esophag
manometri
demonstr
motil
pattern
achalasia
posit
mecholyl
test
variabl
sphincter
pressur
manometri
therefor
may
use
diagnosi
lesion
cardioesophag
junction
increas
plasma
level
mitochondri
enzym
report
frequent
fol
low
ingest
ethyl
alcohol
littl
inform
avai
labl
concern
releas
lysosom
hydrolas
arylsulfatas
arylsulf
sulfohydrolas
catalyz
hydrolysi
arylsulf
widespread
mammalian
tissu
especi
liver
kidney
pancrea
supraren
gland
assay
arylsulfatas
activ
tissu
extract
plasma
carri
studi
highli
sensit
method
rinderknecht
h
et
al
ci
chim
acta
use
methylumbel
iferon
sulfat
substrat
unit
arylsulfatas
activ
express
mole
methylumbeliferon
iber
per
minut
substrat
arylsulfatas
determin
extract
human
liver
u
kidney
u
pancrea
u
heart
u
skelet
muscl
u
concentr
enzym
organ
repres
mean
differ
extract
express
ug
wet
tissu
plasma
va
ue
express
um
mean
norma
subj
ect
patient
acut
alcohol
ic
intox
comparison
two
group
show
highli
signific
differ
p
student
test
find
simi
lar
report
bglucuronidas
activ
geoka
c
et
al
gastroenterolog
may
constitut
addit
evid
increas
permeabl
intracellular
membran
effect
alcohol
variou
organ
especi
liver
enzym
like
protein
antigen
catalyt
action
usual
reduc
correspond
antibodi
stuni
specif
antisera
obtain
immun
rabbit
bovin
achymotrypsin
trypsin
freund
adjuv
isol
yg
globul
fraction
normal
immun
rabbit
sera
result
effect
el
imin
nonspeci
fic
antiproteas
activ
allow
studi
inhibit
antibodi
presenc
two
type
substrat
remazolbri
liant
bluehid
rbbh
high
molecular
weight
protein
substrat
chymotrypsin
trypsin
lol
l
molecular
weight
benzoylarginin
pnitroanilid
bapna
trypsin
acetylltyrosin
ethyl
ester
ate
chymotryosin
complet
inhibit
proteolysi
rbbh
observ
b
ychymotryosin
low
level
homolog
antibodi
wherea
achymotrypsin
requir
three
time
amoun
th
ate
nh
bit
chymot
ryp
ns
exceed
zone
antibodi
excess
wherea
complet
inhibit
proteolysi
trypsin
rbbh
low
level
homolog
antibodi
also
observ
amidas
activ
trypsin
baprla
decreas
per
cent
normal
rabbit
yg
concentr
time
need
complet
inhibit
immun
yg
show
negl
igibl
inhibit
trypsin
chymotrypsin
rbbh
hoever
normal
yg
enhanc
enzym
activ
ate
bapna
per
cent
four
chymotrypsin
wei
trypsin
complet
inhibit
stoichiometr
quantiti
mol
mole
chymotrypsin
trypsin
rbbh
substrat
complex
show
practic
unimpair
activ
ate
activ
complex
bapna
per
cent
less
free
enzym
inhibit
trypsin
antibodi
conclud
iliat
inhibit
peptidas
thei
r
antibodi
di
rectli
relat
size
substrat
inhibitori
effect
result
steric
hind
ranc
ileal
jejun
function
region
enter
evalu
prospect
larg
seri
patient
perform
schill
test
hour
fecal
fat
determin
xylos
excret
test
two
hour
serum
level
gm
dose
addit
jejun
perfus
measur
absorpt
folic
acid
glucos
sodium
water
jejun
cultur
jejun
biopsi
perform
select
patient
result
correl
clinic
laboratori
xray
surgic
data
patient
divid
four
group
surgeri
ns
surgeri
recurr
snr
surgeri
recurr
sr
short
bowel
sb
jejun
present
four
patient
asid
sb
group
signific
factor
signific
differ
ns
sr
schill
p
fat
p
sr
sb
fat
p
exclud
sb
group
gross
abnorm
fecal
fat
excret
rest
appear
correl
better
schill
xylos
patient
steatorrhea
schill
test
perform
low
absorpt
steatorrhea
xylos
test
low
absorpt
jejun
perfus
reveal
normal
absorpt
ail
patient
studi
ns
snr
sr
sb
jejun
biopsi
taken
patient
low
xylos
excret
normal
jejun
cultur
taken
patient
low
xylos
steatorrhea
yield
signific
bacteri
overgrowth
studi
indic
signific
impair
fat
absorpt
especi
surgeri
recurr
steatorrhea
appear
associ
ileal
rather
jejun
dysfunct
jejun
function
preserv
patient
though
malabsorpt
xylos
yet
unexplain
occur
salmonella
enter
studi
inject
strain
salmonella
typhimurium
ligat
loop
rabbit
ileum
strain
fulli
virul
caus
death
mice
guinea
pig
diarrhea
rhesu
monkey
strain
lack
attribut
rabbit
sacrif
hr
heart
blood
liver
spleen
cultur
loop
reaction
note
fluid
volum
measur
tissu
examin
light
fluoresc
microscopi
also
hela
cell
monolay
infect
examin
hr
invas
cell
death
strain
caus
posit
loop
reaction
secret
fluid
soon
hr
differ
doserespons
rate
fluid
secret
strain
organ
caus
fluid
secret
fulli
virul
strain
posit
liver
spleen
cultur
regularli
seen
hr
none
note
time
interv
focal
morpholog
lesion
seen
hr
e
collect
poli
crypt
villi
small
area
ulcer
degener
overli
epithelium
lesion
involv
villi
interven
villi
normal
increas
time
proport
affect
villi
increas
villi
affect
hr
numer
salmonella
seen
area
well
within
epitheli
cell
lamina
propria
peyer
patch
latter
associ
lymphocyt
blast
transform
full
blown
lesion
demonstr
destruct
villi
prolifer
crypt
massiv
infiltr
poli
widespread
antigen
stain
hela
cell
cultur
strain
invad
earli
hr
compar
number
howev
nil
began
kill
monolay
hr
virtual
cell
kill
hr
caus
minim
cell
death
thu
salmonella
typhimurium
caus
posit
rabbit
ileal
loop
test
similar
enter
pathogen
invas
mucosa
occur
elicit
acut
inflammatori
reaction
ultim
destruct
mucosa
differ
strain
abil
spread
beyond
bowel
presum
relat
known
inabl
multipli
surviv
within
macrophag
studi
underway
determin
whether
enterotoxin
may
particip
morpholog
secretori
abnorm
cite
two
group
children
investig
compar
finger
pulp
circul
index
autonom
function
respons
stress
induc
cold
pressor
test
patient
age
year
control
age
year
photoelectr
hemodensitomet
appli
thumb
measur
peripher
circulatori
respons
second
immers
opposit
hand
cold
water
degre
chang
express
percentag
baselin
measur
withth
patient
rest
mean
calcul
group
maximum
reduct
flow
similar
group
viz
control
children
recurr
abdomin
pain
rap
signific
differ
rate
achiev
maximum
reduct
similarli
initi
time
recoveri
baselin
second
respect
highli
signific
differ
augment
flow
finger
initi
recoveri
control
children
rap
find
reflect
instabl
control
peripher
arteriolar
circul
consist
previou
studi
show
unstabl
pupil
reaction
respons
stress
afford
evid
autonom
nervou
function
disturb
children
rap
exist
autoimmun
mechan
cours
gastic
atrophi
pernici
anemia
suggest
presenc
circul
pariet
cell
antibodi
pca
intrins
factor
antibodi
ifa
condit
view
import
jf
antigenantibodycompl
immun
complex
develop
tissu
lnjuri
investig
whether
immun
complex
form
gastric
mucosa
vivo
similarili
organ
whether
particip
develop
gastric
atrophi
autoimmun
mechan
use
indirect
coon
test
fluorescein
label
antiigg
anticompl
c
sera
demonstr
first
vitro
fixat
c
pariet
cell
man
follow
union
microsom
antigen
pca
thereaft
demonstr
similar
complement
fixat
pariet
cell
man
follow
union
ifa
vitro
direct
coon
test
fluorescein
label
antiigg
complement
sera
demonstr
format
immun
complex
vivo
microsom
antigen
pca
c
pariet
cell
rat
inject
daili
week
human
pca
rat
show
mark
thin
gastric
mucosa
reduct
pariet
cell
mass
size
well
hcl
output
final
rat
inject
daili
week
homolog
heterolog
ifa
rat
resp
human
demonstr
format
immun
complex
vivo
ifa
peptic
cell
produc
speci
rat
inject
show
mark
thin
gastric
mucosa
reduct
peptic
cell
mass
pepsin
output
clinic
correl
complement
fixat
atroph
gastric
mucosa
found
decreas
serum
complement
titer
pernici
anemia
patient
atroph
gastriti
gastric
atrophi
add
evid
immun
complex
form
gastric
mucosa
vivo
presenc
circul
pca
ifa
complex
may
decreas
pariet
cell
peptic
cell
mass
reduc
output
hcl
pepsin
result
least
partial
gastric
atrophi
soberman
frank
j
veith
montefior
hospit
albert
einstein
colleg
ledicin
east
street
new
york
n
experi
clinic
segment
pancreat
transplant
indic
simpl
method
drainag
exocrin
pancrea
need
clinic
segment
pancreat
transplant
ligat
pancreat
duct
develop
consider
peripancreat
fluid
high
lase
occur
without
evid
ductal
ruptur
sourc
leakag
accompani
rapid
increas
size
transplant
innumer
advantag
retroperiton
drainag
method
requir
transplant
duodenum
open
periton
caviti
pancreaticenter
anastomosi
led
us
investig
possibl
anastomosi
pancreat
duct
uret
evalu
effect
procedur
pancrea
urinari
tract
dog
underw
right
nephrectomi
mobil
dorsal
pancreat
duct
endtoend
anastomosi
duct
cut
end
uret
polyethylen
stent
place
anastomosi
postop
serum
lase
level
rose
markedli
somogyi
ul
cc
return
control
level
day
urinari
lase
rose
markedli
remain
high
somogyi
ul
cc
serum
electrolyt
urea
nitrogen
blood
sugar
complet
urinalysi
remain
normal
two
dog
continu
surviv
without
distress
ill
effect
month
later
examin
dog
seri
month
transplant
reveal
evid
pancreat
pancreat
atrophi
damag
urinari
tract
dog
patent
anastomos
solid
heal
occur
beyond
one
week
one
diabet
patient
receiv
bodyandtail
pancrea
transplant
duct
uret
anastomosi
well
renal
transplant
blood
sugar
remain
normal
without
insulin
month
transplant
appreci
swell
although
excret
daili
much
ml
pancreat
juic
dysuria
evid
ureter
bladder
urethr
damag
urinari
lase
million
somogyi
ul
cc
thu
pancreat
duct
uret
anastomosi
appear
simpl
safe
effect
mean
provid
exocrin
drainag
pancrea
med
modifi
elimin
step
prepar
plasma
extract
dialysi
procedur
prior
assay
total
reaction
volum
reduc
ml
requir
ml
plasma
incubat
ed
overnight
c
compar
ml
ml
plasma
c
hour
respect
modifi
assay
reproduc
less
complex
routin
use
fiftyf
code
plasma
specimen
assay
cea
techniqu
good
agreement
r
modifi
assay
employ
investig
plasma
cea
level
health
histolog
proven
malign
inflammatori
bowel
diseas
biopsi
proven
chronic
activ
hepat
health
individu
plasma
cea
nglml
less
set
plasma
cea
nglml
abnorm
carcinoma
colon
rectum
patient
posit
cea
significantli
higher
p
unresect
metastat
lesion
posit
resect
lesion
posit
gastrointestin
cancer
patient
includ
primari
carcinoma
esophagu
stomach
pancr
ea
liver
posit
test
also
posit
patient
variou
extraabdomin
primari
cancer
patient
inflammatori
diseas
abdomin
organ
test
posit
chronic
activ
hepat
ulcer
coliti
neg
patient
diverticul
w
e
conclud
simplifi
techniqu
reliabl
cea
frequent
alway
elev
earli
cancer
colon
rectum
level
cea
may
relat
extent
malign
diseas
cea
may
also
elev
primari
cancer
organ
test
must
interpret
cautious
n
presenc
inflammatori
diseas
liver
intestin
test
usual
differenti
variou
condit
health
cooper
et
al
scienc
scienc
demonstr
calcitonin
secret
porcin
thyroid
stimul
pentagastrin
relat
man
studi
interrelationship
hormon
simultan
subject
high
endogen
secret
fast
plasma
immunoreact
human
calcitonin
fast
serum
immunoreact
human
gastrin
measur
specif
radioimmunoassay
clin
re
healthi
individu
patient
histolog
proven
ze
thyroid
diseas
patient
histolog
proven
mcot
patient
normocalcem
except
one
mcot
mean
rang
group
shown
feb
press
associ
raynaud
phenomenon
esophag
motil
abnorm
patient
suggest
motil
chang
relat
impair
esophag
blood
flow
esophag
blood
flow
may
indirectli
assess
measur
time
intralumin
esophag
temperatur
return
normal
follow
ice
water
ingest
previou
studi
zboralsk
et
al
clin
re
feb
confin
scleroderma
extend
sever
ctd
modifi
util
singl
ml
swallow
ice
water
present
studi
involv
patient
scleroderma
raynaud
diseas
mctd
mix
connect
tissu
diseas
normal
volunt
esop
ageal
motil
studi
use
cineroentgenographi
intralumin
manometri
fingertip
rewarm
curv
obtain
subject
follow
minut
total
bodi
exposur
air
temperatur
subject
sit
small
thermistor
time
constant
sec
insert
esophagu
one
locat
distal
proxim
near
junction
zone
smooth
striat
muscl
thermistor
rewarm
curv
record
amplifi
signal
collect
amc
advanc
comput
medic
research
system
storag
analysi
thermistor
curv
analyz
degsec
total
period
rewarm
first
half
temperatur
rewarm
last
half
temperatur
rewarm
last
degre
temperatur
rewarm
time
sec
first
half
rewarm
signific
differ
exist
slope
first
half
rewarm
ctd
patient
normal
lower
esophagu
p
although
lesser
magnitud
signific
differ
also
exist
slope
first
half
rewarm
upper
esophagu
p
preliminari
evalu
suggest
time
first
half
rewarm
sec
may
also
significantli
differ
two
group
data
provid
addit
support
hypothesi
esophag
blood
flow
decreas
ctd
may
relat
manifest
motor
dysfunct
man
depend
upon
liver
metabol
increas
varieti
amin
medic
yet
studi
concern
amin
drug
metabol
human
liver
tissu
diseas
state
pathway
ndemethyl
altern
pathway
involv
noxid
tertiari
amin
recent
demonstr
porcin
liver
measur
ndemethyl
dem
aminopyrin
formaldehyd
ph
also
noxid
nox
n
n
dimethylanilin
oxid
ph
homogen
portion
percutan
surgic
obtain
liver
biopsi
live
patient
histolog
serum
enzym
normal
patient
mean
nox
activ
nmole
oxideminmg
protein
mean
dem
activ
nmole
mg
protein
signific
differ
found
biopsi
group
histolog
clinic
classif
normal
histolog
abnorm
serum
enzym
viral
hepat
cholang
fatti
chang
alcohol
liver
diseas
metastat
tumor
nonspecif
inflammatori
reaction
nox
cirrhot
patient
p
activ
diminish
sever
necrosi
fibrosi
relat
specif
diseas
process
age
sex
biopsi
size
patient
nox
pc
increas
rate
noxid
appear
relat
use
tranquil
amphetamin
demlo
pc
oool
barbitur
given
nox
demlo
drug
abus
suspect
conclus
noxid
demethyl
amin
substrat
demonstr
small
homogen
oj
liver
biopsi
normal
diseas
state
enzym
activ
correl
diseas
sever
specif
patholog
process
human
noxid
may
signific
metabol
pathway
previous
suspect
gctiviti
pathway
may
alter
drug
iv
c
ecysto
n
n
nstea
atti
meal
oral
cholecystographi
produc
painless
reduct
gallbladd
gb
volum
visual
common
duct
cd
control
subject
yr
period
pt
biliari
pain
visual
acalcul
gb
studi
partial
obstruct
cystic
duct
cystic
duct
syndrom
found
pt
indic
gb
volum
reduct
minim
fill
cd
reproduct
spontan
pain
women
age
mean
pain
durat
mo
requir
cholecystecto
pain
relief
anatom
caus
partial
obstruct
includ
extrins
adhes
band
sharp
bend
cystic
duct
intrins
fibromuscular
strictur
obstruct
sphincter
oddi
found
women
age
cck
respons
similarli
abnorm
cd
promin
rom
main
hepat
duct
fill
dye
group
respond
nitroglycerin
andor
anticholinerg
egress
dye
duodenum
pain
relief
suggest
spasm
remain
pta
found
oper
stenosi
reliev
sphincteroplast
cholecystecto
eract
respons
cck
volum
reduct
pain
women
men
suggest
qyperplast
cholecystos
jutra
cholecystect
pain
relief
histolog
resect
gb
show
overlap
find
group
rang
minim
moder
sever
chronic
cholecyst
featur
cholecystos
incl
rokitanskyaschofr
sinus
adenooma
cholesterol
polyp
muscular
qyperplasia
result
suggest
cck
cholecystographi
import
tool
diagnosi
character
pain
acalcul
gb
condit
cck
respons
permit
differenti
normal
gb
contract
qypercontract
impair
contract
pain
latter
caus
partial
obstruct
either
level
cystic
duct
drug
respons
separ
group
spaljlll
stenosi
effect
treatment
base
respons
cck
chronic
acaleul
cholecyst
cholecystos
cystic
duct
syndrom
may
repres
overlap
express
acalcul
gb
diseas
adequ
control
studi
treatment
irrit
bowel
syndrom
ib
report
purpos
studi
develop
test
model
clinic
evalu
therapeut
agent
condit
dilantin
test
previou
uncontrol
studi
indic
possibl
benefit
ib
prestudi
patient
evalu
includ
sigmoidoscopi
barium
enema
lactos
toler
test
psycholog
test
twelv
patient
satisfi
criteria
consent
particip
doubleblind
crossov
studi
last
week
control
period
placebo
patient
receiv
random
order
placebo
dilantin
mg
daili
ident
capsul
altern
agent
given
similar
period
follow
anoth
control
period
placebo
throughout
trial
patient
usual
treatment
regimen
remain
unchang
clinic
benefit
assess
two
way
scorecard
patient
talli
daili
rate
six
indic
physician
interview
biweekli
visit
serum
level
dilantin
also
determin
test
period
studi
result
analyz
analysi
varianc
signific
differ
p
treatment
effect
stool
frequenc
consist
frequenc
sever
abdomin
pain
overal
disabl
score
patient
physician
evalu
overal
wellb
also
differ
moreov
correl
exist
indic
neurot
tendenc
assess
psycholog
test
half
patient
frequent
sever
abdomin
pain
unrel
stool
frequenc
although
daytoday
variat
occur
index
strike
consist
observ
indic
averag
interv
sever
week
find
suggest
approach
may
prove
use
evalu
agent
use
treatment
syndrom
studi
dilantin
found
ineffect
psychotomimet
effect
marihuana
due
probabl
hydroxyl
metabolit
tetrahydrocannabinol
major
activ
alkaloid
cannabi
plant
ingest
marihuana
browni
psychotomimet
hypothes
human
small
intestin
mucosa
abl
hydroxyl
metabol
activ
previous
found
rodent
liver
took
jejun
biopsi
inform
normal
volunt
biopsi
incub
oxygenat
ed
flask
purifi
jgml
nutrient
medium
activ
fresh
biopsi
compar
control
boil
biopsi
heat
minut
prior
addit
flask
incub
extract
unchang
rf
metabolit
rf
chromatograph
separ
quantifi
three
biopsi
mg
total
wet
weight
normal
subject
convert
net
polar
metabolit
hour
experi
metabolit
format
approxim
linearli
relat
durat
incub
tissu
weight
maximum
net
convers
mg
tissu
rat
intestin
mucosa
also
abl
convert
polar
metabolit
polar
metabolit
form
human
intestin
mucosa
consist
one
major
compound
sever
minor
one
major
metabolit
chromatograph
mobil
authent
iihydroxi
thc
solvent
system
defin
rout
transport
absorb
metabolit
fed
acid
intraduoden
rat
equip
thorac
duct
fistula
hour
recov
lymph
urin
contain
fed
indic
transport
absorb
anoth
rout
thirti
minut
intact
rat
given
similar
meal
ratio
portal
blood
radioact
inferior
vena
cava
radioact
compar
conclud
human
rodent
small
intestin
mucosa
hydroxyl
rat
cannabinoid
transport
intestin
absorpt
cell
portal
venou
system
studi
involv
marihuana
administr
human
volunt
noliabsorb
hidic
clinic
studi
use
test
polyethylen
glycol
peg
phenol
red
pr
alan
j
greenwald
duan
l
barhara
reinken
harold
p
schedl
univers
icma
citi
measur
calcium
absorpt
variou
site
along
small
intestin
gave
test
meal
collect
intestin
content
use
transintestin
tube
collect
sampl
nasal
anal
end
consecut
collect
made
new
sampl
ia
begun
soon
tube
dead
space
volum
obtain
ml
test
meal
contain
calcium
chlorid
sodium
chlorid
mm
indic
studi
test
meal
bolu
enter
sampl
site
initi
set
sampl
high
ratio
initi
final
indic
concentr
ci
cf
follow
set
sampl
lower
cicf
latter
sampl
collect
rapid
rate
bulk
test
meal
pass
sampl
site
indic
comparison
sampl
g
studi
cm
nose
normal
men
age
peg
ratio
mean
se
significantli
ller
p
lcr
ratio
sampl
pair
analysi
sever
indic
compar
indicatorest
recov
give
highest
final
concentr
cf
give
llest
indic
ratio
cicf
henc
peg
recoveri
significantli
greater
cr
studi
sampl
pr
ia
also
analyz
ratio
la
peg
ratio
less
ratio
p
peg
pr
ratio
compar
total
studi
mean
peg
ratio
significantli
less
pr
p
patient
activ
granulomat
coliti
three
studi
sampl
em
solut
without
peg
gave
mean
pr
ratio
significantli
r
ratio
p
show
previous
peg
pr
lcr
instil
stomach
ph
gave
recoveri
ivey
schedl
addit
variabl
studi
includ
test
meal
ph
possibl
small
intestin
effect
studi
show
although
pr
may
use
indic
intestin
perfus
measur
intragastr
volum
ph
could
inferior
peg
given
test
meal
valid
peg
ndi
catr
es
tab
shed
experi
immedi
effect
vagal
section
gastric
submucos
deep
mucos
microvessel
mucos
blood
flow
studi
rat
exterior
stomach
anesthet
rat
na
pentobarbit
mgkg
ip
transillumin
cool
light
transmit
high
intens
light
sourc
mean
quartz
rod
care
remov
seros
muscl
layer
small
area
permit
excel
visual
submucos
deep
mucos
microvessel
photomicrograph
taken
magnif
within
minut
bilater
subdiaphragmat
vagal
resect
success
remov
nerv
trunk
confirm
histolog
instanc
measur
diamet
vessel
made
preand
postvagotomi
photograph
statist
analysi
test
pair
differ
reveal
signific
effect
vagotomi
calib
vessel
averag
preand
postvagotomi
diamet
follow
submucos
arteri
v
mucos
arteri
v
deep
mucos
capillari
v
collect
vein
v
submucos
vein
v
preliminari
studi
mucos
blood
flow
anesthet
rat
use
aminopyrin
clearanc
technic
reveal
signific
alter
follow
vagotomi
averag
mucos
blood
flow
vagotomi
mlmin
vagotomi
mlmin
conclus
anesthet
rat
vagotomi
acut
effect
either
gastric
submucos
deep
mucos
microvessel
mucos
blood
flow
report
viral
hepat
posit
titer
hepat
associ
antigen
haa
serumsicknesslik
syndrom
arthrit
manifest
may
caus
circul
immun
complex
anoth
studi
report
rheumatoid
factor
rf
present
patient
haa
posit
hepat
purpos
present
studi
determin
interrelationship
rheumatoid
factor
arthrit
manifest
haa
acut
viral
hepat
serum
patient
hepat
test
haa
use
immunoelectrophoresi
rheumatoid
factor
determin
hyland
ratest
result
present
tabular
form
studi
macroamylasemia
due
bind
amylas
immunoglobulin
g
progress
identifi
bind
site
amylas
immunoglobulin
sediment
coeffici
macroamylas
would
consist
solubl
complex
usual
antigenantibodi
ratio
yglobulin
fraction
serum
patient
macroamylasemia
precipit
satur
ammonium
sulfat
precipit
protein
dissolv
normal
salin
separ
column
agaros
gel
take
advantag
adsorpt
amylas
gel
remov
bulk
yglobulin
bind
protein
recov
elut
macroamylas
complex
ph
glycinehcl
biogel
bind
protein
concentr
obtain
fab
fc
piec
bind
protein
incub
papain
digest
materi
elut
polyacrylamid
gel
remov
whole
yglobulin
fab
fe
piec
use
specif
antisera
fab
fe
piec
precipit
studi
suggest
bind
site
amylas
fab
piec
studi
deaecellulos
purifi
fab
fc
progress
cathetertyp
semiconductor
beta
radiat
detector
system
catelix
develop
use
serial
studi
esophag
perfus
multipl
vascular
suppli
standard
techniqu
measur
esophag
blood
flow
eg
flow
meter
applic
usual
indic
fraction
techniqu
use
anim
kill
determin
util
increas
volum
lucit
cylind
isorespons
curv
catelix
detector
system
uciml
solut
determin
fiftyf
percent
maximum
count
rate
result
radioact
within
mm
detector
outer
surfac
maximum
count
rate
lay
within
mm
detector
variat
indic
fraction
techniqu
allow
serial
determin
perform
catelix
detector
pass
distal
esophagu
anesthet
cat
two
millicuri
inject
intraven
continu
record
catelix
count
versu
time
record
ten
minut
period
ten
minut
anoth
mci
inject
count
record
serial
determin
final
mci
inject
anim
sacrif
second
later
found
least
two
tumor
specif
antigen
gastric
pancreat
colon
rectal
adenocarcinoma
metastas
consid
unusu
perchlor
acid
extract
liver
metastas
gastric
adenocarcinoma
purifi
sepharos
gel
column
chromatographi
repeat
polyacrylamid
gel
electrophoresi
contain
detect
cea
use
highli
specif
antiserum
ouchterloni
gel
doubl
diffus
techniqu
accordingli
explan
neg
find
sought
specif
mask
antigen
natur
occur
antibodi
investig
cea
solubl
immunoglobulin
cea
bound
goat
antibodi
insolubl
n
perchlor
acid
percipit
extract
treat
naci
acidifi
ph
dissoci
glycoprotein
antigen
antibodi
antibodi
precipit
satur
ammonium
sulfat
exhaust
dialysi
concentr
cea
found
supernat
instanc
show
precipitin
band
highli
specif
aatiserum
also
treatment
initi
isoton
salin
homogen
tumor
naci
control
acidif
ph
hci
follow
precipit
result
presenc
antigen
supernat
subsequ
purif
antigen
sepharos
gel
column
chromatographi
repeat
polyacrylamid
gel
electrophoresi
show
similar
chemic
characterist
well
line
ident
antigen
extract
gold
method
hepat
metastas
colon
adenocarcinoma
clear
studi
presenc
cea
cancer
mask
natur
occur
substanc
like
antibodi
perchlor
acid
extract
dissoci
cea
substanc
also
possibl
cea
may
mask
natur
occur
substanc
like
antibodi
serum
give
neg
fals
low
valu
dissoci
procedur
includ
methodolog
gastric
empti
may
import
effect
drug
ahsorpt
man
studi
absorpt
acetaminophen
given
hospit
patient
x
mg
tableff
correl
absorpt
gastric
empti
measur
scintiscan
use
dtpa
chelat
gut
empti
rate
express
halftim
absorpt
drug
assess
magnitud
time
occurr
peak
plasma
concentr
cumul
urinari
excret
patient
gastric
empti
acetaminophen
absorpt
examin
simultan
ml
water
test
meal
simul
clinic
drug
administr
precis
absorpt
assess
patient
ingest
drug
ml
water
separ
studi
gastric
empti
necessari
group
la
perform
use
standard
test
meal
cornflak
sugar
milk
group
time
occurr
peak
plasma
acetaminophen
concentr
correl
significantli
log
gastric
empti
p
log
peak
concentr
show
siqnific
neg
correl
p
twentyfour
hour
recoveri
drug
relat
group
patient
gastric
empti
acetaminophen
absorpt
restudi
method
follow
iv
inject
propanthelin
gastric
enpti
significantli
retard
peak
level
acetaminophen
via
significantli
diminish
delay
convers
iv
inject
metaclopramid
increas
speed
attain
peak
level
group
subject
tablet
given
ml
water
result
indic
gastric
empti
significantli
affect
rate
absorpt
acetaminophen
given
tablet
form
normal
inrlividu
variat
empti
respons
substanti
differ
rate
absorpt
drug
gastric
empti
may
equal
import
drug
condit
clinic
administr
result
replac
esophagu
consecut
patient
use
pedicl
tube
construct
greater
curvatur
stomach
report
patient
carcinoma
carcinoma
middl
upper
third
thorac
esophagu
carcinomat
esophagu
resect
gener
excis
second
stage
procedur
patient
carcinoma
involv
cervic
esophagu
case
revers
gastric
tube
made
long
enough
anastomos
pharynx
base
tongu
twenti
patient
benign
lesion
entir
esophagu
bypass
resect
benign
group
includ
patient
stenosi
bleed
caus
esophag
lye
strictur
one
esophag
constrict
due
enlarg
heart
fortythre
patient
follow
year
patient
year
oper
postop
death
mortal
rate
includ
first
patient
oper
attempt
complic
describ
revers
gastric
tube
esophagoplasti
prove
satisfactori
method
replac
esophagu
enabl
patient
eat
regular
diet
normal
manner
intestin
brush
border
bb
catalyz
hydrolysi
larg
number
small
peptid
number
enzym
involv
substrat
specif
remain
uncertain
present
studi
papain
solubil
rat
bb
enzym
chromatograph
deaecellulos
elut
first
buffer
linear
nacl
gradient
three
well
separ
peak
peptid
hydrolas
activ
isol
iii
iv
activ
ii
minim
activ
addit
peak
appar
enzym
activ
prove
due
free
amino
acid
releas
papain
digest
quantit
assay
phegli
glyph
hydrolas
activ
reveal
phegli
split
rapidli
iii
glyph
iv
ratio
phegli
glyph
hydrolas
activ
peak
iii
iv
respect
specif
activ
phegli
hydrolas
iii
glyph
hydrolas
iv
greater
respect
specif
activ
purifi
bb
use
highvoltag
paper
electrophoresi
screen
techniqu
peak
iii
iv
shown
addit
differ
substrat
specif
enzym
iii
rapidli
hydrolyz
dipeptid
contain
basic
amino
acid
glyli
phearg
lysli
argph
also
tripeptid
test
enzym
iv
split
substrat
poorli
enzym
iv
specif
glytyr
metgli
glyleu
peptid
test
hydrolyz
approxim
equal
enzym
substrat
hydrolyz
intact
bb
also
split
either
peak
iii
peak
iv
substrat
test
hydrolyz
poorli
peak
ii
column
fraction
contain
peak
iii
iv
acrylamid
gel
electrophoresi
concentr
protein
peak
iii
iv
show
heavi
band
peptid
hydrolas
activ
peak
plu
faint
band
consist
disaccharidas
kno
present
peak
conclud
intestin
contain
least
major
peptid
hydrolas
one
specif
tripeptid
basic
dipeptid
specif
neutral
dipeptid
defin
metabol
two
moieti
cholyl
taurin
synthes
administ
healthi
volunt
bile
sampl
obtain
day
conjug
bile
acid
separ
chromatographi
specif
activ
cholyl
taurin
moieti
determin
daili
fraction
turnov
taurin
moieti
similar
cholyl
moieti
fraction
turnov
rate
individu
subject
highli
correl
suggest
cholyl
taurin
conserv
littl
deconjug
enterohepat
cycl
daili
fraction
turnov
taurin
moieti
less
half
previous
observ
us
glycin
moieti
cholyl
glycin
cholyl
moieti
appear
progress
cholyl
glycin
indic
cholyl
moieti
liber
bacteri
deconjug
absorb
conjug
predominantli
glycin
appear
dihydroxi
taurin
conjug
excret
predominantli
urin
dose
day
fraction
excretoo
hour
correl
highli
daili
fraction
turnov
taurin
moieti
taurin
urin
plasma
determin
ion
exchang
chromatographi
label
indic
absorpt
taurin
deconjug
addit
experi
absorb
instil
ileum
cecum
less
radioact
incorpor
cholyl
taurin
hour
intestin
intraven
administr
dilut
endogen
taurin
pool
sulfatetaurin
ratio
urinari
lowest
given
intraven
higher
given
oral
highest
instil
ileum
given
cholyl
suggest
bacteri
origin
urinari
sulfat
deriv
taurin
conclud
cholyl
taurin
deconjug
consider
less
cholyl
glycin
enterohepat
cycl
health
deconjug
littl
reincorpor
either
moieti
cholyl
taurin
cholyl
moieti
enter
cholyl
glycin
pool
taurin
moieti
enter
larg
taurin
pool
taurin
liber
deconjug
absorb
taurin
sulfat
produc
intestin
bacteria
micellar
solubil
greatli
increas
concentr
lipolyt
product
aqueou
phase
intestin
content
consid
import
step
fat
absorpt
man
although
studi
rat
shown
fatti
acid
micellar
form
absorb
rapidli
nonmicellar
fatti
acid
comparison
made
man
compar
rate
absorpt
proxim
jejunum
micellar
oleic
acid
emulsifi
oleic
acid
perfus
techniqu
healthi
volunt
lumen
tube
proxim
occlus
balloon
posit
fluoroscop
endogen
bile
aspir
site
proxim
balloon
test
solut
perfus
mlminut
one
hour
site
distal
balloon
collect
site
cm
distal
solut
use
random
order
subject
solut
contain
oleic
h
dilut
phosphat
buffer
ph
micellar
solut
oleic
acid
present
micellar
form
mm
taurochol
nonmicellar
solut
emuls
mgml
gum
acacia
solut
contain
rate
absorpt
assess
chang
ratio
absorpt
icellar
solut
sever
fold
faster
emuls
experi
show
micellar
fa
absorb
rapidli
nonmicellar
fatti
acid
man
specul
diseas
associ
impair
micellar
dispers
rate
fatti
acid
uptak
reduc
markedli
caus
locu
fat
absorpt
extend
throughout
small
intestin
glycin
util
conjug
bile
acid
de
novo
synthesi
primari
bile
acid
b
intestin
absorpt
primari
secondari
bile
acid
bacteri
deconjug
c
intestin
absorpt
deoxychol
acid
follow
bacteri
dehydroxyl
cholic
acid
calcul
amount
glycin
use
three
conjug
requir
synthes
three
major
glycin
conjug
bile
acid
steroid
moieti
glycin
administ
healthi
volunt
determin
specif
activ
decay
curv
moieti
partit
glycin
util
compon
part
defin
nconj
fra
tion
total
bile
acid
return
liver
conjug
assum
usual
model
enterohepat
circul
singl
well
mix
pool
steadi
state
respect
synthesi
loss
express
nconj
deriv
term
fraction
turnov
steroid
moieti
kst
glycin
moieti
kgl
recycl
frequenc
c
assum
primari
bile
acid
nconj
ckgli
ck
st
daili
glycin
requir
conjug
sum
synthesi
cp
lfab
reconjug
cp
fab
lnconj
p
pool
size
fab
fraction
absorpt
intestin
defin
bile
acid
secondari
free
bile
acid
deoxychol
origin
deconjug
dehydroxyl
henc
nconj
ckgli
c
daili
glycin
requir
involv
reconjug
cp
lncon
j
use
equat
character
fulli
metabol
glycin
conjuga
ted
bile
acid
man
heal
th
free
bile
acid
requir
conjug
form
intestin
liver
calcul
use
allow
estim
glycin
util
bile
acid
conjug
diseas
associ
either
increas
synthesi
increas
deconj
glycin
vol
absorpt
sodium
rat
small
intestin
reduc
increas
intralumin
hydrogen
ion
concentr
suggest
sodium
absorpt
hydrogen
secret
may
link
studi
influenc
intralumin
sodium
concentr
bicarbon
absorpt
perfus
jejunum
anesthet
rat
isoton
solut
contain
either
nacl
cholin
cl
buffer
mm
gass
co
j
hco
j
h
final
pco
less
n
rat
perfus
cholinet
j
eth
po
also
howev
tabl
studi
studi
ii
rssess
effect
water
movement
perfus
rat
solut
buffer
nacl
one
hyperton
mosm
kg
j
net
j
eth
final
pco
differ
significantli
despit
signific
differ
h
influenc
transmur
po
determin
studi
iii
replac
nacl
qth
na
isethion
increas
lumen
neg
mean
mv
signific
differ
occur
j
net
h
transmur
po
n
jneth
final
twenti
patient
duoden
ulcer
du
nondu
subject
given
pentagastrin
intraven
infus
grade
dose
ngkghr
dose
given
sequenti
order
list
three
min
period
peak
min
acid
output
determin
dose
test
fast
serum
gastrin
measur
radioimmunoassay
du
subject
nondu
subject
calcul
maxim
respons
cmr
dose
pentagastrin
requir
onehalf
maxim
respons
determin
comput
program
base
minim
sum
squar
observ
minu
predict
respons
equat
vx
kx
respons
x
dose
v
cmr
k
du
group
mean
significantli
p
less
mean
cmr
significantli
p
greater
compar
nondu
group
mean
serum
gastrin
significantli
p
differ
group
signific
neg
correl
r
gastrin
cmr
nondu
subject
correl
gastrin
either
group
correl
gastrin
cmr
du
group
mean
se
cmr
gastrin
ngkghr
min
pgml
du
nondu
conclud
compar
nondu
subject
du
patient
secret
acid
respons
pentagastrin
also
sensit
pentagastrin
differ
acid
secret
relat
serum
gastrin
concentr
nine
subject
repetit
belch
post
prandial
bloat
wer
studi
cinefluoroscopi
esophag
manometri
five
subject
complain
constant
belch
prior
belch
air
seen
suddenli
distend
esophagu
lower
esophag
sphincter
follow
belch
time
esophagu
complet
empti
air
esophag
manometri
reveal
entri
air
esophagu
simultan
sharp
decreas
upper
esophag
sphincter
esophag
pressur
product
belch
simultan
spikelik
increas
esophag
gastric
pressur
record
four
subject
complain
post
prandial
bloat
fluoroscop
observ
reveal
dri
swallow
entir
esophagu
becam
distend
air
carri
stomach
peristalsi
manometri
reveal
simultan
dri
swallow
deep
inspir
follow
peristalt
complex
repetit
belcher
use
deep
inspir
overcom
resist
upper
sphincter
aspir
air
esophagu
forc
contract
abdomin
thorac
wall
musculatur
forc
air
belch
post
prandial
bloater
continu
inspir
swallow
aspir
air
esophagu
carri
stomach
peristalsi
cytotox
effect
endotoxin
promin
septic
shock
larg
molecular
size
bacteri
lipopolysaccharid
make
unlik
toxin
enter
suscept
cell
alter
enzymat
process
increas
hepat
glycolysi
occur
endotoxin
shock
howev
membranebound
enzym
would
vulner
endotoxin
test
hypothesi
endotoxin
activ
membranebound
adenyl
clase
ac
therebi
increas
intracellular
cyclic
amp
camp
upon
glycolysi
depend
guinea
pig
kill
hour
inject
dose
e
coli
endotoxin
hepat
ac
activ
se
x
camp
formedmg
min
compar
control
anim
levelsof
x
min
p
vitro
incub
liver
tissu
frm
guinea
pig
show
compar
result
incub
fth
endotoxin
x
min
vs
incub
without
endotoxin
x
min
p
dialys
liver
incub
endotoxin
fall
activ
ac
conclus
endotoxin
activ
membranebound
enzym
ac
may
one
earliest
cytotox
effect
endotoxin
shock
effect
endotoxin
liver
ac
mediat
substanc
releas
organ
probabl
direct
effect
support
nih
grant
order
establish
effect
circul
gastrin
concentr
parathyroid
hormon
pth
two
experi
perform
first
five
femal
sheep
receiv
intraven
infus
human
gastrin
thu
increas
concentr
serum
gastrin
determin
radioimmunoassay
least
sixfold
postinfus
level
pth
chang
baselin
valu
secondli
level
immunoreact
pth
measur
five
patient
zollingerellison
syndrom
two
normal
level
pth
despit
elev
serum
gastrin
pgml
third
borderlin
pth
level
oper
resect
duoden
islet
cell
tumor
remain
two
patient
gastrin
pgml
respect
significantli
elev
level
circul
pth
follow
resect
ulcerogen
tumor
partial
gastrectomi
level
hormon
declin
gastrin
pgml
pth
respect
previous
found
sheep
metabol
alkalosi
result
decreas
calcium
elev
level
pth
ze
patient
increas
pth
mild
hypocalcemia
mg
massiv
gastric
hypersecret
ml
meq
hclday
experiment
clinic
data
would
suggest
relationship
gastrin
pth
seem
direct
one
patient
without
parathyroid
adenoma
indirect
factor
alkalosi
anoth
humor
mechan
appear
play
hormon
level
elev
pepsin
secret
stimul
hydrogen
ion
back
diffus
damag
gastric
mucosa
whether
acid
stimul
pepsin
secret
normal
stomach
never
test
sinc
h
usual
present
pepsin
secret
stimul
pepsin
secret
studi
three
dog
vagal
denerv
pouch
oxynt
gland
region
experi
last
three
hour
consist
twelv
ismin
collect
ml
fluid
put
pouch
begin
period
plu
secret
min
solut
mn
hcl
increas
pepsin
secret
basal
condit
pouch
irrig
phosphat
buffer
ph
solut
mn
hcl
produc
gradat
pepsin
secret
basal
level
attain
presenc
mn
hcl
intraven
infus
atropin
gkghr
topic
applic
solut
xylocain
block
pepsin
secret
intraven
infus
unit
kghr
secretin
irrig
pouch
buffer
increas
pepsin
secret
approxim
respons
found
switch
buffer
mn
hcl
combin
secretin
pouch
acidif
howev
result
increas
pepsin
output
experi
provid
evid
cholinerg
reflex
within
oxynt
gland
mucosa
contain
receptor
sensit
h
activ
lead
stimul
pepsin
secret
furthermor
studi
secretin
indic
reflex
may
one
import
physiolog
factor
regul
humor
stimul
chief
cell
antral
duoden
pressur
studi
patient
without
dyspepsia
mean
salinefil
opentip
cathet
simultan
radiolog
evid
duodenogastr
reflux
bariumsalin
suspens
obtain
screen
imag
intensifi
three
gastric
duoden
motil
pattern
associ
reflux
rapid
duoden
contract
weak
antral
contract
b
singl
strong
duoden
contract
link
antral
contract
c
variabl
duoden
contract
absent
antral
contract
reflux
observ
gastroduoden
contract
absent
close
link
metoclopramid
drug
uniqu
action
gastric
smooth
muscl
effect
treatment
flatul
dyspepsia
administ
v
lomg
found
correct
abnorm
motil
increas
strength
antral
contract
increas
linkag
antral
duoden
contract
billroth
partial
gastrectomi
drug
found
increas
strength
contract
gastric
remnant
less
effect
gastroduoden
linkag
like
use
treatment
delay
gastric
empti
oper
atropin
effect
flow
composit
bile
enterohepat
circul
artifici
maintain
infus
bile
salt
low
dosag
present
studi
done
determin
effect
atropin
flow
composit
bile
low
high
rate
bile
salt
infus
effect
intraven
sodium
taurochol
gastric
acid
secret
also
studi
four
dog
prepar
cholecystectomi
gastric
fistula
duoden
cannula
common
duct
intub
test
sodium
taurochol
infus
intraven
dosag
rang
eqmin
dose
doubl
hour
test
atropin
given
intraven
dose
mgmkg
min
follow
continu
infus
mgmkghr
throughout
experi
atropin
significantli
increas
bile
flow
rate
taurochol
infus
eqmin
effect
bile
salt
output
atropin
caus
significantli
higher
output
biliari
bicarbon
chlorid
sodium
taurochol
dose
eqmin
effect
bicarbon
chlorid
concentr
atropin
significantli
reduc
sodium
bile
salt
concentr
potassium
concentr
output
significantli
higher
atropin
taurochol
dosag
eqmin
gastric
acid
output
increas
progress
min
taurochol
infus
rate
eqmin
min
taurochol
infus
rate
eqmin
effect
block
atropin
mechan
choleret
effect
atropin
unknown
entir
due
parasympathet
blockad
studi
vagotomi
result
littl
alter
bile
volum
decreas
bicarbon
output
concentr
atropin
produc
alter
bile
volum
composit
high
low
taurocholateinduc
flow
rate
use
doserespons
curv
studi
result
first
demonstr
atropin
administr
significantli
alter
bile
flow
composit
total
intestin
peptidas
activ
found
within
cell
sap
emphasi
place
absorpt
intact
peptid
intracellular
hydrolysi
role
surfac
brush
border
peptidas
protein
digest
larg
ignor
howev
surfac
peptidas
time
specif
activ
cell
sap
enzym
biochem
distinct
leucylbnaphthylamid
lna
prove
ideal
marker
substrat
major
rat
brush
border
peptidas
analog
peptidas
human
intestin
rat
human
surfac
peptidas
purifi
zonal
gradient
centrifug
sephadex
chromatographi
ppt
singl
band
disc
electrophoresi
ph
optimum
mg
mn
zn
alter
activ
assay
natur
peptid
lamino
acid
oxidas
method
show
competit
inhibit
lna
reveal
maximum
specif
leucin
phenylalanin
methionin
aminoterminu
peptid
peptid
split
avidli
tripeptid
hydrolyz
faster
lower
substrat
concentr
dipeptid
tetrapeptid
greatest
affin
lowest
km
vmax
approach
tripeptid
expect
initi
prefer
substrat
brush
border
peptidas
block
nterminu
cbz
presenc
imino
acid
peptid
elimin
activ
henc
major
intestin
surfac
peptidas
rat
man
aminooligopeptidas
appropri
specif
strateg
locat
handl
product
pancreat
digest
virtu
differenti
affin
tetra
triand
dipeptid
permit
sequenti
scission
amino
acid
transport
cell
surfac
peptidas
like
essenti
termin
digest
major
peptid
known
rich
neutral
amino
acid
residu
absorpt
intact
peptid
probabl
restrict
predomin
glyc
ne
prolin
residu
postprandi
serum
bile
acid
sensit
test
liver
function
neil
kaplowitz
engelin
kok
norman
javitt
cornel
medic
colleg
new
york
new
york
studi
perform
evalu
sensit
fast
two
hour
postprandi
hr
pp
serum
bile
acid
concentr
compar
standard
li
ver
function
test
detect
liver
seas
serum
bile
acid
le
vel
determin
ga
liquid
chromatograph
method
five
normal
volunt
found
less
fjg
fast
hr
pp
serum
bile
acid
sampl
six
patient
viral
hepat
one
drug
hepat
increas
postprandi
bile
acid
concentr
rang
three
patient
follow
recoveri
phase
hr
pp
le
vel
abnorm
jlg
time
fast
concentr
normal
ijg
ml
bilirubin
transaminas
alkalin
phosphatas
normal
bromosulphthalein
bsp
retent
less
ten
patient
sever
chronic
li
ver
diseas
elev
fast
bile
acid
also
follow
consider
hr
pp
increas
rang
find
demonstr
need
uniform
perform
report
serum
bile
acid
level
sinc
valu
vari
sever
fold
relat
meal
enorm
uptak
capac
normal
liver
remov
return
bile
salt
load
enterohepat
circul
follow
meal
singl
serum
bile
acid
determin
two
hour
eat
appear
sensit
indic
hepat
dysfunct
bilirubin
transaminas
may
least
sensit
minut
bsp
test
purpos
studi
compar
endoscopi
convent
radiolog
diagnosi
acidpept
diseas
proxim
duodenum
olympu
gif
type
fiberscop
use
examin
consecut
patient
indic
includ
acut
chronic
upper
gi
bleed
epigastr
pain
abnorm
gastrointestin
seri
duoden
bulb
enter
case
attempt
second
portion
duodenum
enter
attempt
morbid
mortal
seri
case
duoden
ulcer
seen
endoscop
case
studi
upper
gastrointestin
seri
radiologist
diagnos
duoden
ulcer
particular
interest
case
endoscopi
show
one
crater
per
patient
radiolog
fail
document
one
crater
case
inflamm
duoden
bulb
bulbiti
note
patient
activ
ulcer
crater
duoden
without
crater
note
case
endoscop
associ
epigastr
pain
characterist
ulcer
diseas
nine
patient
biopsi
activ
duoden
show
characterist
inflammatori
chang
includ
infiltr
lamina
propria
round
cell
eosinophil
upper
gastrointestin
seri
suggest
duoden
four
case
seri
emphas
limit
radiolog
diagnosi
duoden
ulcer
clinic
signific
duoden
suggest
duodenoscopi
routin
addit
examin
proxim
duodenum
acut
bleeder
patient
chronic
upper
gastrointestin
complaint
seri
thirtytwo
postgastrectomi
patient
studi
olympu
gif
type
fiberscop
convent
upper
gastrointestin
seri
indic
includ
acut
chronic
upper
gastrointestin
bleed
epigastr
pain
vomit
dump
syndrom
group
thirteen
bilroth
ii
nine
bilroth
resect
nine
patient
vagotomi
pyloroplasti
one
gastrojejunostomi
ten
patient
activ
ulcer
crater
five
md
ulcer
sutur
line
four
jejun
margin
ulcer
one
acut
gastric
ulcer
case
sutur
line
ulcer
black
silk
sutur
seen
protrud
base
crater
sutur
materi
remov
endoscop
two
patient
one
bi
resect
one
vagotomi
pyloroplasti
low
gastric
acid
interest
observ
bacteri
growth
sutur
singl
case
cultur
taken
patient
vagotomi
pyloroplasti
heavi
growth
e
coli
obtain
symptom
present
patient
sutur
line
ulcer
rang
epigastr
pain
vomit
acut
upper
gastrointestin
bleed
two
patient
high
gastric
acid
surgic
intervent
requir
sutur
line
ulcer
suggest
one
five
patient
upper
gastrointestin
seri
sutur
line
ulcer
appear
distinct
symptomat
entiti
relat
retain
nonabsorb
sutur
materi
experi
suggest
endoscopi
necessari
part
examin
symptomat
patient
follow
gastric
resect
also
suggest
addit
sutur
materi
pathogenesi
sutur
line
ulcer
may
involv
variabl
gastric
acid
bacteri
colon
instrument
develop
insert
standar
sigmoi
doscop
obtain
cytolog
materi
visual
proxim
colon
previous
describ
date
patient
examin
instrument
prototyp
satisfactori
spe
ci
men
obtain
final
histolog
diagnos
obtain
pat
ient
underw
laparotomi
pati
ent
lesion
within
rang
sigmoido
cope
correl
exist
preoper
cytolog
final
histolog
diagnos
latter
diagnos
includ
lymphosarcoma
well
adenocarcinoma
group
includ
pat
ient
strictur
preoper
surgi
cal
biopsi
feasibl
patient
preoper
surgic
biopsi
interpret
benign
lesion
whose
cyt
olog
posit
mal
gnanci
latter
conf
irm
lapar
ot
orr
patient
sigmoid
left
colon
lesion
beyond
reach
sigmoido
cope
cancer
diagnos
pre
oper
correl
cytolog
f
inal
histolog
diagnos
l
ower
right
colon
l
ite
seri
techniqu
suitabl
gener
popul
well
higher
risk
align
perform
outpati
procedur
physician
time
patient
discomfort
kept
inimum
studi
undertaken
determin
develop
birth
intestin
glucuronidas
activ
rat
man
investig
develop
characterist
bacteria
respons
product
intestin
glucuronidas
rat
bacteri
type
betaglucuronidas
activ
absent
human
fece
birth
increas
human
rat
fece
age
rat
comparison
quantit
cultur
intestin
content
glucuronidas
activ
suggest
associ
activ
develop
anaerob
flora
antibiot
reduc
anaerob
flora
elimin
enzym
activ
rat
cecal
content
vivo
cultur
gross
cultur
rat
cecal
content
produc
glucuronidas
anaerob
condit
enzym
product
rapidli
diminish
absenc
substrat
glucuronid
isol
individu
organ
releas
glucuronidas
media
difficult
requir
mainten
strict
anaerob
condit
substrat
media
varieti
anaerob
found
produc
enzym
effect
lumin
glucuronidas
endogen
exogen
compound
excret
bile
glucuronid
conjug
consid
situat
anaerob
flora
alter
vener
diseas
may
affect
rectal
orific
may
mimic
inflammatori
bowel
diseas
report
deal
experi
gain
diagnosi
manag
four
case
gonorrh
proctiti
gcp
seen
homosexu
men
two
case
lymphogranuloma
venereum
lgv
two
case
traumat
fissureinano
seen
eightmonth
period
gcp
disturb
bowel
function
blood
mucopu
stool
tenesmu
rectal
discomfort
along
proctoscop
find
hyperemia
edema
friabil
seen
suggest
ulcer
coliti
uc
purul
exud
overli
diffus
mucos
abnorm
characterist
gcp
also
seen
patient
uc
gcp
ulcer
proctiti
mucos
abnorm
limit
rectum
uc
abnorm
seen
proctoscopi
barium
enema
extend
beyond
rectum
abnorm
confin
rectum
diagnost
confus
resolv
bacteriolog
cultur
transgrow
medium
treatment
high
dose
penicillin
tetracyclin
spectinomycin
success
case
lgv
present
bloodi
rectal
discharg
rectal
pain
defec
alter
bowel
habit
anal
mass
mistaken
hemorrhoid
perian
ulcer
present
proctoscopi
show
rectal
mucosa
sever
ulcer
inflam
narrow
barium
enema
show
rectal
strictur
rectovagin
fistula
discontinu
involv
colon
beyond
splenic
flexur
crohn
coliti
consid
initi
evalu
serolog
skin
test
confirm
presenc
lgv
despit
appropri
antibiot
treatment
symptom
unreliev
abdominalperin
resect
requir
perian
ulcer
fissur
may
initi
indic
crohn
diseas
multipl
fissuresinano
may
also
traumat
syphilit
origin
import
recogn
vener
natur
rectal
diseas
appropri
therapi
may
given
metastat
infect
may
aris
gcp
activ
partner
rectal
intercours
may
contract
gc
urethr
prompt
treatment
lgv
proctiti
may
prevent
devast
consequ
chronic
diseas
n
serwa
contain
solubl
monoamin
oxidas
mao
deamin
monoamin
studi
mao
yalu
noraal
subject
patient
acut
chronic
liver
diseaa
fortytwo
noraal
subject
age
rang
year
mean
valu
se
unit
thirtyf
patient
clinic
hiatolog
evid
hepat
cirrhosi
ean
mao
level
unita
significantli
greater
p
oool
noraal
level
contst
twentyseven
patient
acut
hepatitia
mean
mao
level
unit
thia
waa
significantli
differ
p
mean
noraal
mao
nil
significantli
less
ean
mao
cirrhot
patienta
mdition
oaitiv
correl
serna
mao
level
atandard
hepat
function
test
transaminasea
alkalin
phosphatas
bilirubin
prothrombin
time
patienta
either
acut
chronic
liver
diseas
find
indic
eley
serna
mao
relat
acut
liver
aay
reflect
develop
hepat
fibrosia
hypethesia
suprt
aniaal
studi
laboratori
preduct
experiment
hepat
fibrosi
ccla
rabbit
pretreat
valu
serum
mao
ef
unit
rose
level
unit
yalu
control
rabbit
show
signific
chang
poatmortem
eyalu
liver
hitolog
hydroxyprolin
content
confir
aark
de
hepat
fibroi
psent
treat
group
conclus
serna
mao
level
eley
liver
diaeaae
hepat
fiobi
present
relat
abnorm
liver
ensy
uniqu
enzym
aay
yaluabl
earli
clue
develop
cirrhosi
n
lincheer
describ
sever
esophag
web
balloon
cathet
mention
applic
techniqu
lower
esophag
strictur
subject
four
patient
lower
esophag
strictur
balloon
pullthrough
bougienag
two
patient
ww
eh
welldocu
peptic
esophag
result
thin
short
fibrou
strictur
third
patient
mh
welldocu
scleroderma
develop
thin
fibrou
lower
esophag
strictur
fourth
patient
md
known
hiatu
hernia
sever
year
develop
dysphagia
rather
suddenli
also
known
carcinoma
colon
radiographi
endoscopi
demonstr
strictur
somewhat
thicker
three
patient
case
esophagoscopi
biopsi
exfoli
cytolog
perform
exclud
possibl
malign
diseas
fluoroscop
control
fabric
elong
foley
cathet
prototyp
pediatr
baker
tube
adult
baker
tube
pass
stomach
balloon
fill
cc
hypaqu
cine
radiogram
taken
balloon
pull
strictur
case
balloon
pullthrough
accomplish
without
difficulti
signific
discomfort
patient
three
four
patient
ww
eh
mh
appreci
signific
improv
follow
procedur
postprocedur
barium
swallow
cine
esophagram
document
increas
diamet
lower
esophagu
one
patient
md
benefit
procedur
review
cine
radiogram
procedur
patient
demonstr
balloon
deform
passag
balloon
pullthrough
bougienag
safe
comfort
effect
treatment
lower
esophag
strictur
seem
appropri
patient
strictur
fibrou
short
origin
descript
thompson
krupey
freedman
gold
assay
system
carcinoembryon
antigen
digest
tract
cea
serum
rel
accuraci
diagnosi
colon
carcinoma
suggest
test
might
especi
use
screen
patient
popul
high
risk
develop
intestin
cancer
radioimmunoassay
employ
rabbit
anticea
label
cea
use
measur
serum
cea
patient
chronic
inflammatori
bowel
diseas
twenti
patient
clinic
patholog
document
ulcer
proctiti
crohn
diseas
ulcer
coliti
sixtyseven
patient
serum
cea
normal
rang
ngml
two
proctiti
four
crohn
diseas
four
ulcer
coliti
serum
cea
level
greater
ngml
one
ten
patient
elev
serum
cea
detect
carcinoma
colon
appar
correl
level
serum
cea
clinic
activ
diseas
patient
although
one
patient
elev
serum
cea
proven
carcinoma
possibl
exist
test
may
detect
clinic
inappar
carcinomata
premalign
state
studi
requir
determin
evalu
use
serum
cea
level
diagnosi
intestin
carcinoma
patient
chronic
inflammatori
bowel
diseas
preliminari
result
suggest
studi
would
worthwhil
acut
gastrointestin
ulcer
hemorrhag
associ
intracrani
diseas
known
clinic
sinc
rokitanski
descript
howev
pathophi
ogi
th
cond
ion
rema
ns
unc
ear
n
present
studi
gastr
c
acid
output
studi
six
adult
femal
rhesu
monkey
period
intracrani
hypertens
fol
low
twelvehour
fast
anim
anesthet
intraven
nembut
trephin
open
made
right
record
site
left
epidur
balloon
posterior
pariet
area
nasogastr
tube
insert
stomach
posit
confirm
roentgenograph
gastric
content
present
aspir
discard
system
arteri
blood
pressur
intracrani
pressur
monitor
indwel
ling
transduc
gastric
aspir
begun
carri
everi
minut
fol
low
twohour
control
period
intracrani
pressur
elev
mm
hg
ten
fold
inflat
bal
loon
epidur
space
gastric
aspir
continu
anoth
twohour
period
acut
period
intracrani
hypertens
volum
gastric
aspir
decreas
mean
cc
per
hour
control
period
cc
per
hour
p
total
acid
output
decreas
mean
meqhour
meqhour
p
period
intracrani
hypertens
mean
arteri
blood
pressur
rose
mm
hg
mm
hg
sinc
shown
rise
system
arteri
blood
pressur
period
increas
intracrani
pressur
due
peripher
vaso
constrict
includ
splanchnic
area
postul
decreas
blood
flow
stomach
studi
period
might
account
decreas
volum
acid
output
dog
vagal
innerv
gastric
pouch
pp
gastric
fistula
fistula
half
maxim
acid
respons
pentagastrin
pgkghr
urecholin
mgkghr
obtain
gastric
acid
secret
reach
plateau
either
caerulein
infus
intraven
dose
rang
ngkghr
ltryptophan
lleucin
mixtur
instil
intraduoden
rate
moleshr
releas
cholecystokinin
cck
endogen
caerulein
caus
dose
relat
inhibit
pp
respons
pentagastrin
maximum
reach
dose
kghr
caerulein
produc
dose
relat
increas
pp
respons
urecholin
maximum
reach
dose
ngkghr
endogen
cck
produc
pancreat
protein
output
equal
obtain
dose
ngkghr
caerulein
reduc
pp
respons
pentagastrin
augment
pp
respons
urecholin
follow
surgic
convers
pp
vagal
denerv
heidenhaln
pouch
hp
endogen
cck
dose
caerulein
produc
equal
rate
pancreat
protein
secret
ineffect
inhibit
pentagastrin
induc
acid
secret
hp
stimul
pentagastrin
combin
threshold
dose
urecholin
increas
suscept
hp
inhibit
caerulein
endogen
cck
addit
sensit
denerv
pouch
urecholin
profoundli
increas
caerulein
endogen
cck
augment
urecholin
induc
acid
secret
markedli
hp
pp
result
tent
conclud
cholinerg
innerv
play
direct
role
action
cck
gastric
acid
secret
seri
sigmoidoscop
biopsi
includ
clinic
ulcer
coliti
granulomat
coliti
indetermin
coliti
colon
inflamm
control
biopsi
remov
reason
analyz
seek
characterist
differ
diagnost
categori
without
prior
knowledg
diagnosi
count
made
averag
mucos
crypt
cell
per
biopsi
distinguish
mucou
goblet
epitheli
cell
besid
mitot
pyknot
karyorrhect
epitheli
cell
also
connect
tissu
cell
lamina
propria
count
per
case
includ
fibroblast
macrophag
mast
cell
lymphocyt
plasma
cell
eosinophil
neutrophil
polymorphonuclear
leukocyt
comparison
diagnost
categori
show
posit
find
fragment
epitheli
cell
time
control
mean
ulcer
coliti
goblet
cell
reduc
twothird
normal
lamina
propria
mast
cell
time
control
valu
neutrophil
time
normal
eosinophil
time
normal
drug
steroid
therapi
affect
paramet
rectosigmoid
biopsi
help
distinguish
ulcer
granulomat
coliti
base
partli
upon
cytolog
differ
reduc
goblet
cell
increas
nuclear
fragment
mast
cell
indic
ulcer
coliti
granulomat
coliti
lack
combin
cytolog
chang
approach
serv
supplement
clinic
radiolog
distinct
two
condit
blood
remov
rate
alcohol
tolbutamid
compar
enzym
level
liver
biopsi
patient
pt
repeat
studi
made
pt
wk
hospit
pt
wk
patient
sever
chronic
alcohol
free
drug
use
mo
studi
free
cirrhosi
biopsi
receiv
paraldehyd
alcohol
withdraw
drug
use
hospit
test
begun
day
admiss
pt
begun
eat
well
iv
alcohol
given
dose
gmkg
hr
follow
hourli
blood
sampl
result
express
mg
hr
blood
clearanc
halflif
min
measur
hourli
blood
level
dose
gm
iv
liver
biopsi
studi
histolog
analyz
alcohcl
dehydrogenas
adh
molmghr
microsom
ethanol
oxid
system
meo
mmolmgmin
result
test
individu
chang
rate
given
tabl
data
shown
mean
se
week
nll
alcohol
tolbutamid
metabol
slow
first
wk
fluctuat
randomli
howev
appear
meo
decreas
ten
week
interv
may
indic
chang
meo
unrel
metabol
evid
correl
chang
alcohol
remov
rate
chang
either
adh
meo
adh
meo
data
suggest
factor
activ
two
liver
enzym
rate
limit
remov
blood
alcohol
determin
whether
drug
influenc
metabol
rate
disappear
alcohol
tolbutamid
meprobam
blood
measur
singli
pair
sequenc
patient
studi
day
admiss
hospit
alcohol
given
v
dose
gm
g
hr
follow
hourli
blood
level
tolbutamid
blood
clearanc
measur
hourli
blood
level
dose
gm
v
meprobam
mg
g
given
oral
crush
tablet
blood
sampl
taken
hr
administr
alcohol
either
tolbutamid
meprobam
simultan
given
tolbutamid
given
peak
alcohol
blood
level
mg
meprobam
given
hr
alcohol
infus
begun
lowest
alcohol
blood
level
test
mg
result
tolbutamid
test
individu
chang
rate
given
correl
activ
intestin
alkalin
phosphatas
andor
calciumactiv
atpas
intestin
calcium
transport
influenc
vitamin
suggest
microvillu
phosphatas
play
function
role
intestin
calcium
absorpt
studi
undertaken
determin
relationship
alkalin
phosphatas
activ
calcium
atpas
activ
calcium
transport
duodenum
jejunum
ileum
rat
rais
calciumdefici
control
diet
calcium
transport
measur
vitro
evert
gut
sac
techniqu
use
seros
ca
mucos
sm
concentr
ratio
measur
transport
alkalin
phosphatas
calcium
atpas
activ
measur
purifi
brush
border
prepar
sm
ratio
calciumdefici
anim
mean
se
duodenum
jejunum
ileum
compar
control
duodenum
jejunum
ileum
alkalin
phosphatas
activ
calcium
defici
anim
mean
iu
se
duodenum
jejunum
ileum
compar
control
duodenum
jejunum
ileum
alcium
atpas
activ
calcium
defici
anim
mean
iu
se
odenum
jejunum
compar
control
duodenum
jejunum
ca
atpas
activ
found
ileal
segment
result
demonstr
gradient
alkalin
phosphatas
activ
calcium
atpas
correspond
part
transport
data
correl
enhanc
transport
elev
alkalin
phosphatas
activ
produc
dietari
calcium
restrict
present
duoden
segment
suggest
alkalin
phosphatas
may
particip
intestin
transport
calcium
rat
duodenum
distal
segment
diabet
hltesthlal
amino
acid
transport
siti
iowa
iowa
citi
iola
dheeraj
harold
universtudi
diabet
rat
shol
l
increas
intestin
groth
hexos
transport
disaccharidas
activ
although
intestin
sho
increas
growth
diabet
bodi
growth
occur
sinc
amino
acid
requir
growth
like
hexos
transport
link
ua
lie
studi
amino
acid
absorpt
diahet
use
aaminoisohutyr
acid
alb
metabolisz
transport
behavior
neutral
amino
acid
ie
perfus
entir
small
intestin
vivo
diabet
match
control
c
rat
day
inject
alloxan
sal
ine
c
perfus
solut
contain
alb
tracer
mm
nacl
phenol
red
end
perfus
entir
small
intestin
measur
mucosa
obtain
scrape
iith
microscop
slide
small
intestin
measur
g
data
mean
se
llere
group
day
gut
dri
wt
g
absorpt
umoleshr
p
ool
significantli
greater
ln
diabetlc
day
wet
dri
weight
whole
gut
mucosa
absorpt
blo
group
day
day
absorpt
per
rat
significantli
greater
per
unit
gut
differ
thu
day
weight
intestin
c
differ
amino
acid
transport
day
increas
intestin
growth
rat
associ
proport
increas
total
intestin
absorpt
per
rat
increas
per
unit
intestin
fit
failur
diabet
rat
grow
demonstr
select
control
transport
diabet
factor
control
hepat
blood
flow
incomplet
understood
order
evalu
differenti
effect
hormon
influenc
liver
blood
flow
clearanc
radioxenon
hepat
arteri
perfus
bed
ha
portal
vein
perfus
bed
pv
studi
parenter
administr
pitocin
glucagon
pentagastrin
purifi
prepar
cholecystikinin
secretin
studi
chronic
surgic
prepar
made
implant
separ
cathet
splenic
arteri
splenic
vein
time
splenectomi
premat
allow
recoveri
surgeri
anim
intens
studi
next
week
radioxenon
inject
via
subcutan
reservoir
splenic
arteri
splenic
vein
cathet
four
minut
clearanc
curv
obtain
right
lobe
liver
use
inch
nai
detector
specif
organ
blood
flow
calcul
disappear
rate
obtain
best
fit
analysi
use
pdpio
comput
almost
instanc
clearanc
monoexponenti
interv
anesthet
primat
specif
flow
ha
flow
via
pv
hormon
stimul
wide
differ
effect
ha
pv
flow
exampl
dose
pitocin
suffici
caus
mark
depress
pv
flow
control
valu
gradual
recoveri
complet
minut
much
less
effect
ha
caus
initi
drop
flow
recoveri
minut
inject
dose
glucagon
suffici
caus
doubl
pv
flow
increas
ha
flow
prompt
return
control
valu
pentagastrin
littl
influenc
ha
flow
pv
flow
increas
conclus
hepat
arteri
portal
vein
perfus
bed
appear
react
discret
function
entiti
respons
hormon
stimul
studi
chang
pattern
metabol
end
product
urin
brought
ingest
alcohol
could
assist
defin
pathway
alter
attribut
alcohol
metabol
examin
excret
pattern
organ
acid
alcohol
seven
chronic
alcohol
subject
three
healthi
young
male
control
seven
chronic
alcohol
four
cirrhot
three
normal
liver
physic
laboratori
biopsi
criteria
organ
acid
extract
derivat
gasliquid
chromatograph
method
mg
ec
horn
fast
urin
urin
form
hr
follow
ingest
gm
etohkg
min
acid
compon
seen
emerg
time
correspond
methylen
unit
mu
alcohol
urin
noncirrhot
alcoholi
cs
show
increas
compon
mean
jighr
decreas
compon
mean
jighr
result
net
mean
rise
jighr
cirrhot
urin
alcohol
show
increas
compon
mean
jighr
decreas
compon
mean
jghr
net
mean
fall
jighr
p
compon
show
consist
contrari
direct
chang
noncirrhot
cirrhot
subject
parahydroxyphenyl
acet
acid
phpaa
identifi
mass
spectrographi
mu
substanc
rose
alcohol
noncirrhot
mean
valu
jighr
decreas
cirrhot
subject
mean
valu
jighr
p
normal
subject
increas
decreas
output
phpaa
suggest
decreas
substanc
consequ
cirrhosi
find
suggest
gener
effect
alcohol
cirrhot
subject
inhibit
oxid
process
give
rise
urinari
acid
influenc
pronounc
noncirrhot
systemat
studi
need
measur
inhibit
variou
oxid
system
metabol
alcohol
larger
group
normal
subject
nonalcohol
ci
rrhoti
cs
willem
g
linscheer
lemuel
shattuck
hospit
tuft
univers
school
medicin
boston
massachusett
purpos
investig
compar
rate
absorpt
holeic
acid
oa
solubil
clear
micellar
nataurochol
tc
solut
equimolar
concentr
oa
mix
micellar
solut
oa
present
particl
micel
free
soap
experiment
design
two
consecut
jejun
loop
cm
rat
simultan
perfus
control
test
solut
contain
equimolar
concentr
oa
random
order
perfus
time
hr
tc
constant
control
sol
vari
test
sol
tcoa
follow
complet
perfus
two
loop
wash
isoton
salin
follow
albumin
radioact
measur
bowel
juic
emulsifi
bowel
segment
addit
histochem
studi
done
bowel
biopsi
taken
perfus
result
constant
concentr
oa
mm
tcoa
ratio
found
rat
lowest
rate
absorpt
occur
clear
micellar
solut
tcoa
gradual
increas
absorpt
found
decreas
tc
concentr
maxim
absorpt
obtain
mix
micellar
solut
tcoa
rate
absorpt
mjlmolmincm
jejunum
minimum
rate
highest
tc
concentr
tcoa
ab
rate
mjlmol
p
result
reproduc
depend
tcoa
ratio
similar
curv
obtain
lower
concentr
oa
similar
reoa
ratio
rat
toxic
effect
test
sol
observ
light
lectron
microscop
effect
due
adsorpt
oa
evidenc
albumin
lash
procedur
accumul
oa
particl
villi
microscopi
conclus
oa
better
absorb
jejun
loop
perfus
mix
micellar
solut
compar
clear
micellar
solut
invers
relationship
found
absorpt
bile
saltfa
ratio
indic
condit
absorpt
oa
tcfa
micel
optim
upper
limit
dissolv
fa
tc
micel
exceed
jame
f
lon
divis
biolog
research
schere
corpor
bloomfield
new
jersey
purpos
present
studi
determin
effect
intraven
administ
oleic
acid
gastric
secretori
respons
meat
meal
four
dog
vagal
innerv
gastric
pouch
ip
dog
vagal
denerv
pouch
dp
fed
gm
meal
ground
beef
heart
gastric
juic
collect
made
minut
interv
hour
thereaft
oleic
acid
infus
femor
vein
ueqkgmin
min
start
min
feed
solut
contain
glucos
licithin
polyethylenepolypropylen
glycol
ml
min
control
studi
perform
feed
alon
glucos
infus
infus
vehicl
oleic
acid
produc
signfic
inhibit
gastric
secret
start
min
feed
continu
durat
experiment
period
period
min
min
feed
gastric
acid
output
inhibit
ip
dog
dp
dog
five
percent
dextros
alter
gastric
secret
wherea
vehicl
produc
inhibit
ip
dog
rebound
secret
observ
result
suggest
oleic
acid
inhibit
gastric
secret
differ
mechan
recogn
exist
within
mucosa
small
intestin
iv
administ
fatti
acid
stimul
specif
inhibitori
mechan
malakoplakia
gastrointestin
tract
rare
diseas
character
grossli
soft
yellowbrown
mucos
plaqu
nodul
microscop
numer
histiocyt
contain
pathognomon
michaelisgutmann
bodi
although
infect
implic
etiolog
pathogenesi
morphogenesi
lesion
particularli
relationship
bacteri
infect
aeretofor
elucid
opportun
demonstr
bacteri
pathogenesi
ultrastructur
morphogenesi
anorect
malakoplakia
twomonth
old
infant
present
diarrhea
anal
polypoid
lesion
associ
hypogammaglobulinemia
present
death
result
age
month
gramneg
septicemia
lesion
intracellular
bacilliform
bodi
pathognomon
inclus
observ
anorect
tissu
obtain
incision
excision
biopsi
age
month
respect
also
autopsi
electron
microscop
examin
perform
tissu
fix
immedi
paraformaldehydeglutaraldehyd
fix
reveal
numer
gramneg
bacilli
vari
state
morpholog
integr
within
histiocyt
stage
phagolysosom
bacteri
degrad
found
advanc
state
phagolysosom
bodi
repres
ultrastructur
equival
typic
pasposit
granul
observ
light
microscopi
ultrastructur
focal
crystallin
deposit
show
morpholog
histochem
characterist
calcium
phosphat
found
variou
stage
morphogenesi
format
final
trace
well
form
concentr
structur
constitut
classic
michaelisgutmann
bodi
ultrastructur
relationship
intact
bacteria
phagolysosom
product
bacteri
disintegr
intracellular
precipit
deposit
calcium
phosphat
salt
pathogenesi
morphogenesi
characterist
lesion
diseas
process
present
evid
bacteri
etiolog
malakoplakia
demonstr
foundat
oklahoma
citi
oklahoma
lpx
occur
almost
case
liver
diseas
associ
histolog
surgic
proven
cholestasi
therefor
consist
paramet
diagnosi
obstruct
jaundic
semiquantit
immunoelectrophoret
method
exist
detect
lpx
cathod
migrat
agar
use
specif
antiserum
method
unequivoc
detect
lpx
quantit
difficult
sinc
depend
upon
visual
comparison
test
sampl
immunoprecipit
control
lpx
sampl
addit
antiserum
titer
vari
batch
lpxposit
control
sampl
lose
activ
month
present
method
util
cathod
migrat
lpx
agar
electrophoresi
constant
phospholipid
content
follow
electrophoresi
disc
agar
remov
cathod
sampl
well
region
lpx
would
migrat
present
disc
assay
phosphoru
standard
method
use
serial
dilut
lpxposit
sera
purifi
lpx
procedur
prove
simpl
accur
reproduc
coeffici
variat
repeat
determin
differ
sera
contain
mgioo
ml
lpx
level
lpx
mgioo
ml
lpx
coeffici
becom
higher
due
rais
level
low
densiti
lipoprotein
sera
mean
level
lpx
mgioo
ml
percent
posit
lpx
test
total
number
test
parenthes
found
variou
disord
obstruct
jaundic
respect
extra
hepat
biliari
obstruct
primari
biliari
cirrhosi
post
necrot
cirrhosi
acut
neonat
hepat
alcohol
cirrhosi
alcohol
steatosi
chronic
hpatiti
hepat
failur
quantit
assay
lpx
therefor
elimin
requir
specif
antiserum
allow
better
correl
lpx
degre
cholestasi
clinic
statu
mechan
k
secret
investig
use
unilater
prepar
frog
gastric
mucosa
bath
seros
side
buffer
ringer
contain
k
vari
concentr
rom
microsampl
ul
secret
obtain
interv
analyz
h
na
k
potenti
differ
pd
measur
continu
use
kfree
nacl
agar
bridg
lumen
secretori
k
linearli
relat
seros
k
rang
rom
seros
rom
k
rom
seros
rom
k
slope
relat
indic
k
concentr
fold
secret
initi
pd
rest
state
averag
mv
fell
rapidli
mv
incept
secret
extent
fall
predict
close
approach
expect
liquid
junction
potenti
content
particularli
h
sampl
n
nacl
bridg
possibl
calcul
electr
gradient
secret
expos
mv
similar
initi
pd
mv
somewhat
higher
k
equilibrium
potenti
conclud
k
move
passiv
instanc
electrochem
potenti
gradient
experi
control
seros
solut
rom
k
render
hyperton
addit
rom
nacl
procedur
enabl
k
secret
dissoci
h
secret
k
concentr
decreas
parallel
water
flow
h
concentr
increas
seros
secretori
osmol
studi
form
basi
model
k
secret
secretori
k
origin
labil
intracellular
compart
travers
lumin
cell
membran
water
channel
process
osmot
equilibr
distribut
secret
fluid
near
electrochem
equilibrium
model
provid
readi
explan
characterist
earli
k
transient
parallel
h
k
secret
evid
similar
vitro
secret
mammalian
vivo
secret
support
wide
valid
model
cckpz
coordin
contract
gallbladd
pancreat
enzym
secret
surgic
disrupt
mechan
may
impair
digest
therefor
defin
respons
organ
hormon
health
investig
chang
follow
denerv
vagotomi
remov
bile
reservoir
cholecystectomi
three
group
five
individu
studi
healthi
volunt
year
oper
either
vagotomi
pyloroplasti
cholecystectom
steadi
state
intraduoden
perfus
normal
salin
contain
peg
total
ou
put
bile
acid
trypsin
determin
period
iv
cckpz
given
sequenti
increas
dose
chr
ukgmin
three
consecut
collect
analyz
dose
level
health
gallbladd
contract
peak
bile
acid
output
occur
wherea
pancrea
sensit
cckpz
trypsin
secret
commenc
thereaft
exponenti
increas
output
occur
maxim
secret
establish
vagotomi
differ
effect
gallbladd
pancrea
sensit
gallbladd
cckpz
enhanc
contract
occur
addit
bile
acid
output
much
exceed
health
p
contrast
basal
trypsin
output
less
health
p
submaxim
dose
cckpz
evok
smaller
respons
p
although
maxim
enzym
output
cholecystectomi
bile
acid
output
remain
basal
level
dose
cckpz
basal
trypsin
output
threshold
respons
cckpz
health
concern
action
cckpz
conclud
pancrea
sensit
gallbladd
health
b
vagotomi
decreas
sensit
pancrea
increas
sensit
gallbladd
addit
increas
gallbladd
capac
c
cholecystectomi
predict
decreas
bile
acid
output
studi
follow
cholecystectomi
also
valid
quantit
assess
gallbladd
contract
health
vagotomi
demonstr
direct
effect
cckpz
hepat
bile
acid
output
order
studi
pathogenesi
chylou
ascit
patient
cirrhosi
test
meal
contain
medium
chain
triglycerid
mct
long
chain
triglycerid
lct
fed
alcohol
cirrhot
chylou
ascit
group
alcohol
cirrhot
nonchyl
ascit
group
b
noncirrhot
patient
chylou
ascit
due
lymphatc
obstruct
group
c
test
meal
contain
triolein
le
label
holeic
acid
trioctanoin
mole
label
coctano
acid
radioact
marker
outsid
chylomicron
fraction
determin
serial
sampl
ascit
fluid
venou
blood
period
hour
addit
ratio
triglycerid
tg
phospholipid
p
cholesterol
c
measur
reflect
cm
size
result
ascit
time
appear
hr
interv
ingest
peak
level
hr
halflif
time
hr
h
label
ascit
similar
three
group
howev
ingest
triolein
present
ascit
group
peak
level
group
b
much
group
c
p
group
cm
fraction
remain
constant
much
higher
chylou
ascit
mean
se
clear
ascit
p
serum
cm
time
lower
chylou
ascit
patient
chylou
ascit
larg
size
cm
contrast
patient
clear
ascit
small
cm
peak
serum
level
occur
patient
hour
primarili
nonesterifi
serum
ascit
cirrhot
patient
esterifi
ascit
group
c
peak
serum
concentr
cirrhot
time
higher
ascit
conclus
fat
chylou
ascit
cirrhot
exogen
origin
reach
ascit
fluid
via
intestin
lymphat
tg
incorpor
cm
primarili
larg
size
cm
intestin
lymphat
cirrhot
patient
clear
ascit
permeabl
small
cm
blood
vessel
well
intestin
lymph
vessel
contribut
ascit
format
cirrhot
chylou
ascit
enterohepat
circul
intact
chenodeoxychol
acid
cdca
slower
turnov
rate
acid
ca
et
gastroenterolog
major
compon
bile
acid
pool
ileal
resect
cdca
usual
major
bile
acid
present
measur
rate
fecal
excret
coeffici
absorpt
woodburi
kern
j
invest
simultan
five
patient
ileal
resect
one
pancreat
insuffici
sinc
biolog
effect
fecal
bile
acid
mediat
bile
acid
aqueou
solut
determin
percentag
total
fecal
radioact
ca
cdca
fecal
water
prepar
centrifug
fecal
sampl
x
g
minut
three
patient
slowest
excret
bile
acid
includ
one
pancreat
insuffici
excret
ca
rapidli
cdca
coeffici
absorpt
cdca
greater
ca
differ
small
two
two
three
percent
half
time
excret
cdca
consider
greater
three
patient
essenti
differ
excret
rate
bile
acid
two
excret
bile
acid
rapidli
four
five
hour
fecal
water
contain
larger
rel
percentag
patient
concentr
metabolit
fecal
water
vari
directli
stool
ph
aqueou
concentr
metabolit
independ
ph
three
patient
ileal
resect
studi
second
time
equilibr
homogen
liquid
diet
egg
albumin
corn
oil
sucros
consist
differ
bile
acid
kinet
proport
bile
acid
solut
fecal
water
result
show
patient
ileal
resect
cdca
absorb
effici
excret
slowli
ca
ca
solut
fecal
water
find
help
explain
mechan
underli
predomin
cdca
ileal
resect
indirect
experi
amphibian
stomach
vitro
implic
cyclic
amp
camp
intracellular
mediat
acid
secretlon
sinc
camp
synthes
ac
degrad
pdase
test
hypothet
role
camp
mammalian
stomach
vitro
measur
effect
secretagogu
canin
gastric
mucos
enzym
ac
assay
method
krishna
et
al
pdase
method
butcher
sutherland
found
l
histamin
ttoo
activ
ac
wherea
sodium
fluorid
naf
activ
ac
fold
combin
histami
naf
produc
increas
activ
naf
alon
urecholn
alon
stimul
ac
slightli
significantli
augment
stlmulatori
effect
naf
histamin
block
addit
effect
urecholin
naf
activ
gastric
pdase
unaffect
histamin
result
differ
data
obtain
amphibian
gastric
mucosa
histamin
neither
activ
ac
norinibit
pdae
dog
stomach
seem
unlik
camp
play
role
medlatlng
canln
gastrlc
secretori
respons
histamin
support
nih
grant
previou
experi
rat
subject
twothird
proxim
smallbowel
resect
subsequ
metabol
studi
perform
four
week
prior
kill
resect
rat
grew
rate
control
manifest
elev
fecal
nitrogen
second
postop
week
oral
intak
control
fell
toward
normal
fourth
week
fall
fecal
nitrogen
accompani
twofold
proxim
increas
tissu
enterokinas
brushbord
enzym
sinc
appar
improv
protein
absorpt
could
easili
explain
sole
assum
increas
lumen
trypsin
possibl
associ
chang
activ
peptid
hydrolas
anoth
brushbord
enzym
studi
particul
solubl
fraction
intestin
segment
normal
fourweek
resect
rat
segment
examin
normal
total
specif
activ
particul
solubl
peptid
hydrolas
leuala
substrat
rose
progress
duodenum
midileum
contrast
jejun
midil
homogen
assay
sucras
total
segment
specif
activ
lower
distal
segment
sa
jejunum
ug
sa
ileum
ug
p
ool
follow
resect
total
protein
content
wet
weight
standard
segment
increas
fold
signific
chang
total
specif
activ
sucras
occur
peptid
hydrolas
activ
markedli
elev
two
segment
studi
chang
greatest
second
part
duodenum
particul
specif
activ
control
ug
resect
p
total
particul
activ
per
standard
segment
control
ug
ect
ug
p
similar
chang
note
distal
increas
solubl
enzym
activ
mark
less
signific
total
activ
per
duoden
segment
control
ug
resect
ug
p
total
activ
per
midil
segment
control
resect
ug
p
ol
zymogram
solubl
particul
enzym
fraction
reveal
ident
pattern
group
data
suggest
specif
role
peptid
hydrolas
adapt
protein
maldigest
follow
resect
gl
se
import
action
gastric
pancreat
secret
controversi
exist
regard
effect
hormon
jejun
water
electrolyt
transport
accordingli
investig
effect
iv
administr
gl
se
jejun
transport
water
electrolyt
healthi
human
tripl
lumen
perfus
techniqu
net
jejun
transport
water
electrolyt
unidirect
movement
cation
measur
subject
serum
electrolyt
glucagon
insulin
glucos
level
measur
measur
control
period
c
subject
given
gi
either
bodi
wthr
contin
iv
infus
pgkg
gl
prodjc
reduct
absorpt
p
pair
analysi
pgkg
gi
produc
secret
water
electrolyt
p
gi
produc
less
secret
p
see
tabl
consist
alter
unidirect
movement
cation
random
c
gi
period
alter
result
compar
alter
serum
glucos
insulin
level
influenc
jejutl
absorpt
costrini
se
gih
unit
kgbodywthr
also
produc
secret
water
electrolyt
see
tabl
exsorpt
sodium
significantli
increas
p
chang
insorpt
studi
indic
glucagon
secretin
alter
jejun
fluid
transport
thu
may
playa
role
diarrheal
syndrom
associ
pancreat
tumor
minu
sign
secret
normal
small
amount
ba
deconjug
absorb
colon
oral
administr
ba
ileal
diseas
greater
amount
ba
may
enter
colon
absorb
studi
rate
absorpt
cholic
ca
deoxychol
dca
chenodeoxychol
acid
cdca
test
effect
ph
solubl
absorpt
ba
colon
subject
intub
tripl
lumen
tube
thorough
cleans
perfus
physiolog
electrolyt
solut
ph
contain
ba
polyethylen
glycol
ba
absorpt
calcul
steadi
state
condit
mass
analysi
disappear
label
ba
rom
concentr
concn
ba
absorpt
mean
sd
pmolesmincolon
respect
rom
concn
cdca
absorpt
pmolesmincolon
respect
rom
concn
dca
absorpt
colon
cdca
fa
absorpt
greater
ca
concentr
test
p
mean
cdca
absorpt
greater
dca
concentr
differ
signific
rom
concn
p
absorpt
ca
cdca
concn
depend
linear
rom
rom
concn
respect
lack
increas
absorpt
dca
rom
may
due
secret
water
produc
rom
dca
solubl
ba
test
vitro
found
ph
depend
differ
ba
sharp
risei
sorubl
ca
occur
ph
ph
cdca
dca
form
gel
ph
true
solut
ph
perfus
colon
ba
ph
produc
signific
increas
absorpt
rom
ca
p
cdca
absorpt
ph
chang
ph
dca
absorpt
could
test
low
ph
valu
gel
format
conclud
signific
differ
exist
solubl
colon
absorpt
rate
unconjug
ba
physiolog
concentr
ph
cdca
greatest
absorpt
colon
absorpt
ba
cdca
particular
could
contribut
maintain
expans
ba
pool
dog
frequent
employ
model
studi
serum
pancreat
enzym
appropri
may
question
sinc
concentr
amylas
dog
serum
approxim
time
human
chromatograph
separ
serum
amylas
column
agaros
gel
reveal
amylas
peak
dog
serum
singl
low
molecular
weight
peak
human
dog
first
peak
amylas
activ
elut
immedi
larg
size
protein
wherea
third
peak
elut
volum
human
serum
amylas
appear
concentr
serum
amylas
dog
greater
somogyi
unit
may
attribut
variat
amount
larg
size
enzym
dog
amylas
labil
low
ph
human
chromatographi
ph
dissoci
macroamylas
human
appli
dog
porcin
pancreat
amylas
often
use
evalu
assay
techniqu
amylas
porcin
serum
amylas
found
distribut
differ
molecular
size
peak
agaros
chromatographi
consider
experiment
anim
studi
contribut
pancrea
total
serum
amylas
includ
concentr
molecular
size
enzym
neither
dog
pig
appear
appropri
anim
numer
studi
shown
chronic
administra
tion
pentagastrin
lead
pariet
cell
hyperplasia
rat
indic
ga
strin
may
prolif
well
secretori
effect
gastric
mucosa
primari
explant
rat
human
gastric
mucosa
oxynt
gland
region
cultur
flask
medium
consist
minimum
essenti
medicum
eagl
nctc
fetal
calf
serum
rat
mucosa
human
cord
serum
human
mucosa
cultur
disturb
outgrowth
fibroblast
epitheli
cell
occur
latent
period
last
approxim
seven
day
either
pentagastrin
concentr
gml
equal
volum
salin
ad
daili
cultur
subsequ
subcultur
control
salin
cultur
show
rapid
growth
fibroblast
ultim
loss
epitheli
cell
fibroblast
outgrowth
inhibit
epitheli
cell
prolifer
stimul
cultur
receiv
pentagastrin
light
microscopi
show
typic
mosaic
epitheli
pattern
electron
microscop
observ
defin
primit
epitheli
populac
present
composit
anatom
featur
seen
differenti
gastric
mucos
cell
flora
result
impli
gastrin
direct
prolif
effect
gastric
mucos
epithelium
establish
featur
peutz
jegher
syndrom
pj
mendel
domin
herit
mucocutan
melanot
pigmentat
ion
g
polyposi
one
case
led
larg
affect
clan
costa
rica
founder
die
whole
gener
ii
fami
i
becam
affect
follow
group
outlin
ten
dead
case
accord
brother
son
oral
pigment
three
die
tth
acut
abdomin
condit
medic
evid
avail
three
well
document
case
die
pj
complic
two
femal
year
old
die
periton
surgeri
intestin
invagin
resect
ava
labl
specimen
show
typic
pj
polyp
yearold
male
die
mal
gnant
degener
intestin
polyp
autopsi
show
polyp
metastasi
lymph
node
liver
eighteen
ive
case
pj
rang
year
age
mucocutan
pigment
one
famili
diffu
se
frecklel
ike
facial
distribut
nine
case
pigment
hand
feet
one
case
viti
ligo
polyp
demonstr
case
gastric
intestin
colon
absent
yearold
boy
radiolog
exam
nation
complet
four
elder
case
former
emerg
procedur
intestin
nvagin
andor
occlus
gross
g
bleed
occur
case
five
case
recent
laparatomi
polipectomi
bleed
invagin
complementari
procedur
cesarean
oper
one
case
extens
appendix
involv
two
normal
girl
monthold
daughter
affect
mother
potentialcas
seen
oral
pigment
appear
late
year
age
high
fertil
ty
widespread
medic
care
costa
rica
combin
produc
seem
largest
pj
famili
report
although
mani
clinician
advoc
use
fresh
blood
replac
therapi
cirrhot
patient
gastrointestin
bleed
clinic
evid
support
approach
scanti
obtain
fresh
blood
fb
hour
old
put
strain
blood
bank
therefor
prospect
studi
design
bleed
patient
randomli
assign
one
three
replac
schedul
fb
group
unit
bank
blood
bb
unit
fb
group
unit
bb
unit
fb
substitut
consist
unit
pack
cell
unit
fresh
frozen
plasma
unit
platelet
concentr
group
site
bleed
determin
combin
endoscopi
radiolog
evalu
patient
stratifi
accord
site
bleed
group
purpos
random
bleed
esophag
varic
hemorrhag
gastriti
diffus
gastrointestin
ooz
miscellan
caus
includ
gastric
duoden
ulcer
thirtythre
patient
biopsi
proven
laennec
cirrhosi
admit
studi
patient
group
respect
signific
differ
age
sex
clinic
find
liver
function
test
admiss
studi
group
requir
blood
x
unit
longer
durat
bleed
x
day
either
group
p
differ
latter
group
mean
platelet
fibrinogen
valu
first
day
observ
significantli
lower
group
compar
either
group
p
ool
incid
consumpt
coagulopathi
hepat
coma
mortal
rate
similar
group
data
indic
may
signific
therapeut
advantag
transfus
least
fresh
blood
activ
bleed
cirrhot
earli
use
endoscopi
determin
site
bleed
patient
pt
lc
recent
ethanol
consumpt
led
disagr
frequenc
esophag
varic
ev
hemorrhag
group
assess
prospect
studi
plan
endoscopi
would
perform
within
hour
clinic
recogn
onset
bleed
pt
histolog
proven
lc
recent
episod
ethanol
consumpt
admit
studi
pt
esophagogastroscopi
follow
upper
gi
seri
case
endoscop
diagnosi
made
observ
sm
pt
bleed
admiss
remain
onset
hemorrhag
hospit
follow
tabl
summar
data
divid
pt
group
pt
felt
bleed
primarili
ev
bleed
anoth
sourc
pt
ev
major
sourc
hemorrhag
among
pt
recent
consum
alcohol
found
bleed
admiss
bleed
ev
hg
major
sourc
bleed
pt
sourc
bleed
nonbleed
ev
visual
presenc
ev
confirm
case
radiolog
examin
pt
ev
longer
durat
bleed
day
pt
day
p
ol
determin
clear
aspir
nasogastr
tube
initi
hematocrit
transfus
requir
similar
group
differ
age
sex
initi
liver
function
test
conclus
studi
indic
frequent
site
bleed
pt
lc
recent
ethanol
ingest
ev
incid
hg
lower
report
other
bleed
sourc
offer
far
better
prognosi
mortal
bleed
ev
mortal
rabbit
ileum
wide
studi
overal
model
electrolyt
h
transport
develop
sever
predict
model
includ
singl
doubl
quadrupl
ionexchang
net
absorpt
secret
test
rabbit
hr
perfus
contain
mm
anerob
recircul
isol
ileal
segment
plexigla
reservoir
sampl
remov
min
interv
net
flux
calcul
period
psp
volum
correct
mean
psp
recoveri
se
initi
mean
mucos
pd
thereaft
remain
rang
na
cl
linearli
relat
regress
indic
isosmot
na
absorpt
secret
perfus
ph
rang
never
less
blood
calcul
rang
mm
hg
never
exceed
blood
data
incompat
hna
exchang
greatli
simplifi
predict
model
possibl
exchang
thu
cl
decreas
na
decreas
na
absorpt
nao
clo
increas
na
net
na
secret
invers
relationship
obtain
ratio
remain
uniti
throughout
na
absorpt
secret
predict
fulfil
cl
linearli
relat
na
net
na
absorpt
mean
cl
remain
constant
vmolescm
net
na
secret
also
linearli
relat
na
net
na
secret
mean
remain
constant
net
na
absorpt
net
absorpt
net
cl
secret
never
observ
ratio
vari
curvilinearli
na
absorpt
secret
respect
find
appear
incompat
signific
exchang
propos
nacl
absorpt
secret
occur
differ
site
perhap
differ
cell
absenc
obviou
anion
cation
exchang
suggest
latter
speciesrel
rais
phylogenet
question
regard
biochem
signific
ionexchang
particularli
respons
hormon
cholera
toxin
import
liquid
junction
potenti
ej
gastric
pd
measur
merit
emphasi
exampl
use
mm
nacl
mucos
bridg
chang
e
j
h
chang
mm
mv
ie
chang
mucos
pd
mv
could
entir
due
variat
ej
studi
first
attempt
provid
detail
estim
measur
e
j
complex
solut
concentr
rang
found
gastric
juic
devis
simpl
vitro
system
indirect
ej
measur
two
balanc
agagcl
electrod
without
liquid
junction
mount
plexigla
halfchamb
separ
cm
window
seal
viscos
membran
solut
mix
magnet
potenti
record
mv
sec
interv
orion
research
digit
electromet
observ
potenti
et
repres
sum
e
transmembran
clactiv
potenti
e
j
membran
diffus
potenti
mechan
gastric
mucos
stress
injuri
studi
combat
soldier
admit
manag
brain
thorac
abdomin
wound
evacu
hospit
long
binh
vietnam
ten
gross
bleed
acut
eros
ulcer
stomach
duodenum
ooz
ml
blood
per
l
gastric
secret
first
posttrauma
week
hour
gastric
collect
obtain
ice
day
period
averag
patient
week
measur
volum
total
acid
filter
centrifug
dialyz
lyophil
sent
air
new
york
assay
heme
bile
pigment
protein
sulfat
nonsulf
glycoprotein
fucos
hexosamin
hexos
sialic
acid
blood
content
hour
output
compon
variou
variabl
mean
st
dev
obtain
comput
mean
volum
gastric
juic
markedli
depress
day
posttrauma
ml
gradual
increas
ml
day
hour
acid
output
rose
bleeder
day
day
nonbleed
meq
hour
mean
total
protein
output
rose
day
g
day
bleeder
day
g
day
nonbleed
serum
protein
bleeder
maintain
high
level
g
day
posttrauma
blood
admixtur
respons
serum
protein
rise
hour
hour
mucosubst
output
markedli
increas
bleeder
day
nonsulf
glycoprotein
sulfat
glycoprotein
fucos
hexosamin
hexos
sialic
acid
mg
nonbleed
increas
much
less
peak
day
pom
trauma
initi
depress
acid
output
follow
serum
protein
leak
g
stric
hemorrhag
blood
ooz
consist
concept
increas
back
diffus
h
ion
intj
gastric
mucosa
trauma
bile
reflux
seen
patient
would
result
mucos
injuri
proven
histolog
case
lev
strempl
press
sharp
increas
mucosubst
output
bleeder
day
post
trauma
reflect
discharg
mucu
damag
gastric
mucosa
find
subdetermin
hepat
b
antigen
hbag
mutual
exclus
rais
question
whether
subtyp
afford
crossimmun
prospect
studi
hemodialysi
patient
lo
angel
countyusc
medic
center
provid
pertin
observ
seventeen
patient
acquir
antigenemia
probabl
result
indirect
intraunit
transmiss
requir
unit
hbag
unscreen
blood
period
month
becom
hbagposit
monitor
addit
month
nonrecurr
antigenemia
detect
counter
lectrophoresi
patient
receiv
unit
j
reappear
subtyp
patient
unit
intermitt
antigenemiaj
persist
subtyp
patient
unit
chronic
antigenemia
unrel
studi
redek
cowork
unpubl
ish
data
indic
expect
rate
infect
per
unit
sourc
therefor
lack
infect
among
hemodialysi
patient
prior
infect
suggest
protect
immun
reciproc
seem
ike
occurr
two
appar
separ
episod
acut
viral
hepat
remain
unexplain
basi
recogn
type
subtyp
sinc
hypoxia
anemia
featur
clinic
stress
syndrom
precipit
acut
gastric
lesion
studi
effect
hypoxia
acut
anemia
stomach
rat
subject
wire
mesh
restraint
stress
seven
hour
experiment
rat
expos
nitrogen
hour
pair
control
rat
kept
similar
chamber
room
air
breath
awak
arteri
rat
breath
oxygen
two
hour
sd
mm
hg
anemia
produc
doubl
ml
exchang
blood
plasmalyt
solut
reduc
hematocrit
hypoxia
influenc
number
gastric
eros
ulcer
control
vs
hypoxia
vs
erosionsstomach
p
vs
ulcersstomach
p
hour
vs
p
vs
p
hour
vs
p
vs
p
epinephrin
given
mgkg
intraperiton
prior
hour
restraint
hypoxia
number
gastric
lesion
unchang
dose
increas
mgkg
signific
increas
gastric
eros
hypox
rat
compar
control
rat
p
ooi
without
p
oi
epinephrin
incid
ulcer
unchang
acut
anemia
reduc
number
gastric
eros
vs
p
ulcer
anemia
combin
hour
hypoxia
number
restraint
induc
gastric
eros
still
decreas
vs
p
decreas
arteri
partial
pressur
oxygen
alon
combin
reduc
red
cell
mass
advers
affect
stress
ulcer
format
rodent
restraint
model
action
epinephrin
gastric
blood
flow
togeth
decreas
arteri
partial
pressur
oxygen
necessari
precipit
stress
gastric
lesion
effect
bilater
nephrectomi
metabol
acidosi
stomach
rat
subject
restraint
stress
studi
determin
factor
would
influenc
stress
ulcer
format
independ
trauma
infect
usual
accompani
acut
renal
failur
arf
patient
previous
normal
kidney
sinc
rat
die
hour
bilater
nephrectomi
studi
done
hour
arteri
ph
sd
urea
mg
potassium
meql
increas
incid
gastric
eros
ulcer
either
p
hour
p
restraint
hour
arf
arteri
ph
restrain
rat
hour
ph
chang
gastric
lumin
equilibr
mark
increas
hour
gastric
acid
product
unrestrain
vs
peq
p
ool
restrain
vs
p
rat
arf
increa
ed
gastric
acid
product
restrain
nephrectom
rat
reduc
prior
vagotomi
pyloroplasti
vs
p
ool
arf
increas
gastric
tissu
water
vs
p
five
day
drink
ammonium
chlorid
solut
arteri
ph
signific
increas
number
gastric
eros
p
ulcer
p
restraint
metabol
acidosi
effect
gastric
acid
product
lumin
equilibr
either
unrestrain
restrain
rat
metabol
acidosi
gastric
tissu
water
increas
vs
p
factor
eg
sepsi
present
patient
posttraumat
renal
failur
may
greater
etiolog
signific
stress
ulcer
format
sinc
metabol
acidosi
also
occur
arf
factor
present
arf
may
mollifi
effect
acidosi
longer
period
acidosi
may
need
increas
incid
gastric
lesion
nakayama
e
weser
univers
texa
medic
school
san
antonio
san
antonio
texa
small
bowel
resect
rat
mucos
hyperplasia
increas
cell
turnov
occur
remain
intestin
cellular
prolifer
nucleic
acid
synthesi
limit
intestin
crypt
cell
pyrimidin
biosynthet
enzym
activ
primarili
local
crypt
parallel
rate
cell
prolifer
male
spraguedawley
rat
underw
resect
cm
proxim
distal
intestin
sham
oper
one
mo
surgeri
intestin
remnant
remov
homogen
prepar
whole
mucosa
crypt
layer
remov
villi
intestin
plane
apparatu
follow
enzym
assay
aspart
transcarbamylas
atc
dihydroorotas
dho
uridin
kinas
uk
specif
enzym
activ
greater
normal
proxim
distal
mucosa
one
month
proxim
resect
total
enzym
activ
per
cm
distal
remnant
increas
significantli
control
follow
atc
dho
uk
distal
resect
increas
proxim
remnant
atc
dho
uk
specif
enzym
activ
crypt
layer
umolesm
protein
follow
proxim
sham
proxim
remnant
atc
dho
uk
three
enzym
increas
proxim
remnant
p
h
thymidin
incorpor
dna
crypt
epithelium
proxim
remnant
increas
cpmug
dna
p
conclus
control
proxim
distal
gut
activ
atc
dho
uk
suggest
rapid
proxim
cell
turnov
resect
increas
enzym
incorpor
thymidin
dna
remain
bowel
indic
increas
pyrimidin
biosynthesi
associ
greater
cell
prolifer
previous
report
hepat
encephalopathi
hyperammonemia
occur
germfre
dog
follow
portacav
shunt
hyperammonemia
occur
convent
anim
follow
ingest
blood
meal
work
extend
encompass
urea
toler
studi
convent
eck
fistula
dog
fast
convent
eck
fistula
dog
fed
urea
meal
gm
urea
dissolv
ml
water
rise
blood
ammonia
averag
control
valu
observ
nour
follow
ingest
urea
convent
anim
rise
blood
ammonia
record
anim
observ
littl
rise
blood
ammonia
follow
urea
meal
ck
fistula
dog
convent
exhibit
massiv
increas
favor
tne
concept
hydrolysi
urea
ammonia
complet
depend
enzym
system
deriv
bacteri
flora
tne
gastrointestin
tract
hyperammonemia
observ
eck
fistula
aoimal
result
hydrolysi
urea
ammonia
product
dog
probabl
result
digest
breakdown
enzym
system
nitrogen
substanc
amino
acid
recent
data
froil
laboratori
indic
consist
decreas
lover
esophag
sphincter
i
pressur
follow
fat
aeal
recent
obaerv
horaon
strin
deterain
li
collpet
studi
relationship
fat
inhibit
known
stiaulatori
effect
pentastrin
sphincter
le
pressur
record
continu
eht
ilorm
subject
use
illtus
opentip
systea
penstrin
ia
dose
previous
showa
produc
increas
ill
le
pressur
w
qf
suboutan
result
aeaa
peak
pressur
iilcreas
hg
given
subject
fast
state
e
dose
produc
aean
peak
pressur
increas
hg
given
follow
fat
aeal
al
corn
oil
al
increas
pressur
less
p
oool
obtain
tast
state
order
investt
aechanisa
fat
induc
inhibitiojl
le
dose
respons
curv
le
respons
rapid
intrav
inject
penstrin
va
construct
fast
state
clirv
va
soid
abap
peak
chang
i
pressur
hg
w
qf
fifteen
ainut
ingest
tat
aeal
anotb
reapons
cwrve
va
obtain
curv
also
soid
shape
shoveel
parallel
shift
rbt
aaximul
sphincter
pressur
chang
hg
nificantli
differ
froa
obtain
tast
state
occur
ng
qf
pentagastrin
tbese
stuie
indic
fatinduc
inhibit
tbe
le
like
act
throw
h
antagon
trill
aeehan
strill
antagoni
would
appear
one
cepetit
inhibit
major
problem
diagnosi
stagnant
loop
syndrom
determin
whether
bacteri
overgrowth
caus
steatorrhea
patient
multipl
patholog
purpos
studi
determin
use
diagnost
test
situat
three
group
subject
studi
group
b
consist
subject
anatom
stagnant
loop
subject
group
steatorrhea
attribut
bacteri
overgrowth
caus
steatorrhea
altern
caus
fecal
fat
excret
decreas
markedli
follow
ampicillin
subject
group
b
steatorrhea
attribut
caus
steatorrhea
steatorrhea
altern
caus
decreas
fecal
fat
excret
follow
ampicillin
group
c
consist
subject
known
gastrointestin
diseas
fast
postprandi
sampl
obtain
intub
variou
level
small
intestin
free
conjug
bile
acid
measur
enzymat
follow
separ
thin
layer
chromatographi
sampl
also
cultur
aerob
anaerob
bacteria
diagnost
test
urinari
indican
excret
schill
test
plu
intrins
factor
upper
jejun
sampl
free
bile
acid
detect
postprandi
subject
group
none
group
band
c
detect
lower
jejun
sampl
subject
group
also
lower
concentr
subject
group
b
subject
group
c
ileal
sampl
diagnost
valu
sinc
high
concentr
free
bile
acid
detect
normal
control
group
c
bacteriolog
studi
urinari
indican
excret
schill
test
fail
show
clear
demark
subject
group
group
b
conclus
screen
postprandi
upper
jejun
sampl
free
bile
acid
use
diagnost
test
assess
signific
bacteri
overgrowth
caus
steatorrhea
lower
jejun
ileal
sampl
presenc
free
bile
ac
id
normal
find
rectosphincter
manometr
studi
perform
six
patient
proven
untreat
anal
fissur
investig
associ
motor
disord
rel
role
intern
extern
anal
sphincter
physiolog
effect
sphincterotomi
empir
accept
effect
therapi
disord
air
fill
balloon
record
pressur
rectum
intern
anal
sphincter
extern
sphincter
via
pressur
transduc
patient
intern
anal
sphincter
respons
character
initi
normal
relax
follow
immedi
strong
contract
persist
second
rang
second
extern
sphincter
respons
normal
overshoot
reflect
spasm
intern
sphincter
deeper
bundl
extern
sphincter
sinc
present
even
patient
exern
sphincter
paralysi
due
spinal
cord
lesion
furthermor
diazepam
valium
mg
iv
abolish
extern
sphincter
respons
effect
intern
sphincter
overshoot
cours
medic
therapi
overshoot
disappear
also
absent
one
patient
underw
sphincterotomi
without
fissurectomi
motil
stlldi
provid
object
evid
sphincter
spasm
associ
fissur
indic
intern
sphincter
rather
extern
sphincter
respons
explain
good
respons
intern
sphincterotomi
without
fissurectomi
provid
support
concept
viciou
cycl
pathogenesi
fissur
medic
heal
fissur
reliev
associ
intern
sphincter
spasm
also
intern
sphincterotomi
btllsk
oper
dilat
induc
heal
fissur
abolish
sphincter
spasm
two
patient
previous
unexplain
constip
exist
fissur
initi
miss
end
proctoscopi
diagnosi
made
motil
studi
subsequ
confirm
side
view
anoscopi
thu
addit
provid
inform
concern
pathophysiolog
anal
fissur
treatment
anorect
motil
studi
offer
diagnost
tool
high
sensit
ornla
lego
ornla
liver
regener
remark
phenomenon
fundament
biolog
import
clinic
relev
treatment
hepat
diseas
develop
techniqu
liver
transplant
inbr
rat
free
complic
influenc
immunolog
reject
immunosuppress
therapi
made
possibl
conduct
three
detail
sudi
qualit
quantit
influenc
blood
suppli
regener
hepat
isograft
transplant
heterotop
rat
liver
graft
regener
evalu
measur
chang
wet
weight
dri
weight
protein
content
number
mitos
nuclea
dna
synthesi
autoradiograph
determin
incorpor
thymidineh
first
studi
rat
show
graft
vascular
portal
vein
alon
portal
vein
hepat
arteri
doubl
initi
weight
two
week
graft
suppli
hepat
arteri
alon
system
venou
blood
alon
combin
hepat
arteri
system
venou
blood
lost
weight
even
total
affer
blood
flow
greater
normal
second
studr
rat
show
liver
transplant
provid
portal
blood
suppli
develop
explos
cel
prolifer
regener
vigor
whi
ie
graft
depriv
portal
venou
blood
fai
led
regener
circumst
rat
design
evalu
combin
influenc
liver
regener
host
hepatectomi
rout
portal
blood
either
host
liver
graft
show
phenomenon
interliv
competit
simpli
contest
finit
amount
trophic
humor
agent
portal
blood
result
studi
provid
definit
evid
hepatotroph
portal
blood
factor
hpbf
essenti
liver
regener
longterm
effect
pancrea
transplant
diabet
mellitu
insulin
secret
pancreat
morpholog
matter
potenti
clinic
import
determin
previou
studi
pancrea
transplant
involv
partial
pancreat
autograft
allograft
genet
dissimilar
anim
necess
complic
graft
reject
need
immunosuppress
therapi
develop
microvascular
surgic
techniqu
transplant
whole
pancrea
duodenum
inbr
rat
made
possibl
longterm
studi
endocrin
function
morpholog
diabet
mellitu
induc
alloxan
mg
kg
lewi
strain
rat
proven
serial
blood
glucos
level
mg
anim
divid
three
group
group
made
diabet
control
group
consist
shamoper
rat
group
iii
contain
rat
pancreaticoduoden
transplant
rat
pancrea
transplant
immedi
perman
reduct
blood
grucos
level
normal
control
shamoper
rat
maintain
high
blood
glucos
level
year
iii
strike
contrast
two
group
transplant
rat
gain
weight
normal
activ
normal
fur
textur
serial
morpholog
studi
graft
show
pancreat
loss
acini
normal
islet
langerhan
abund
secretori
granul
second
studi
involv
diabet
rat
divid
three
group
serial
blood
insulin
level
determin
radioimmunoassay
anim
pancrea
transplant
consist
normal
blood
insulin
level
mean
ngml
control
shamoper
rat
markedli
depress
level
mean
ngml
respect
final
transplant
rat
reliev
diabet
pancrea
graft
remov
month
diabet
promptli
recur
blood
glucos
level
rang
mg
conclud
heterotop
transplant
pancrea
isograft
capabl
consist
produc
immedi
last
relief
alloxaninduc
diabet
mellitu
system
manifest
six
patient
variou
gastrointestin
disord
maintain
parenter
nutrit
period
week
except
one
patient
receiv
kcalkg
patient
receiv
kcalkg
bodi
weight
electrolyt
plu
vitamin
intraven
protein
form
amigen
sorbitol
glucos
solut
given
hr
daili
remain
calori
given
ntralipid
hr
patient
receiv
equival
gkgday
protein
casein
hydrolys
period
seven
day
level
nitrogen
balanc
studi
reveal
posit
balanc
achiev
infus
level
gkg
true
either
glucos
sorbitol
carbohydr
sourc
whole
blood
aminogram
obtain
seventh
day
infus
level
hr
sudden
rise
observ
blood
level
threonin
valin
methionin
tryptophan
coincid
posit
nitrogen
balanc
achiev
gkg
casein
hydrolys
suggest
fulfil
amino
acid
requir
end
gkgday
intraven
feed
period
three
patient
fed
mouth
one
week
gkgday
milk
protein
form
cottag
chees
kcalkg
nonprotein
calori
given
intraven
oral
protein
greater
posit
nitrogen
balanc
achiev
conclud
daili
amount
protein
requir
form
casein
hydrolys
optim
parenter
nutrit
adult
approxim
gkg
bodi
weight
adequ
suppli
calori
given
close
relationship
exist
rise
blood
level
essenti
amino
acid
posit
nitrogen
balanc
oral
protein
appear
better
util
intraven
protein
healthi
volunt
assign
ad
random
control
diet
meadjohnson
au
element
diet
meadjohnson
g
bounou
ann
surg
similar
carbohydr
composit
protein
fraction
hydrolys
form
partial
substitut
lct
mct
diet
given
exclus
day
biochem
hematolog
microbiolog
data
obtain
treatment
period
quantit
pancreat
secret
enzym
assess
establish
techniqu
duoden
perfus
dietari
manipul
transit
time
intestin
follow
radioopaqu
marker
subject
control
element
diet
group
lost
weight
au
ib
ggm
rare
inherit
disord
describ
previous
adult
go
man
sever
diarrhea
sinc
birth
surviv
infanc
sucros
formula
subsequ
develop
normal
usual
diet
stool
volumin
lday
acid
ph
contain
lactat
mml
glucos
mgml
normal
fat
histolog
disaccharidas
concentr
lactas
sucros
umg
jejun
mucosa
normal
toler
test
confirm
diagnosi
diarrhea
decreas
dramat
reduct
dietari
sugar
fructos
supplement
jejun
absorpt
studi
perfus
use
isoton
sugarelectrolyt
na
meql
solut
tabl
minu
secret
glucos
absorb
concentr
gradient
glucos
galactos
absorpt
similar
less
fructos
sodium
water
secret
persist
even
sugar
absorb
sucros
lactos
perfus
hydrolysi
confirm
sugar
content
perfus
absorpt
per
min
mgml
salin
na
potenti
differ
jejunum
normal
mucosa
neg
unrespons
glucos
fructos
test
meal
lundh
jejun
ph
trypsin
lipas
bile
acid
micellar
fat
correct
dilut
within
normal
limit
dilut
peg
meal
excess
fold
ggm
secret
sodium
water
lack
activ
glucos
absorpt
suggest
failur
coupl
transport
sodium
glucos
result
consist
hypothesi
activ
hexos
transport
necessari
sodium
absorpt
preoper
identif
obstruct
extrahepat
bile
duct
infant
persist
cholestat
jaundic
remain
diagnost
challeng
needl
biopsi
liver
convent
irb
excret
test
vitamin
ebas
erythrocyt
stabil
test
test
lpx
jr
poley
et
al
gastroenterolog
help
identifi
sever
cholestasi
may
fail
local
site
obstruct
extrav
intrahepat
presenc
sever
intrahepat
cholestasi
therefor
attempt
modifi
irb
excret
test
sinc
yield
valuabl
inform
hepat
biliari
excretori
function
modif
accomplish
addit
ch
twofold
action
reduc
liver
injuri
patient
patent
extrahepat
bile
duct
bind
mainli
electrostat
irb
excret
intestin
prevent
enterohepat
cycl
test
use
ch
infant
sever
cholestat
jaundic
total
bilirubin
mg
posit
lpx
irb
excret
hour
convent
test
liver
biopsi
restudi
irb
excreti
test
week
oral
ch
gmday
ch
infant
excret
inject
label
hour
stool
wherea
remain
excret
differ
mean
signific
p
oool
level
result
former
group
consist
extrahepat
biliari
obstruct
surgic
explor
recommend
instanc
obstruct
lesion
atresia
etc
document
latter
group
repres
neonat
hepat
oper
cholangiogram
demonstr
patent
extrahepat
bile
duct
one
remain
oper
upon
lost
jaundic
continu
ch
treatment
therefor
suggest
irb
excret
test
ch
offer
excel
opportun
correct
preoper
identif
obstruct
extrahepat
bile
duct
determin
biliari
cholesterol
c
excret
clearli
defin
control
b
extrahepat
factor
consid
test
influenc
human
growth
hormon
gh
gallbladd
bile
gb
composit
studi
ghdefici
patient
f
control
normal
gh
secret
turner
syndrom
male
constitut
short
statur
treatment
gh
follow
dosag
schedul
previous
describ
jr
poley
et
al
gastroenterolog
gb
sampl
obtain
duoden
drainag
follow
stimul
gb
flow
essenti
amino
acid
vlw
go
et
al
j
clin
invest
composit
gb
bile
obtain
stimul
virtual
identtc
obtain
needl
aspir
gallbladd
zr
vlahcev
et
al
amer
j
dig
di
total
biliari
bile
acid
ba
phospholipid
pl
c
analyz
result
plot
triangular
coordin
two
ghdefici
patient
show
good
growth
acceler
gh
treatment
progress
oversatur
bile
c
crystal
make
lithogen
baplc
ratio
decreas
markedli
bile
composit
move
micellar
zone
cessat
gh
treatment
one
year
follow
return
gb
composit
normal
one
patient
contract
ghdefici
patient
show
growth
develop
lithogen
bile
patient
turner
syndrom
lithogen
bile
prior
gh
treatment
exogen
gh
slightli
accentu
oversatur
gb
c
one
gb
composit
return
normal
third
control
initi
excess
oversatur
gb
c
abolish
continu
gh
treatment
return
gb
composit
micellar
zone
associ
instanc
conspicu
rise
glycinetaurin
ratio
ba
develop
lithogen
bile
may
entertain
ghdefici
patient
upon
longterm
gh
treatment
sodiwn
retent
annoy
complic
small
percentag
ulcer
patient
success
treat
carbenoxolon
biogastron
clinic
side
effect
manifest
weight
gain
hypokalemia
alkalosi
pictur
resembl
hyperaldosteron
without
escap
two
possibl
mechan
respons
side
effect
evalu
use
vitro
membran
system
e
carbenoxolon
possess
inher
mineralorticoid
properti
potenti
aldosteron
transepitheli
sodiwn
flux
measur
shortcircuit
current
scc
match
quarter
ventral
toad
skin
addit
aldosteron
skin
scc
declin
ithr
rise
abruptli
plateau
anoth
hr
magnitud
rise
design
scc
use
quantit
mineralocorticoid
action
sodiwn
flux
addit
carbenoxolon
fail
induc
scc
system
therefor
inher
aldosteronelik
action
account
carbenoxolon
sodiwnretain
effect
howev
carbenoxolon
ad
either
ithr
simultan
aldosteron
scc
exceed
aldosteron
alon
pa
p
pa
p
respect
addit
carbenoxolon
lthr
aldosteron
fail
potenti
synerg
carbenoxolon
aldosteron
rather
specif
sinc
carbenoxolon
pretreat
fail
potenti
vasopressin
stimul
na
flux
prior
treatment
enhanc
aldosteroneinduc
scc
two
possibl
explan
observ
carbenoxolonealdosteron
synerg
includ
alter
turnov
aldosteroneinduc
intermedi
carbenoxolon
increas
util
metabol
substrat
sodiwn
pwnp
andor
carbenoxolon
increas
affin
actual
nwnber
avail
intracellular
aldosteron
receptor
site
purpos
studi
develop
techniqu
simultan
independ
measur
gastric
empti
small
intestin
propuls
rat
determin
extent
differ
paramet
fed
fast
rat
radioact
test
solut
contain
na
andor
introduc
stomach
gavag
plastic
tube
surgic
place
duodenum
stomach
small
intestin
remov
minut
later
amount
distribut
radioact
separ
determin
isotop
pass
gastrointestin
tract
collim
scintil
detector
graphic
record
count
rate
isotop
introduc
simultan
site
signific
differ
result
fast
rat
isotop
empti
stomach
minut
compar
minut
fed
rat
gastric
empti
rate
ponenti
fast
rat
minut
fed
rat
minut
intragastr
administr
test
solut
lead
edg
point
halfact
small
intestin
intestin
fast
rat
fed
rat
group
activ
move
small
intestin
bolu
rate
movement
similar
decreas
exponenti
variabl
result
within
fed
rat
greatli
differ
within
fast
rat
doubl
isotop
techniqu
offer
mean
simultan
measur
gastric
empti
small
intestin
transit
base
anatom
present
elsewher
bare
area
liver
larger
text
refer
extend
far
later
aspect
one
would
imagin
text
use
vertic
xray
centlal
ray
tangenti
midaxillari
line
supin
posit
inspir
apnea
eas
determin
width
ot
bare
zone
limit
aspect
shadow
caudal
aspect
neal
determin
averag
extens
cm
accord
anatom
determin
use
ot
metal
marker
skin
identifi
easili
intersect
ot
midplan
axillari
local
anesthesia
use
menghini
needl
liver
biopsi
done
patient
anicter
patient
use
control
case
ot
bronchogen
carcinoma
stage
miscellan
group
ot
group
jaundic
laboratori
evid
ot
cholestasi
studi
latter
group
tha
total
serua
rang
ot
mg
per
al
alkalin
phosphatas
rang
ka
unit
per
ml
instanc
local
biopsi
expect
instanc
ot
bile
wal
seen
ascit
aspir
procedur
excel
correl
ot
final
histopatholog
case
ot
obstruct
ident
biopsi
instanc
intrahepat
cholestasi
clinic
evolut
aocord
liver
biopsi
cytolog
done
instanc
posit
casea
metastat
techniqu
appear
sate
recommend
select
case
special
cholestasi
larg
ascit
fact
caviti
enter
aak
bile
risk
involv
proteolyt
enzym
inhibitor
obtain
bodi
wall
nematod
ascari
lumbricoid
low
molecular
weight
crystallin
protein
deriv
tca
extract
ethanol
precipit
combin
stoichiometr
pepsin
trypsin
chymotrypsin
compar
standard
legum
inhibitor
soybean
ascari
inhibitor
clearli
superior
soybean
inhibitor
possess
activ
pepsin
slight
antichymotrypt
activ
antitrypt
activ
ascari
inhibitor
ascari
inhibitor
equal
effect
pepsin
trypsin
chymotrypsin
studi
dog
prepar
isol
jejun
loop
fistula
abdomin
irradi
fistula
inject
follow
time
daili
day
trypsin
chymotrypsin
physiolog
concentr
ph
normal
salin
ph
control
trypsin
chymotrypsin
crude
soybean
trypsin
inhibitor
ph
trypsin
chymotrypsin
ascari
lumbricoid
trypsin
inhibitor
ph
hour
anim
sacrif
section
variou
loop
taken
histolog
studi
result
dramat
loop
uninhibit
loop
show
sever
gross
histolog
damag
loop
soybean
protect
loop
show
moder
damag
loop
control
loop
ascari
protect
loop
minim
gross
histolog
damag
studi
suggest
pancreat
proteolyt
enzym
neutral
suitabl
inhibitor
intens
intestin
radiat
damag
markedli
reduc
also
suggest
possibl
clinic
use
ascari
inhibitor
amelior
enteropathi
divers
origin
enzym
damag
may
contribu
character
quantit
precis
esophag
motor
abnorm
achalasia
undergon
dramat
revis
past
decad
hypertens
ncomplet
relax
lower
esophag
sphincter
le
report
signific
mecholyl
test
question
studi
achalasia
patient
untreat
use
infus
mlmin
manometr
techniqu
cineradiographi
untreat
patient
le
pressur
mmhg
sd
oder
significantli
elev
control
subject
mmhg
pol
region
profil
relax
show
mean
per
cent
le
relax
swallow
mmhg
distal
half
sphincter
compar
mmhg
proxim
half
instanc
le
relax
complet
le
respons
grade
increas
intraabdomin
pressur
g
caus
extern
abdomin
compress
determin
untreat
treat
patient
untreat
group
lesg
ratio
greater
wherea
untreat
group
ratio
less
normal
greater
peristalt
strip
wave
identifi
proxim
cm
mean
cm
esophag
segment
patient
upper
esophag
sphincter
ue
function
normal
rest
swallow
abdomin
compress
mecholyl
test
posit
achalasia
patient
clearli
separ
achalasia
patient
esophag
disord
mean
pressur
rise
six
minut
mgm
mecholyl
achalasia
group
mmhg
compar
mmhg
latter
group
pol
fluoroscop
monitor
reveal
concurr
lumen
obliter
contract
distal
esophagu
posit
mecholyl
test
studi
show
le
pressur
significantli
higher
achalasia
patient
compar
normal
numer
differ
great
howev
partial
occasional
complet
le
relax
swallow
mainten
le
barrier
esophagogastr
reflux
peristalsi
proxim
esophagu
normal
ue
functidn
reaffirm
clinic
use
mecholyl
test
effect
synthet
ctermin
octapeptid
cholecystokinin
opcck
squibb
institut
medic
research
new
brunswick
nj
lower
esophag
sphincter
le
pressur
studi
normal
male
subject
mean
age
year
intralumin
pressur
record
use
perfus
polyvinyl
tube
side
open
sensor
tube
anchor
distal
sensor
gastric
fundu
next
sensor
le
proxim
sensor
lower
esophagu
min
basal
period
nacl
ml
inject
intraven
control
min
interv
thereaft
grade
dose
opcck
ngkg
inject
intraven
sec
order
list
le
pressur
measur
sec
interv
mean
se
basal
le
pressur
mm
hg
le
pressur
min
inject
compar
le
pressur
min
min
inject
mean
chang
le
pressur
mm
hg
min
min
nacl
alon
opcck
ngkg
opcck
ngkg
opcck
ngkg
opcck
ngkg
opcck
ngkg
dose
opcck
mean
lowest
consecut
le
pressur
significantli
p
less
mean
preinject
pressur
magnitud
durat
decreas
le
pressur
increas
increas
dose
opcck
conclud
opcck
decreas
le
pressur
man
intestin
microvasculatur
implic
pathogenesi
shock
possibl
explor
anesthet
dog
monkey
subject
endotox
hemorrhag
shock
use
silicon
rubber
inject
techniqu
dog
monkey
segment
jejunum
prepar
hour
anim
receiv
endotoxin
ldso
iv
chang
intestin
vascular
architectur
includ
follow
villu
height
reduc
subepitheli
capillari
plexu
villu
core
vessel
coil
subepitheli
plexu
congest
dilat
diffus
extravas
rubber
submucos
core
vessel
chang
compat
known
action
endotoxin
vascular
smooth
muscl
suggest
etiolog
mechan
account
observ
increas
mesenter
vascular
resist
characterist
canin
endotoxemia
similar
segment
gut
analyz
dog
hour
hypovolem
shock
l
hour
follow
reinfus
shed
blood
appear
microvascular
architectur
hour
follow
hemorrhag
shockwa
essenti
unchang
control
howev
l
hour
follow
reinfus
follow
chang
note
extravas
rubber
core
villi
mani
vi
lli
entir
ly
fi
lie
rubber
subepi
lia
capi
llari
plexu
unremark
contrast
studi
perform
subhuman
primat
reveal
essenti
chang
control
architectur
pattern
either
endotox
hemorrhag
shock
find
indic
mark
speci
differ
exist
monkey
dog
term
intestin
microvascular
respons
experiment
shock
canin
model
also
signific
differ
respons
endotox
hemorrhag
shock
thu
littl
evid
support
thesi
gut
common
pathway
pathophysiolog
irrevers
shock
either
dog
subhuman
primat
presum
man
well
gener
darken
skin
frequent
seen
patient
chronic
jaundic
often
underli
disord
primari
biliari
cirrhosi
bile
duct
strictur
bile
duct
carcinoma
skin
darken
due
increas
melanin
rather
deposit
abnorm
pigment
caus
factor
could
includ
increas
serum
bile
acid
concentr
increas
serum
lipid
irrit
scratch
primari
import
latter
suggest
frequent
presenc
patient
butterflyshap
area
decreas
pigment
upper
back
edg
area
correspond
limit
patient
reach
scratch
exampl
much
larger
area
seen
one
patient
concomit
arthriti
limit
mobil
arm
easili
visibl
butterfli
sign
present
patient
primari
biliari
cirrhosi
occasion
patient
bile
duct
strictur
due
cholang
bile
duct
cancer
present
patient
earli
primari
biliari
cirrhosi
without
pruritu
obviou
patient
combin
primari
biliari
cirrhosi
scleroderma
amer
j
med
determin
trypsin
activ
enterokinaseactiv
pancreat
extract
two
differ
substrat
benzoylarginin
bapna
remazolbrilli
bluehid
rbbhide
furnish
wide
diverg
valu
evid
obtain
laboratori
show
discrep
due
new
inhibitor
postul
haverback
et
al
clin
re
presenc
vari
proport
isoenzym
trypsin
wide
differ
activ
electrophoresi
pancreat
extract
human
bovin
porcin
canin
murin
rat
pancrea
result
case
separ
anion
cation
speci
trypsinogen
activ
zymogen
yield
trypsin
variant
isoenzym
strikingli
differ
specif
activ
toward
two
substrat
exampl
ratio
bapnarbbhid
read
set
crystallin
bovin
cation
trypsin
ratio
bovin
anion
trypsin
human
cation
trypsin
anion
trypsin
canin
cation
trypsin
anion
trypsin
find
confirm
electrofocus
techniqu
present
fraction
test
data
demonstr
cation
anion
trypsin
speci
possess
differ
specif
activ
differ
substrat
differ
also
exist
activ
similarli
charg
trypsin
differ
speci
result
dramat
illustr
difficulti
interpret
measur
enzym
activ
biolog
fluid
depend
measur
type
standard
substrat
employ
order
clarifi
mechan
diarrhea
frequent
found
bing
drink
alcohol
effect
acut
administr
ethanol
intestin
motil
investig
chronic
alcohol
sixteen
studi
perform
jejunum
ileum
use
polyethylen
tube
flaccid
distal
balloon
place
fluoroscop
control
first
jejun
loop
ileum
cm
incisor
minut
baselin
record
gkg
ethanol
administ
either
oral
jejun
ileal
studi
intraven
jejun
studi
continu
record
obtain
hour
comparison
jejun
motil
measur
two
addit
patient
oral
urea
amino
acid
concentr
isosmolar
ethanol
oral
ethanol
signific
decreas
analysi
varianc
overal
effect
newmankeul
test
simpl
effect
frequenc
amplitud
motil
index
product
frequenc
amplitud
durat
type
wave
occur
jejunum
within
minut
maximum
suppress
hour
intraven
ethanol
similar
inhibit
occur
minut
maximum
respons
hour
effect
persist
hour
invers
correl
blood
alcohol
level
motil
index
type
wave
type
iii
wave
remain
unchang
signific
chang
found
ileum
intragastr
urea
amino
acid
produc
immedi
decreas
within
one
minut
type
iii
wave
maximum
effect
minut
recoveri
toward
normal
one
hour
motor
inhibit
produc
ethanol
seem
repres
specif
action
rather
associ
hyperton
sinc
time
cours
ethanol
chang
differ
solut
similar
tonic
ethanol
contrast
solut
inhibit
type
wave
motil
inhibit
iv
ethanol
select
inhibit
type
wave
follow
ethanol
ingest
suggest
mechan
diarrhea
associ
acut
alcohol
bing
sinc
type
segment
wave
serv
imped
forward
progress
intralumin
content
gener
depress
variou
type
diarrhea
recent
studi
small
bowel
ipid
reesterifi
enzym
involv
process
lipid
absorpt
transport
suggest
enzym
level
relat
load
fat
present
absorpt
investig
acylcoa
monoglycerid
acyl
transferas
mgacyltran
assay
use
microsom
prepar
jejunum
ileum
rat
fed
one
diet
week
gp
regular
chow
fat
gp
regular
chow
ad
lard
fat
gp
synthet
liquid
diet
fat
lard
result
nmolesminsampl
enzym
activ
greater
rat
fed
high
fat
diet
site
increas
activ
small
bowel
appear
influenc
consist
diet
next
effect
type
long
chain
fatti
acid
fa
diet
satur
vs
unsatur
studi
jejun
microsom
sampl
addit
enzym
palmit
acidcoa
igas
pcoa
ig
oleic
acidcoa
igas
ocoa
ig
assay
rat
studi
consum
one
two
synthet
liquid
diet
week
diet
contain
fat
ipid
suppli
corn
oil
one
satur
fa
lard
satur
fa
total
jejun
enzym
activ
sd
express
nmolesminsampl
follow
thirtyeight
patient
activ
arteriocapillari
gastrointestin
bleed
treat
select
arteri
infus
epinephrin
vasopressin
vasoconstrict
therapi
success
rate
smallvessel
bleed
complet
control
bleed
achiev
twenti
temporari
control
three
control
two
twentyf
patient
gastriti
superfici
stress
ulcer
malloryweiss
syndrom
colon
lesion
select
vasoconstrict
limit
valu
manag
largearteri
bleed
peptic
ulcer
afford
complet
control
two
temporari
control
two
use
control
nine
thirteen
patient
individu
factor
import
conduct
treatment
includ
patient
immedi
viabil
angiograph
demonstr
bleed
charact
locat
bleed
lesion
obtain
degre
infus
select
choic
vasoconstrictor
vascular
respons
achiev
patient
clot
mechan
believ
appropri
chosen
patient
select
vasoconstrictor
therapi
offer
improv
manag
activ
arteriocapillari
gastrointestin
hemorrhag
confus
data
studi
autonom
regul
pancreat
secret
investig
effect
specif
autonom
stimul
block
agent
dog
prepar
duoden
thoma
cannula
gastric
fistula
steadi
state
pancreat
secret
obtain
respons
secretin
ukgmin
secretin
plu
pancreozymin
ukgmin
studi
vagal
stimul
insulin
ukg
lv
parasympatholyt
atropin
mgkg
lv
alphaadrenerg
epinephrin
pgkgmin
alphaadrenolyt
phentolamin
mgkg
betaadrenerg
isoproterenol
pgkgmin
betaadrenolyt
propanolol
mgkg
v
experi
repeat
antrectomi
anim
vagal
stimul
insulin
stimul
enzym
output
without
affect
volum
effect
block
atropin
atropin
absenc
vagal
stimul
inhibit
pancreozyminstimul
enzym
output
without
alter
volum
epinephrin
inhibit
volum
chang
enzym
concentr
phentolamin
produc
transient
increas
enzym
output
isoproterenol
inhibit
volum
enzym
concentr
profoundli
propanolol
effect
antrectomi
markedli
reduc
vagal
mediat
effect
insulin
enzym
output
influenc
atropin
effect
thu
vagal
stimul
primarili
stimul
enzym
secret
effect
depend
vagal
releas
antral
gastrin
atropin
thu
vagolyt
effect
inhibit
permiss
effect
acetylcholin
pancrea
independ
antrum
may
also
direct
andrenerg
effect
predominantli
enzym
fraction
pancreat
secret
evalu
role
gastron
g
rabbit
immun
gastron
b
separ
pool
anacid
human
gastric
juic
pahgj
fraction
fr
gel
filtrat
sephadex
gloo
antigastron
serum
ag
form
singl
precipitin
arc
gel
diffus
differ
pahgj
well
fr
sever
sephadex
pahgj
fraction
pool
acid
human
gastric
juic
one
reutral
vivo
sephadex
fr
contain
precipitin
reaction
occur
potent
antisera
two
normal
human
sera
cohn
fr
ii
specif
de
ag
confirm
abil
remov
gastric
inhibitori
activ
g
soluti
optimum
reaction
mixtur
g
ag
determin
quantit
precipitin
test
accordingli
supernat
reaction
product
g
g
ml
ag
incub
overnight
centrifug
inject
iv
chronic
fistula
rat
effect
volum
acid
output
compar
g
mix
normal
rabbit
serum
treat
similarli
well
g
alon
salin
control
total
assay
use
chronic
gastric
fistula
rat
permit
comparison
individu
rat
variou
experiment
condit
assay
ag
treat
g
demonstr
time
greater
acid
secret
g
alon
ool
similar
seen
salin
control
remov
g
activ
ag
confirm
antibodi
biolog
specif
use
ag
fluorescein
antirabbit
igg
indirect
coon
test
presenc
immunoreact
g
detect
immunofluoresc
surfac
epithelium
pylor
gland
antral
human
gastric
mucosa
pykric
duoden
bulb
gland
dog
local
probabl
reflect
cellular
deriv
g
two
speci
similar
studi
rat
inconclusivehuman
dog
fundal
gastric
mucosa
neg
immunoreact
g
jmmunofluoresc
test
use
normal
rabbit
serum
salin
control
thu
vitro
method
gastron
b
detect
develop
cellular
deriv
gastron
b
antral
epitheli
cell
man
dog
gland
canin
duoden
bulb
demonstr
antigastron
antibodi
may
use
extend
studi
gastron
physiolog
role
gastric
secretori
mechan
human
jejun
glycolyt
enzym
activ
gea
adapt
dietari
sugar
folic
acid
gea
hexokinas
fructokinas
fructoseiphosph
aldolas
pyruv
kinas
higher
high
carbohydr
diet
carbohydratefre
diet
role
adapt
gastrointestin
physiolog
unknown
adapt
import
physiolog
failur
adapt
associ
gastrointestin
diseas
studi
adapt
respons
jejun
gea
group
patient
patient
damag
intestin
muco
celiac
diseas
tropic
sprue
etc
patient
appar
function
gastrointestin
disord
cramp
ga
lightheaded
bloat
diarrhea
neg
gastroenterolog
evalu
group
gea
low
loss
adapt
respons
dietari
sugar
prompt
respons
folic
acid
tropic
sprue
celiac
diseas
tropic
sprue
adapt
respons
sugar
return
toward
normal
therapi
group
patient
fail
adapt
sugar
test
brother
fail
adapt
glucos
restrict
dietari
carbohydr
produc
long
term
improv
year
patient
temporari
improv
month
other
studi
demonstr
failur
jejun
gea
adapt
dietari
sugar
maladapt
associ
gastrointestin
diseas
addit
studi
normal
subject
fed
carbohydratefre
diet
day
produc
nonadapt
state
challeng
acut
gm
oral
glucos
subject
experienc
cramp
bloat
lightheaded
within
hour
sinceit
take
hour
adapt
respons
symptom
occur
first
hour
sugar
ingest
physiolog
maladapt
model
normal
reproduc
symptom
patient
failur
adapt
therefor
propos
intestin
maladapt
syndrom
clinic
entiti
primari
maladapt
patient
normal
mucosa
secondari
maladapt
patient
damag
mucosa
cholic
acid
increas
turnov
intestin
cell
germ
free
mice
pse
bm
recent
shown
invitro
jejun
transport
glucos
increas
bile
fistula
rat
natur
natur
decreas
bile
ligat
anim
interest
see
absorpt
chang
could
relat
way
altera
ion
mucos
cell
prolifer
loss
one
hour
iv
inject
hthymidin
luci
per
g
bodi
weight
spraguedawley
rat
oper
hour
previous
small
bowel
ligament
treitz
ileocec
valv
rapidli
remov
mucosa
scrape
anim
could
distinguish
basi
initi
bodi
weight
weight
loss
intestin
length
mucos
weight
protein
dna
content
howev
dna
sa
cpm
x
mg
dna
significantli
decreas
p
bile
ligat
anim
bile
fistula
rat
compar
sham
anim
cell
loss
evalu
group
rat
normal
salin
infus
hour
rate
mlmin
polyethylen
tube
tie
jejunum
duodenojejun
flexur
wash
collect
cannul
distal
ileum
differ
initi
weight
anim
weight
loss
postop
hour
preced
studi
dna
exfoli
intestin
wash
dri
weight
small
bowel
follow
studi
perfus
dna
content
ug
significantli
lower
p
bile
fistula
bile
ligat
sham
anim
decreas
dna
specif
activ
bile
fistula
ligat
rat
interpret
term
reduct
prolif
cell
pool
induc
interrupt
enterohepat
cycl
bile
acid
disproportion
larg
shed
cell
relat
prolif
activ
bile
ligat
anim
may
affect
transport
gastrointestin
disturb
includ
malabsorpt
often
report
chronic
alcohol
although
small
intestin
mucosa
gener
consid
normal
light
microscopi
therefor
investig
rat
effect
ethanol
electron
microscop
em
appear
mucosa
small
intestin
rat
fed
nutrit
adequ
liquid
diet
contain
total
calori
ethanol
isocalor
carbohydr
month
light
microscopi
intestin
mucosa
appear
normal
rat
fed
ethanol
em
examin
jejun
ileal
villi
show
increas
endoplasm
reticulum
mani
cell
dilat
vesicular
focal
rarefact
matrix
occasion
myelin
figur
present
mitochondria
autophag
vacuol
lysosom
increas
cisterna
golgi
apparatu
often
dilat
crypt
cell
appear
normal
result
rat
prompt
us
attempt
verifi
effect
ethanol
small
intestin
man
nall
intestin
biopsi
obtain
volunt
day
ethanol
administr
total
calori
adequ
diet
alter
seen
light
microscopi
em
chang
similar
rat
note
volunt
except
mitochondri
abnorm
conspicu
mani
cell
mitochondria
irregular
size
shape
often
contain
dens
osmiophil
materi
occasion
crypt
cell
display
irregular
cytoplasm
bleb
extend
lumen
biopsi
specimen
obtain
week
discontinu
ethanol
show
improv
toward
normal
data
indic
chronic
ethanol
ingest
produc
ultrastructur
chang
mucos
cell
small
intestin
presenc
adequ
diet
chang
similar
induc
ethanol
liver
sinc
present
ileum
mere
result
high
intralumin
ethanol
concentr
structur
alter
shown
studi
may
explain
part
impair
gastrointestin
function
chronic
alcohol
plasma
obtain
patient
chronic
inflammatori
bowel
diseas
test
presenc
circul
carcinoembryon
antigen
cea
radioiinununoassay
level
greater
equal
ng
ceaml
posit
assa
random
error
seri
plasma
ng
ceaml
seri
patient
granulomat
diseas
posit
ileocol
show
highest
posit
group
patient
ulcer
show
circul
cea
ulcer
proctiti
show
e
lowest
posit
gener
level
cea
proport
extent
diseas
throughout
gut
diseaseact
level
although
patient
polyp
test
one
ceaposit
ambulatori
healthi
control
neg
cealevel
nonact
normal
control
remain
fairli
constant
rise
level
cea
associ
inflammatori
flareup
may
thu
possibl
diagnost
cancer
studi
vitro
respons
lymphocyt
phytohemagglutininm
pha
patient
crohn
diseas
cd
patient
ulcer
coliti
uc
normal
control
subject
nc
patient
manifest
wide
vari
stage
diseas
activ
none
receiv
steroid
acth
immunosuppress
therapi
separ
studi
patient
cd
uc
receiv
daili
steroid
therapi
st
mg
prednison
fha
ad
triplic
lymphocyt
cultur
stepwis
concentr
pgmml
lymphocyt
respons
determin
day
measur
cellular
incorpor
iudr
group
subject
compar
percent
incorpor
iudr
unstimul
cultur
time
requir
achiev
maxim
stimul
day
concentr
fha
elicit
optim
respons
pgmml
howev
group
differ
magnitud
peak
respons
median
peak
incorpor
nc
uc
cd
st
patient
distribut
maxim
lymphocyt
respons
group
bimod
peak
respons
fall
either
low
rang
high
rang
low
rang
compris
nc
subject
includ
uc
cd
st
patient
convers
high
rang
compris
nc
uc
cd
st
patient
repeat
studi
subject
lymphocyt
respons
vari
differ
day
correl
clinic
statu
absolut
lymphocyt
count
sera
cd
patient
hyporespons
lymphocyt
suppress
phastimul
normal
lymphocyt
similarli
stimul
impair
addit
azulfidin
cultur
concentr
flgmml
conclud
intrins
defect
lymphocyt
respons
common
though
constant
specif
find
patient
cd
uc
gastric
epithelium
normal
act
effect
barrier
back
diffus
hydrogen
ion
virtu
mucu
secret
low
proton
permeabl
mucos
membran
surfac
cell
aspirin
acid
howev
act
p
roton
carrier
across
membran
possibl
damag
cell
either
induc
ph
chang
aspirin
sensit
index
cell
damag
measur
possibl
conduct
pathway
tissu
sever
pathway
epithel
ia
transcellular
transport
occur
across
seros
mucos
membran
cell
seri
paracellular
transport
occur
across
tissu
extracellular
rout
intercellular
molecul
move
cell
cell
via
high
conduct
channel
remain
patent
result
metabol
activ
microelectrod
measur
cell
membran
resist
macroelectrod
measur
tissu
resist
allow
assess
paracel
lular
contribut
transport
across
tissu
one
microelectrod
use
send
current
cell
anoth
use
measur
voltag
chang
cell
function
distanc
current
sourc
estim
rout
obtain
ie
coupl
ing
techniqu
shown
paracellular
rout
minor
signific
gastric
mucosa
differ
cell
type
ie
surfac
pariet
oxynt
chief
cell
act
singl
electr
coupl
system
addit
aspirin
mh
mucos
surfac
mucosa
result
initi
increas
tissu
resist
account
increas
cell
membran
resist
b
larg
decreas
intercellular
conduct
may
due
mitochondri
effect
aspirin
result
higher
intracellular
ca
phase
follow
decreas
tissu
resist
due
increas
paracellular
conduct
approach
thu
allow
quantit
assess
damag
gastric
barrier
precis
definit
locu
action
variou
agent
nih
nsf
stephen
tint
norma
deer
nyu
medic
school
new
york
va
hospit
new
york
new
york
neutral
sterol
composit
determin
gallston
remov
surgic
individu
adult
male
young
southerwestern
american
indian
women
sterol
separ
chromatographi
quantit
gasliquid
chromatographi
identif
sterol
base
upon
correspond
rf
column
retens
time
valu
obtain
sterol
refer
standard
sterol
compris
dri
weight
stone
gramsgram
cholesterol
quantit
import
sterol
constitut
ofth
total
sterol
howev
substanti
quantiti
cholestanol
lajhosterol
lanosterol
plu
methyl
sterol
found
sterol
fraction
gallbladd
bile
aspir
subject
stone
contain
cholesterol
cholestanol
lathosterol
indic
sterol
origin
liver
contrast
sterol
fraction
bile
normal
subject
contain
cholesterol
trace
sterol
result
indlcat
substanti
amount
dihydro
satur
sterol
secret
bile
liver
particip
format
gallston
sterol
detect
usual
colorimetr
assay
satur
configur
carbon
consequ
present
report
may
underestim
total
gallston
sterol
secret
compound
patient
cholelithiasi
point
defect
hepat
biosynthesi
metabol
sterol
patient
endoscop
proven
duoden
ulcer
enter
doubleblind
placebo
control
studi
carbenoxolon
sodium
contain
positionreleas
capsul
duogastron
patient
either
neg
equivoc
barium
meal
respons
week
treatment
assess
symptomat
week
duodenoscopi
week
week
employ
standard
procedur
ulcer
record
photograph
size
assess
refer
anatom
landmark
calibr
biopsi
forcep
patient
treat
carbenoxolon
show
unequivoc
evid
heal
week
compar
j
patient
placebo
p
week
howev
patient
placebo
show
endoscop
evid
heal
compar
carbenoxolon
patient
treat
carbenoxolon
relationship
symptomat
improv
ulcer
heal
ulcer
recur
week
follow
earli
heal
carbenoxolon
diagnosi
assess
heal
duoden
ulcer
shown
accur
duodenoscopi
either
radiolog
analysi
symptom
carbenoxolon
sodium
duogastron
shown
promot
earli
heal
duoden
ulcer
spite
natur
tendenc
ulcer
heal
longer
period
galloway
r
symposium
carbenoxolon
sodium
p
salmon
pr
brown
p
theinhtut
read
ae
gut
butterworth
press
gastric
electr
control
activ
pacesett
activ
stomach
anesthet
dog
stimul
bipolarli
two
silver
wire
electrod
cm
long
cm
apart
usual
msec
puls
v
could
driven
anywher
electr
activ
region
maximum
driven
frequenc
mdf
intact
stomach
cmin
control
wave
site
stimul
phase
lead
control
wave
site
stomach
divid
three
segment
circumferenti
cut
muscl
layer
distal
antral
segment
could
driven
frequenc
cmin
mdf
proxim
middl
segment
cmin
mdf
antral
segment
also
depend
sympathet
parasympathet
activ
g
atropin
iv
rais
mdf
antral
segment
cmin
g
physostigmin
iv
lower
mdf
antral
segment
cmin
mdf
proxim
middl
segment
much
affect
either
drug
intact
stomach
singl
stimuli
appli
differ
site
differ
phase
control
wave
cycl
determin
refractori
properti
oscil
result
similar
report
earlier
ia
inject
acetylcholin
predict
gastric
comput
model
control
wave
cycl
immedi
occurr
control
potenti
absolut
refractori
rest
cycl
rel
refractori
e
prematur
control
potenti
pcp
could
produc
period
stimulu
adequ
amplitud
threshold
valu
stimulu
requir
produc
pcp
fell
progress
rel
refractori
period
conclus
intrins
frequenc
gastric
segment
abil
upper
middl
segment
follow
electr
stimuli
determin
refractori
period
characterist
oscil
mutual
coupl
involv
abil
antrum
driven
may
limit
refractori
period
parasympathet
blockad
otherwis
studi
suggest
possibl
use
electron
pacemak
influenc
gastric
control
activ
henc
mechan
activ
gastric
empti
previou
prospect
random
studi
evalu
select
gastric
vagotomi
vs
truncal
vagotomi
show
select
gastric
technic
superior
achiev
vagal
denerv
stomach
incid
incomplet
vagotomi
select
gastric
vagotom
vs
incid
incomplet
vagotomi
truncal
technic
clinic
benefit
preserv
extragastr
vagal
fiber
impress
follow
observ
select
gastric
vagotomi
usual
achiev
complet
vagal
denerv
stomach
anoth
prospect
random
studi
initi
year
ago
compar
two
adjuv
procedur
antrectomi
pyloroplasti
wide
util
vagotomi
surgic
treatment
duoden
ulcer
followup
studi
obtain
patient
antrectomi
pyloroplasti
evalu
oper
includ
clinic
followup
regular
interv
person
patient
interview
postop
studi
gastrointestin
function
radiolog
examin
gastric
secretori
test
preliminari
report
show
differ
two
group
later
report
continu
followup
observ
year
indic
superior
clinic
result
select
vagotomi
pyloroplasti
two
recurr
ulcer
develop
patient
undergo
antrectomi
recurr
ulcer
occur
patient
pyloroplasti
incid
dump
diarrhea
differ
two
group
acut
hemorrhag
pancreat
induc
dog
techniqu
close
duoden
loop
first
seri
experi
surviv
time
studi
untreat
dog
anim
receiv
inject
vasopressin
ten
untreat
dog
averag
surviv
time
hour
rang
hour
twelv
dog
treat
unit
vasopressinkg
surgeri
unit
vasopressinkg
everi
hour
demis
show
increas
averag
surviv
time
hour
rang
hour
second
seri
experi
gross
microscop
appear
pancrea
close
duoden
loop
examin
hour
period
untreat
dog
compar
dog
receiv
unit
vasopressinkg
everi
hour
pancrea
vasopressin
treat
dog
show
extravas
rbc
wbc
tissu
space
blood
vessel
engorg
edema
acinar
tissu
disrupt
characterist
seen
untreat
dog
present
close
duoden
loop
treat
dog
show
littl
necrosi
villi
fluid
loop
characterist
foul
odor
present
untreat
dog
postul
vasopressin
reduc
intens
experimentallyinduc
pancreat
increas
surviv
rate
increas
permeabl
epitheli
surfac
passag
fluid
duoden
loop
pancreat
duct
prevent
increas
pressur
would
ruptur
pancreat
duct
system
intestin
growth
hexos
absorpt
disaccharidas
activ
enhanc
diabet
rat
despit
stimul
gut
diabet
anim
fail
ro
grow
henc
import
examin
effect
diabet
transport
build
block
nutrient
calcium
studi
match
control
c
alloxan
diabet
rat
situ
perfus
balanc
studi
ca
balanc
posit
c
rat
negitin
rat
significantli
increas
fecal
ca
excret
diabet
howev
show
significantli
increas
effici
fat
absorpt
excret
intak
c
p
situ
perfus
show
net
absorpt
na
lumentoplasma
flux
lp
ca
tooeiignificantli
decreas
duodenum
rat
na
c
lp
c
differ
c
rat
ileal
ca
transport
fed
proc
examin
biochem
mechan
e
renc
duoden
ca
transport
c
rat
studi
calcium
bind
protein
cabp
deluca
biochem
j
mean
specif
activ
crude
duoden
extract
chelex
assay
bound
per
mgml
protein
c
rat
fraction
extract
biogel
p
gave
sharp
cabp
peak
void
volum
c
rat
sp
act
sharp
peak
absent
rat
broad
peak
reduc
activ
sp
act
similarli
fraction
biogel
chromatographi
exhibit
peak
endogen
concentr
cabp
peak
c
rat
present
rat
thu
decreas
duoden
ca
absorpt
rat
associ
decreas
cabp
transport
stimul
ate
suppress
di
abet
di
abet
rat
uniqu
model
studi
mechan
control
intestin
transport
women
hepat
b
antigen
hbag
posit
icter
diseas
pregnanc
transmit
infect
infant
high
frequenc
previous
describ
seri
john
wesler
hospit
schweitzer
spear
new
eng
j
med
includ
mother
overt
diseas
pregnanc
within
month
deliveri
hbag
posit
found
infant
contrast
observ
women
found
asymptomat
carrier
time
del
iveri
reveal
low
frequenc
transmiss
infant
fol
low
motherinf
pair
hbag
posit
found
one
infant
hbag
subtyp
also
demonstr
definit
differ
two
group
mother
overt
hepat
direct
test
weak
hbag
reaction
presumpt
basi
infant
subtyp
hbag
posit
subtypf
found
infant
mother
acut
diseas
subtyp
one
infant
develop
antigenemia
mother
asymptomat
carrier
none
hadth
subtyp
subtyp
thisgroup
result
one
infect
infant
thu
predomin
among
infect
infant
may
one
two
explan
acut
infect
readi
iy
transmit
chronic
infect
frequenc
either
subtyp
among
infant
therefor
explain
term
rel
frequenc
among
acut
case
strain
type
b
viru
biolog
characterist
faci
litat
transmiss
infant
addit
data
center
infect
frequent
acut
hepat
infect
frequent
among
carrier
wi
need
distinguish
possibi
liti
high
activ
pentos
phosphat
shunt
previous
demonstr
isol
gastric
mucosa
rat
fed
proc
insofar
relat
gastric
acid
secret
shunt
activ
might
expect
vari
chang
acid
secret
reason
select
stimul
inhibitor
acid
secret
ad
mucos
supernat
fraction
contain
shunt
enzym
carbachol
histamin
gastrin
cyclic
amp
dinitrophenol
thiocyan
ouabain
ad
mucos
supernat
fraction
howev
rate
shunt
oxi
dati
remai
ned
unchang
compar
wi
th
untreat
pai
red
control
similarli
ratio
label
evolv
glucos
evolv
glucos
c
significantli
increas
addit
carbachol
rat
mucos
slice
incub
radioisotop
convers
rate
shunt
oxid
rat
mucos
supernat
fraction
increas
nearli
threefold
additi
gl
utathi
one
agent
di
appreci
increas
acid
secret
isol
rat
gastric
mucosa
result
support
view
wherea
basal
acid
secret
rat
gastric
mucosa
may
support
shunt
activ
stimul
acid
secret
may
instead
maintain
oxid
altern
like
citric
acid
cycl
hepat
bile
obtain
surgeri
patient
cholesterol
gallston
supersatur
cholesterol
derang
hepat
function
assign
primari
role
format
lithogen
bile
new
eng
j
med
howev
control
data
avail
patient
without
cholesterol
gallston
known
whether
liver
gallston
patient
continu
secret
lithogen
bile
recoveri
cholecystectomi
therefor
examin
rel
composit
j
clin
invest
hepat
bile
obtain
surgeri
patient
cholesterol
gallston
control
subject
pigment
stone
without
hepatobiliari
diseas
indwel
ttube
allow
daili
postop
collect
fast
postprandi
bile
week
cholesterol
gallston
control
patient
surgeri
hepat
bile
cholesterol
gallston
group
supersatur
cholesterol
hepatkbil
control
patient
contain
less
cholesterol
p
postop
fast
postprandi
bile
becam
undersatur
patient
within
day
clamp
ttube
reestablish
enterohepat
circul
patient
cholesterol
gallston
well
control
patient
fast
bile
contain
rel
cholesterol
p
postprandi
bile
signific
differ
patient
group
thu
patient
cholesterol
stone
bile
clearli
differ
control
surgeri
cholecystectomi
bile
revert
pattern
indistinguish
either
cholecystect
pigment
stone
nonston
patient
function
gallbladd
conclud
cholesterol
gallston
diseas
gallbladd
influenc
liver
secret
lithogen
bile
remov
gallbladd
bile
composit
restor
orma
pattern
hypothesi
initi
action
ethanol
stomach
activ
transport
process
investig
use
electrophysiolog
biochem
techniqu
transmucos
potenti
differ
short
circuit
current
electrolyt
concentr
situ
rat
stomach
determin
activ
adenyl
cyclas
membranebound
enzym
respons
format
cyclic
amp
atp
assay
measur
amount
radioact
sadenosin
monophosph
form
adenosin
triphosph
krishna
weiss
brodi
j
pharm
exp
therap
solut
ethanol
lso
mn
nacl
mn
nacl
mn
hcl
instil
mucosa
fast
fat
stomach
minut
threshold
concentr
produc
effect
ethanol
ethanol
mn
nacl
decreas
transmucos
potenti
mv
increas
tissu
electr
resist
chang
pronounc
ethanol
present
mix
naclhcl
solut
nacl
solut
within
minut
topic
ethanol
administr
lumin
chlorid
concentr
decreas
smeq
meq
p
os
time
consist
chang
sodium
potassium
concentr
volum
ethanol
slightli
alter
basal
adenyl
cyclas
activ
inhibit
sodium
fluorid
activ
adenyl
cyclas
earliest
action
alcohol
appear
inhibit
chlorid
transport
sinc
electr
resist
increas
effect
activ
transport
chlorid
rather
ilian
increas
permeabl
back
flux
ion
inhibit
activ
chlorid
transport
postul
inhibit
membranebound
enzym
adenyl
cyclas
support
nih
grant
rol
incid
stress
ulcer
increas
yet
mortal
remain
high
agreement
exist
optim
treatment
current
experiment
stress
ulcer
usual
fail
produc
massiv
hemorrhag
seen
clinic
simpl
reproduc
exsanguin
gastric
mucos
bleed
model
present
one
hundr
ten
cat
prepar
asept
condit
gastric
cannula
indwel
plastic
femor
cathet
ten
day
later
fast
cat
given
histaminebeeswax
mgkg
subcutan
aspirin
rom
cckg
intragastr
two
hour
later
stomach
empti
ethanol
cckg
instil
hour
dose
repeat
cat
weigh
daili
hemoglobin
determin
receiv
ringer
lactat
cckg
first
cat
sacrif
gross
histolog
studi
three
group
studi
evalu
treatment
control
ii
effect
fresh
acd
blood
replac
iii
effect
antacid
cc
bid
intragastr
result
gross
bleed
occur
cat
initi
studi
diffus
eros
present
antral
ulcer
cannula
eros
perfor
combin
lesion
thirtyseven
control
anim
exsanguin
hemoglobin
fall
averag
gr
rang
day
rang
five
antacid
treat
anim
exsanguin
hemoglobin
fall
averag
gr
rang
day
rang
two
ten
transfus
anim
exsanguin
receiv
averag
cckg
rang
cc
kg
conclus
gross
hemorrhag
occur
anim
studi
death
exsanguin
occur
control
prevent
tran
develop
mathemat
model
circulatori
control
gut
determin
whether
metabol
feedback
mechan
could
account
autoregul
blood
flow
autoregulatori
escap
model
consist
four
set
equat
describ
hemodynam
oxygen
transport
local
nervou
effect
mesenter
arteriolar
precapillari
sphincter
tone
local
system
control
interstiti
regul
arteriolar
resist
chang
blood
flow
open
close
precapillari
sphincter
therebi
determin
capillari
densiti
number
open
capillari
diffus
paramet
surfac
area
diffus
distanc
sympathet
activ
enhanc
arteriolar
precapillari
sphincter
tone
comput
simul
model
respond
step
chang
arteri
pressur
autoregul
blood
flow
maintain
oxygen
deliveri
degre
autoregul
increas
whenev
amount
extract
oxygen
blood
decreas
observ
experiment
skelet
muscl
yet
intestin
simul
autoregulatori
escap
sustain
sympathet
activ
caus
fall
mesenter
blood
flow
capillari
densiti
oxygen
deliveri
capillari
densiti
remain
depress
blood
flow
oxygen
deliveri
return
toward
control
end
sympathet
activ
follow
hyperemia
overshoot
capillari
densiti
result
agre
obtain
experiment
howev
model
predict
degre
autoregulatori
escap
poststimul
hyperemia
increas
capillari
densiti
depress
sympathet
input
relationship
yet
examin
experiment
degre
autoregul
vari
greatli
initi
flow
condit
yet
escap
index
chang
slightli
relationship
could
account
failur
experiment
attempt
correl
degre
autoregul
degre
escap
conclud
metabol
feedback
hypothesi
adequ
explain
blood
flow
autoregul
autoregulatori
escap
howev
descript
complet
enough
account
intestin
hemodynam
experiment
condit
eg
venou
pressur
elev
must
also
includ
certain
myogen
properti
intestin
vasculatur
support
grant
number
grant
miss
heart
assoc
us
armi
contract
number
dada
recent
report
cyclic
amp
camp
may
function
intracellularli
second
messeng
beta
adrenerg
stimul
led
us
postul
within
mesenter
vascular
smooth
muscl
increas
intracellular
camp
concentr
regardless
mode
product
would
caus
vasodil
anesthet
dog
measur
blood
flow
superior
mesenter
arteri
electromagnet
flowmetri
monitor
system
arteri
portal
venou
pressur
transduc
control
measur
compar
measur
intraarteri
infus
vasoact
agent
increas
intracellular
level
camp
agent
produc
signific
p
oo
increas
superior
mesenter
arteri
flow
prostaglandin
el
ug
kgl
minl
isoproterenol
uy
kgl
minl
papaverin
mg
kgl
tinl
exogen
camp
mg
kgl
min
dibutyryl
camp
mg
kgl
min
propranolol
block
vasodilatori
effect
isoproterenol
agent
data
consist
hypothesi
increas
camp
level
mesenter
vascular
smooth
muscl
cell
whether
stimul
adenyl
cyclas
isoproterenol
prostaglandin
e
l
inhibit
phosphodiesteras
papaverin
administ
exogen
camp
dibutyryl
deriv
caus
vasodil
although
nonadrenerg
beta
adrenerg
drug
may
alter
camp
level
differ
rout
find
support
view
camp
serv
intracellular
mediat
beta
adrenerg
drugjnduc
vasodil
mesenter
vascular
bed
antiau
detect
incub
australia
antigen
au
test
serum
follow
precipit
antiaubound
au
rabbit
antihuman
igg
igm
plu
polyethylen
glycol
although
precis
threshold
antiau
posit
difficult
determin
cutoff
point
au
precipit
select
inspect
plot
data
criterion
consecut
blood
donor
sera
contain
antiau
donor
deni
recognit
previou
hepat
among
acut
phase
sera
hepat
patient
found
auposit
counterimmunoelectrophoresi
ciep
andor
ria
coexist
antiau
demonstr
ate
anticip
au
suffici
excess
would
preclud
detect
coexist
antiau
vice
versa
among
sera
patient
auneg
hepat
ciep
ria
contain
antiau
number
includ
patient
fulmin
hepat
necrosi
antiau
posit
possibl
explan
increas
frequenc
antiau
group
includ
patient
hepat
due
agent
unrel
au
high
preval
preexist
antiau
reflect
averag
past
exposur
detect
antiau
sera
patient
alcohol
liver
diseas
support
concept
onspecif
aubind
factor
develop
respons
hepat
necrosi
andor
normal
preval
antiau
found
among
patient
halothan
hepat
primari
biliari
cirrhosi
ls
patient
auassoci
hepat
au
still
present
obscur
antiau
might
resolv
determin
antiau
titer
convalesc
sera
though
result
sera
current
avail
group
patient
studi
underway
milk
protein
implic
etiolog
factor
wide
varieti
gastrointestin
problem
infant
children
coliti
like
pictur
infant
month
age
occult
blood
loss
protein
exud
older
infant
steatorrhea
sensit
gluten
protein
attribut
intestin
intoler
one
cow
milk
protein
mani
patient
differ
age
mild
symptamatolog
common
denomin
find
eosinophil
gastroenteropathi
eg
syndrom
character
diarrhea
vomit
peripher
eosinophilia
eosinophil
infiltr
mucos
biopsi
affect
gastrointestin
gi
lesion
fourteen
infant
two
year
age
diagnos
eg
nine
male
seven
infant
present
bloodi
diarrhea
peripher
eosinophilia
intoler
repeatedli
bovin
milk
cereal
month
follow
seven
otherwis
thrive
infant
month
age
present
sign
allerg
gastroenteropathi
ie
iron
defici
anemia
accult
blood
stool
proteinlos
enteropathi
rel
mild
gi
complaint
anemia
excess
stool
protein
loss
eosinophilia
clear
dietari
manipul
three
simpl
milk
product
withdraw
three
requir
elimin
milk
product
plu
beef
veal
one
remov
milk
product
gluten
last
clear
remov
milk
product
gluten
anim
protein
except
eosinophil
infiltr
biopsi
small
intestin
colon
normal
studi
steatorrhea
occur
concurr
glutenintoler
three
older
infant
show
addit
unexplain
specif
profound
clinic
intoler
develop
shock
like
state
ingest
rice
two
case
chicken
one
instanc
antibodi
bovin
protein
sera
stool
absent
primari
immunolog
abnorm
chang
serum
complement
note
protein
intoler
persist
molth
pflfollow
manifest
shock
bloodi
diarrhea
eosinophilia
measur
protein
cha
lenq
hyperallment
syndrom
stephen
e
silvi
pablo
paraga
jr
gi
section
veteran
administr
hospit
univ
minn
minneapoli
minn
three
case
unusu
complic
parenter
hyper
aliment
observ
malnourish
individu
case
develop
mark
hypophosphatemia
mean
serum
phosphat
mg
muscular
weak
two
three
patient
paresthesia
convuls
coma
one
patient
die
coma
studi
done
produc
similar
reaction
starv
anim
mongrel
dog
weight
loss
infus
fibrin
hydrolys
andor
glucos
superior
vena
cava
cathet
rate
calkiloday
starv
dog
mean
surviv
day
control
anim
surviv
sacrif
day
profound
fall
serum
inorgan
phosphat
occur
starv
anim
mean
serum
phosphat
starv
anim
mg
fifth
day
serum
phosphat
control
anim
mg
time
serum
electrolyt
osmol
remark
result
observ
glucos
amino
acid
glucos
alon
equival
amount
mainten
serum
phosphat
normal
level
influenc
mortal
starv
dog
starv
rat
weight
loss
infus
calkiloday
mean
surviv
day
control
rat
infus
rate
mean
surviv
day
rate
reduc
starv
rat
surviv
increas
day
starv
rat
maintain
constant
weight
week
infus
calkiloday
mortal
respect
mortal
observ
infus
rate
immedi
weight
loss
starv
rat
infus
calkiloday
mortal
calori
increas
calkiloday
either
dextros
amino
acid
mortal
increas
total
fast
infus
rat
weight
loss
decreas
mortal
compar
chronic
starv
infus
anim
studi
demonstr
fatal
reaction
starv
human
dog
rat
high
calor
infus
fatal
reaction
produc
glucos
alon
glucos
amino
acid
chronic
starvat
continu
weight
loss
appear
import
product
syndrom
etiolog
syndrom
undetermin
known
pancreat
digest
enzym
transport
endoplasm
reticulum
golgi
complex
zymogen
granul
thenc
secret
cell
use
pulselabel
techniqu
subcellular
fraction
migrat
c
label
protein
microsom
zymogen
granul
secret
medium
may
examin
studi
rat
pancreata
puls
labe
led
vitro
c
influenc
certain
drug
migrat
secret
pancreati
c
protein
investig
bethanechol
chlorid
alter
transport
microsom
zymogen
granul
increas
secret
label
granul
medium
puromycin
well
known
inhibitor
protein
synthesi
alter
rate
transport
label
microsom
zymogen
granul
alter
secret
label
medium
amphotericinb
tetracyclin
impair
transport
microsom
zymogen
granul
well
secret
label
zymogen
granul
medium
lidocain
impair
releas
zymogen
granul
medium
although
increas
secret
preform
amylas
use
techniqu
process
eventu
synthesi
transport
secret
pancreat
digest
protein
examin
renew
interest
ethanol
metabol
demonstr
microsom
ethanol
oxidizingsystem
differ
found
rate
ethanol
metabol
alcohol
subject
object
present
summer
result
obtain
standard
ethanol
absorpt
test
studi
carri
volunt
subject
use
ethanol
water
ml
per
kg
bodi
weight
administ
fast
state
blood
sampl
taken
minut
ethanol
blood
concentr
determin
ga
chromatographi
subject
maximum
blood
ethanol
concentr
reach
minut
subject
peak
reach
minut
subject
delay
absorpt
peak
minut
observ
accord
maximum
ethanol
blood
concentr
patient
divid
three
group
low
maximum
gil
subject
standard
maximum
gil
subject
high
maximum
gil
subject
slope
ethanol
oxid
curv
vari
relat
found
rate
absorpt
maximum
blood
ethanol
concentr
conclud
consider
individu
variat
exist
ethanol
absorpt
rate
standard
test
may
use
elucid
variou
paramet
alcohol
metabol
includ
gastric
absorpt
ethanol
oxid
effect
hepat
injuri
hepat
bile
hb
gallbladd
bile
gbb
cholesterol
stone
former
shown
satur
supersatur
cholesterol
lithogen
bile
normal
subject
uhsatur
sinc
popul
countri
previous
studi
detail
composit
hb
gbb
stone
former
examin
sampl
obtain
oper
stone
former
control
patient
pigment
stone
without
gallston
diseas
stone
former
biliari
fistula
multipl
hb
sampl
obtain
ceas
extern
biliari
drainag
rel
proport
bile
salt
phospholipid
cholesterol
measur
sampl
determin
lithogen
sampl
examin
microscop
cholesterol
microcryst
proport
individu
bile
salt
amount
lecithin
lysolecithin
determin
bile
stone
former
chang
found
rel
amount
individu
bile
salt
lysolecithin
made
total
phospholipid
cholesterol
crystal
found
lithogen
bile
previous
accept
criteria
lithogen
therefor
appear
valid
howev
gbb
sampl
stone
former
lithogen
hb
sampl
although
control
produc
lithogen
bile
mark
overlap
stone
former
control
degre
cholesterol
satur
bile
sampl
hb
bile
fistula
patient
vari
unsatur
supersatur
even
reconstitut
patient
bile
salt
pool
result
indic
l
contrari
earlier
studi
possibl
separ
stone
former
control
studi
random
sampl
hepat
gallbladd
bile
product
lithogen
bile
liver
continu
process
intermitt
one
establish
cyclic
amp
intermedi
stimul
acid
secret
histamin
criteria
fulfil
inhibitor
phosphodiesteras
produc
secret
cyclic
amp
mimic
effect
histamin
adenyl
cyclas
stimul
histamin
level
cyclic
amp
tissu
secret
increas
addit
histamin
case
necturu
vitro
gastric
mucosa
nonsecret
mount
uss
chamber
theophyllin
cyclic
amp
stimul
acid
secret
adenyl
cyclas
present
membran
fraction
tissu
stimul
histamin
pentagastrin
cyclic
amp
level
tissu
also
increas
theophyllin
contrast
case
dog
theophyllin
neither
stimul
secret
alter
histamin
dose
respons
inject
cyclic
amp
stimul
acid
secret
fact
may
inhibit
cyclic
amp
level
tissu
slightli
increas
theophyllin
although
tissu
contain
typic
phosphodiesteras
one
five
dog
cyclic
amp
level
gastric
juic
increas
histamin
stimul
adenyl
cyclas
present
purifi
membran
fraction
monitor
ampas
electron
microscopi
variabl
stimul
histamin
insensit
fluorid
base
observ
consider
evid
cyclic
amp
intermedi
amphibian
acid
secret
dog
howev
situat
appear
consider
complex
moment
evid
argu
second
messeng
role
nucleotid
postop
peptic
ulcer
patient
vagotomypyloroplasti
vagotomi
bii
insul
test
tolbutamid
test
result
signific
prolong
gastric
acid
inhibit
basal
acid
output
meqhr
consist
higher
poststimul
hour
hour
maxim
inhibit
usual
occur
within
first
hour
involv
decreas
volum
acid
concentr
total
acid
output
insul
ii
tolbutamideinduc
inhibitori
respons
repeat
test
altern
agent
result
convers
posit
respons
signific
differ
acid
respons
initi
repeat
test
occur
second
hour
inject
hypoglycem
agent
test
p
use
kcl
infus
instanc
doubt
signific
convers
posit
case
inhibit
insul
tolbutamid
repeat
altern
test
fail
convert
seven
recurr
ulcer
duoden
gastric
stomal
associ
test
convert
clearli
posit
misinterpret
acid
inhibit
induc
hypoglycemia
neg
respons
led
sever
erron
report
recurr
ulcer
face
complet
vagotomi
e
xact
mechan
circumst
respons
acid
inhibit
hypoglycemia
till
unc
ear
prolong
remiss
cure
accomplish
appropri
antibiot
therapi
whippl
diseas
clinic
symptom
complex
pa
posit
materi
biopsi
light
microscopi
suggest
diagnost
confirm
must
await
electron
micrograph
reveal
yet
unidentifi
bacilliform
bodi
small
bowel
mucosa
duodenoscopi
present
report
disclos
previous
describ
gross
buttermilk
sky
appear
duoden
mucosa
characterist
may
prove
help
establish
earli
diagnosi
present
find
correl
well
light
electron
microscop
examin
diminish
almost
complet
disappear
clinic
anatom
patholog
improv
three
seven
month
followup
examin
effect
synthet
ctermin
octapeptid
op
cholecystokinin
squibb
institut
medic
research
new
brunswick
nj
gall
bladder
gb
size
studi
male
volunt
three
subject
studi
follow
dose
ngkg
op
inject
intraven
one
minut
subject
underw
cholecystographi
twice
op
inject
one
day
salin
alon
control
anoth
day
doubleblind
fashion
order
inject
random
gb
xray
film
obtain
minut
inject
vital
sign
serial
blood
chemistri
measur
symptom
follow
inject
record
gb
area
measur
planimetri
percentag
reduct
area
determin
dose
maximum
decreas
gb
area
occur
minut
op
inject
salin
alon
mean
area
vari
within
preinject
area
one
subject
experienc
nausea
ngkg
one
nausea
abdomin
cramp
ngkg
symptom
last
minut
signific
chang
vital
sign
blood
chemistri
op
conclud
op
cholecystokinet
agent
man
ngkg
effect
higher
dose
test
aim
project
conduct
control
therapeut
trial
use
antacid
anticholinerg
antipept
agent
activ
duoden
ulcer
diseas
diagnosi
base
upon
clinic
symptom
roentgen
demonstr
ulcer
crater
design
studi
doubleblind
consecut
patient
randomli
assign
one
four
treatment
group
antacidaluminum
hydroxid
mg
magnesium
oxid
mg
singl
capsul
anticholinerg
propanthelin
mg
antipept
agent
amylopectin
sulfat
mg
combin
mg
propanthelin
mg
amylopectin
sulfat
capsul
ident
appear
code
patient
ask
take
one
capsul
everi
two
hour
wake
period
therapeut
success
evalu
basi
rapid
relief
symptom
prompt
heal
ulcer
persist
ulcer
distress
beyond
therapi
andor
appear
complic
consid
failur
total
patient
duoden
ulcer
admit
studi
drop
patient
remain
studi
result
follow
patient
antacid
therapi
good
result
observ
poor
result
patient
propanthelin
therapi
good
result
observ
poor
result
patient
amylopectin
sulfat
therapi
good
result
observ
poor
result
lrlo
patient
combin
propanthelin
amylopectin
sulfat
good
result
observ
poor
result
lrlo
analysi
data
show
evid
failur
rate
within
form
treatment
depend
upon
clinic
paramet
ie
durat
symptom
intens
abdomin
pain
occurr
radiat
nocturn
pain
chisquar
analysi
reveal
failur
rate
significantli
higher
antacid
propanthelin
group
amylopectin
sulfat
group
thu
amylopectin
sulfat
antipept
agent
good
antiulc
drug
distinct
made
hepat
associ
australia
antigen
u
l
hepat
associ
studi
prospect
patient
posttransfus
hepat
philadelphia
gener
hospit
receiv
least
one
unit
au
l
contain
blood
receiv
blood
antigen
detect
au
oa
group
similar
respect
age
sex
number
unit
transfus
number
clinic
followup
visit
seven
au
l
recipi
develop
detect
serum
au
l
one
develop
antibodi
neither
antigen
antibodi
found
sera
au
recipi
group
similar
clinic
sign
symptom
three
au
l
recipi
four
au
recipi
becam
jaundic
sinc
icter
incub
period
taken
time
transfus
first
observ
serum
glutam
pyruv
transaminas
sgpt
elev
median
incub
period
au
l
case
day
rang
au
case
day
rang
signific
differ
differ
time
reach
maximum
sgpt
durat
sgpt
elev
maximum
sgpt
level
similar
group
maximum
serum
bilirubin
prothrombin
time
histolog
distinct
could
made
median
peak
serum
alkalin
phosphatas
au
l
recipi
intern
unit
iu
au
recipi
iu
signific
differ
two
group
suggest
obstruct
factor
found
often
recipi
au
blood
sole
except
se
find
indic
hospit
patient
distinguish
featur
hepat
occur
recipi
au
l
vs
au
blood
regard
incub
period
symptom
physic
find
clinic
cours
laboratori
find
sever
diseas
support
grant
nation
institut
health
offic
naval
research
appropri
commonwealth
pennsylvania
endogen
catecholamin
norepinephrin
ne
epinephrin
e
vasoconstrictor
canin
mesenter
circul
regardless
dose
method
inject
swan
gastroenterolog
sinc
respons
vascular
bed
experiment
shock
distinctli
differ
dog
monkey
swan
gastroenterolog
question
aris
effect
catecholamin
mesenter
circul
subhuman
primat
adult
oliv
baboon
papio
anubi
anesthet
pentobarbit
superior
mese
nteric
arteri
blood
flow
mbf
measur
electromagnet
flowmet
first
branch
superior
mesenter
arteri
cannul
intraarteri
ia
drug
infus
system
arteri
ap
portal
venou
pp
pressur
measur
control
period
mbf
se
mlmin
ap
pp
mm
hg
ia
infus
pgkgmln
caus
progress
incr
se
mbf
andat
minut
valu
mlmin
significantli
greater
control
p
mbf
remain
elevat
level
durat
minut
infus
follow
cessat
infus
mbf
return
control
concentr
ne
caus
vasoconstrict
character
autoregulatori
escap
dose
catecholamin
increas
pgkgmin
e
exert
vasoconstrictor
effect
reduc
mbf
mlmin
within
one
minut
p
mbf
remain
depress
som
tendenc
toward
autoregulatori
escap
end
minut
infus
ne
exhibit
similar
respons
dose
find
reveal
vasodil
effect
epinephrin
upon
mesenter
circul
subhuman
primat
effect
dose
depend
contrast
observ
dog
equat
dose
concentr
circul
catecholamin
measur
experiment
shock
monkey
suggest
epinephrin
would
like
effect
increas
rather
decreas
flow
gut
shock
cyclic
amp
stimul
gastric
acid
secret
vitro
frog
anesthet
rat
studi
unanesthet
rat
perman
gastric
fistula
show
effect
dbcamp
basal
gastric
secret
physiolog
set
male
rat
mean
wt
gm
fit
stainless
steel
cannula
train
five
day
restrain
cage
hr
glucos
diet
salin
infus
continu
via
tail
vein
secretori
rate
stabil
basal
gastric
secret
collect
four
ismin
period
depend
drainag
next
dbcamp
loougmin
ad
infus
gastric
secret
collect
three
ismin
period
dbcamp
remov
infus
collect
gastric
juic
continu
two
ismin
period
valu
shown
rat
express
total
per
min
period
basal
role
sympathet
nervou
system
control
gastrointestin
function
uncertain
studi
sympathet
activ
rat
gut
use
tritiat
norepinephrin
hne
tracer
dose
inject
tail
vein
unanesthet
anim
endogen
ne
concentr
fraction
turnov
rate
halflif
turnov
rate
ne
determin
esophagu
nonglandular
glandular
portion
stomach
duodenum
jejunum
ileum
colon
concentr
endogen
ne
vari
ugg
highest
duodenum
colon
p
oo
compar
tissu
studi
group
fraction
turnov
rate
halfliv
duodenum
k
hr
jejunum
k
hr
ileum
k
hr
colon
k
hr
significantli
greater
esophagu
k
hr
nonglandular
stomach
k
hr
glandular
stomach
k
hr
p
oo
ne
turnov
rate
reflect
level
sympathet
activ
g
ne
releasedg
tissuehour
highest
colon
duodenum
studi
demonstr
applic
tracer
method
gut
suggest
way
effect
sympathet
nervou
system
normal
gastrointestin
physiolog
pathophysiolog
may
studi
use
silversilv
chlorid
electrod
place
phrenoesophag
ligament
isol
perfus
canin
stomach
esophagu
electr
activ
record
similar
intact
dog
low
amplitud
mv
low
frequenc
electr
record
obtain
electrod
usual
definit
pattern
distal
sphincter
electr
activ
superimpos
steadi
baselin
chang
even
thouh
rest
gastroesophag
sphincter
pressur
alter
phasic
cpm
proxim
part
sphincter
larger
action
potenti
mv
cp
superimpos
coincid
phasic
increas
pressur
gastroesophag
sphincter
chang
proxim
distal
part
gastroesophag
sphincter
relat
antral
electr
phase
pressur
electr
activ
could
ever
record
bodi
esophagu
balloon
distens
esophagu
caus
distal
part
sphincter
relax
accompani
reduct
basic
electr
activ
distal
proxim
part
sphincter
relax
follow
contract
relat
fast
activ
noradrenalin
adrenalin
larg
dose
acetylcholin
pentagastrin
caus
contract
sphincter
fast
activ
proxim
isoprenalin
produc
relax
chang
electr
activ
none
drug
alter
electr
activ
distal
part
sphincter
intraarteri
sodium
thiopenton
abolish
electr
activ
electrod
associ
fall
sphincter
pressur
consider
disagr
normal
level
urinari
excret
indican
valu
test
suspect
stagnant
loop
syndrom
studi
undertaken
investig
two
problem
one
hundr
forti
one
control
patient
examin
mean
indican
excret
hr
sd
posit
correl
dietari
tryptophan
indican
excret
group
r
p
dietari
increas
tryptophan
contain
protein
increas
g
tryptophan
per
day
randomli
select
group
control
increas
urinari
indican
excret
significantli
hr
sd
p
one
hundr
fifti
post
gastrectomi
patient
examin
rais
indican
level
found
patient
affer
loop
creat
surgeri
ardtherebi
liabl
bacteri
colonis
mean
tryptophan
intak
group
significantli
less
control
correl
dietari
tryptophan
indican
p
signific
associ
weight
loss
indican
p
faecal
fat
indican
r
p
patient
whose
jejun
flora
examin
rais
indican
e
coli
organismsmi
patient
normal
indican
e
coli
count
organismsmi
conclud
normal
level
indican
excret
depend
dietari
tryptophan
intak
factor
becom
insignific
search
evid
small
bowel
bacteri
overgrowth
gastric
surgeri
gastrin
believ
playa
crucial
role
control
rate
gastric
acid
secret
man
fast
serum
gastrin
level
patient
duoden
ulcer
shown
increas
normal
present
studi
direct
examin
compar
gastrin
releas
normal
individu
patient
duoden
ulcer
respons
physiolog
stimulu
addit
duoden
ulcer
patient
prior
pyloroplasti
vagotomi
antrectomi
vagotomi
studi
studi
perform
subject
fast
sera
obtain
prior
ingest
proteinrich
meal
gm
beef
five
minut
interv
thereaft
radi
oimmunoassay
mean
fasti
ng
serum
gastri
n
concentrati
patient
duoden
ulcer
sem
pgml
differ
control
subject
pgml
rel
plateau
serum
gastrin
concentr
achiev
group
interv
minut
follow
feed
respons
feed
mean
serum
gastrin
concentr
control
subject
increas
increment
pgml
wherea
mean
serum
gastrin
concentr
patient
duoden
ulcer
diseas
increas
increment
pgml
mean
serum
gastrin
concentr
patient
prior
antrectomi
pgml
increas
follow
feed
contrast
patient
prior
vagotomi
pyloroplasti
fast
level
pgml
increas
serum
gastrin
concentr
increas
significantli
greater
control
subject
differ
unoper
duoden
ulcer
patient
summari
result
thi
studi
ndi
cate
increas
gastri
n
releas
respons
feedi
ng
duoden
ulcer
patient
patient
follow
vagotomi
pyloroplasti
follow
antrectomi
vagotomi
thu
studi
indic
spite
absenc
fast
hypergastrinemia
potenti
import
gastrin
hypersecretori
state
frequent
character
duoden
ulcer
diseas
previous
identifi
increas
concentr
gastrin
fast
sera
patient
zollingerellison
tumor
howev
date
report
serum
gastrin
level
patient
gastric
carcinoma
present
studi
patient
carcinoma
stomach
fast
serum
gastrin
concentr
measur
radioimmunoassay
basal
maximum
peak
gastric
acid
output
rate
determin
patient
place
three
group
carcinoma
locat
antrum
bodi
stomach
region
antralbodi
junction
mean
fast
serum
gastrin
level
patient
antral
carcinoma
sem
pgml
differ
similar
control
popul
pgml
mean
fast
serum
gastrin
level
carcinoma
antralbodi
junctur
region
gastric
bodi
elev
p
ool
pgml
pgml
respect
three
group
patient
mark
differ
basal
maxim
peak
acid
output
gastric
secretori
rate
also
found
mean
basal
maxim
peak
acid
output
patient
carcinoma
antrum
meqhr
respect
wherea
carcinoma
involv
antralbodi
junction
region
meqhr
acid
secretori
rate
lowest
carcinoma
gastric
bodi
four
five
patient
achlorhydr
patient
invers
relationship
fast
serum
gastrin
concentr
rate
gastric
acid
secret
mark
fast
hypergastrinemia
patient
carcinoma
bodi
stomach
almost
achlorhydr
degre
patient
pernici
anemia
neglig
amount
gastrin
less
pgmg
found
tumor
tissu
provid
evid
observ
hypergastrinemia
result
gastrinreleas
gastric
carcinoma
studi
reveal
substanti
elev
serum
gastrin
concentr
p
oool
patient
carcinoma
gastric
bodi
antralbodi
junction
region
particularli
mark
reduct
gastric
acid
secretori
rate
gastric
sinc
childhood
peptic
ulcer
registri
establish
peptic
ulcer
report
registri
one
hundr
fifti
nine
children
ulcer
studi
treat
statist
studi
show
male
femal
duoden
ulcer
gastric
ulcer
famili
histori
posit
ulcer
children
fifti
eight
children
surgic
procedur
perform
repres
total
number
ulcer
ulcer
may
occur
congenit
diseas
gastrointestin
tract
ulcer
follow
burn
usual
time
hemorrhag
day
frequent
fatal
p
ostburn
complic
sepsi
ulcer
may
occur
complic
cystic
fibrosi
acut
gastroduoden
ulcer
may
follow
cardiovascular
surgeri
ulcer
rare
complic
hiatal
hernia
hypoglycemia
may
etiolog
factor
peptic
ulcer
may
complic
gastric
surgeri
gastric
ulcer
pylor
obstruct
common
ferrou
sulfat
poison
peptic
ulcer
may
occur
liver
diseas
hepat
portal
hypertens
neonat
ulcer
may
occur
usual
hemorrhag
perfor
day
region
enter
ulcer
coliti
may
complic
duoden
ulcer
rokitanskycush
ulcer
occur
intracrani
diseas
acut
ulcer
demand
emerg
therapi
stress
ulcer
occur
hypoxia
fever
surgeri
shock
life
threaten
situat
ulcer
may
follow
steroid
therapi
children
occur
ill
polyarter
nephrosi
rheumatoid
arthriti
ulcer
coliti
world
literatur
plu
registri
yield
total
case
peptic
ulcer
children
treat
surgic
trauma
uncommon
caus
ulcer
children
one
case
zollingerellison
syndrom
report
registri
case
recent
collect
tumor
registri
report
wilson
calcium
transport
rat
cecum
ernest
urban
thoma
c
smith
dept
physiol
medicin
univers
texa
medic
school
san
antonio
san
antonio
texa
previou
studi
report
calcium
ca
movement
across
rat
colon
vivo
appear
follow
ca
concentr
gradient
lumen
serum
gastroenterolog
order
better
defin
ca
transport
colon
effect
electr
forc
requir
consider
investig
vitro
transmur
ca
movement
cecum
normal
rat
use
short
circuit
current
techniqu
uss
zerahn
acta
physiol
scand
cecum
clamp
two
lucit
halfcel
bath
either
sodium
ringer
nar
cholin
ringer
chr
usual
contain
mm
ca
continu
aerat
glucos
g
mg
ml
also
present
experi
short
circuit
current
scc
appli
min
potenti
differ
pd
measur
min
min
unidirect
ca
flux
measur
ad
radioact
either
mucos
previou
studi
laboratori
demonstr
growth
hormon
partial
pro
e
ct
product
restraintstress
ulcer
rat
also
promot
heal
ulcer
aftt
induc
present
studi
preliminari
report
use
human
growth
hormon
hgh
patient
massiv
hemorrhag
stress
ulcer
stress
ulcer
cument
patient
gastroscopi
patient
bled
massiv
requir
larg
volum
blood
sever
day
week
potenti
bleed
lesion
rule
patient
continu
bleed
massiv
medic
therapi
surgeri
patient
neoplast
diseas
present
patient
sourc
bleed
hgh
administ
subcutan
patient
dose
mg
daili
four
six
patient
appar
stop
bleed
within
hour
fifth
patient
stop
bleed
temporarili
exsanguin
sixth
patient
bleed
slow
appear
stop
patient
die
suddenli
undetermin
reason
repeat
gastro
copi
two
patient
show
heal
gastri
c
eros
administr
sever
dose
hgh
mechan
action
hgh
benefici
eff
ct
bleed
stress
ulcer
known
origin
hypothesi
suggest
ction
base
stimul
dna
rna
protein
synthesi
counteract
eff
ct
stress
gastri
c
mucosa
howev
sinc
patient
stop
bleed
hour
hgh
possibl
benefi
cial
effect
mediat
via
hemostat
mechan
view
grave
prognosi
patient
stress
ulcer
small
experi
hgh
seem
warrant
report
dog
truncal
vagotomi
increas
acid
output
heidenhain
pouch
respons
meal
increas
acid
output
could
due
either
increas
serum
gastrin
releas
decreas
releas
inhibitor
vagal
control
four
dog
heidenhain
pouch
gastric
fistula
fed
gkg
beef
liver
serum
gastrin
respons
measur
radioimmunoassay
heidenhain
pouch
acid
output
determin
truncal
vagotomi
perform
studi
repeat
week
later
complet
vagotomi
confirm
failur
insulin
elicit
acid
respons
gastric
fistula
vagotomi
heidenhain
pouch
peak
acid
output
respons
meal
increas
min
p
basal
serum
gastrin
vagotomi
pgml
differ
prevagotomi
pgml
howev
peak
postprandi
serum
gastrin
concentr
lower
follow
vagotomi
vs
pgml
p
integr
hr
gastrin
output
baselin
vs
hr
p
indic
vagotomi
result
moder
decreas
serum
gastrin
respons
feed
doserespons
studi
reveal
signific
increas
p
calcul
maxim
respons
heidenhain
pouch
pentagastrin
follow
vagotomi
dose
requir
elicit
halfmaxim
respons
unchang
respons
histamin
unchang
studi
indic
increas
heidenhain
pouch
acid
respons
meal
follow
vagotomi
due
increas
antral
gastrin
releas
instead
appear
pouch
sensit
gastrin
remov
vagallymedi
noncompetit
inhibitor
gastrin
well
known
carcinoid
syndrom
cs
abnorm
larg
percentag
circul
tryptophan
divert
normal
metabol
pathway
substrat
increas
synthesi
serotonin
sht
relat
indol
substanc
result
decreas
blood
would
expect
might
playa
part
genesi
carcinoid
heart
lesion
sinc
defici
one
prerequisit
experiment
product
carcinoidlik
heart
lesion
guinea
pig
spatz
evalu
measur
made
plasma
serum
sht
level
cs
patient
larg
number
normal
individu
plasma
serum
sht
determin
fluorimetr
appropri
extract
cs
patient
evid
carcinoid
heart
diseas
evid
cardiac
diseas
plasma
level
normal
adult
rang
iss
mcg
ml
mean
cs
patient
plasma
level
rang
mcgf
ml
mean
normal
rang
serum
sht
mcgfml
mean
previous
establish
control
subject
serum
silt
level
cs
patient
rang
mcgfml
mean
silt
level
correl
plasma
level
cs
patient
heart
diseas
level
megfml
mean
cs
patient
without
heart
diseas
level
mcgfml
mean
serum
silt
cs
patient
heart
diseas
rang
meg
fml
cs
patient
without
heart
diseas
silt
rang
mcgfml
data
support
previou
report
other
silt
level
cs
correl
presenc
absenc
carcinoid
heart
diseas
addit
conclud
plasma
level
almost
invari
reduc
cs
patient
degre
reduct
correl
presenc
absenc
carcinoid
heart
diseas
studi
support
part
carcinoid
tumor
serotonin
research
foundat
inc
year
elaps
sinc
ivi
clearli
establish
intestin
dog
releas
humor
stimul
gastric
acid
secret
appropri
stimul
littl
progress
made
sinc
defin
physiolog
characterist
substanc
three
compound
increas
acid
output
known
exist
within
gastrointestin
tissu
gastrin
cholecystokinin
cck
histamin
follow
experi
design
test
whether
intestin
stimul
acid
physiolog
similar
substanc
first
experi
dog
prepar
chronic
gallbladd
fistula
gastric
fistula
thiryvella
loop
proxim
jejunum
jejun
loop
perfus
n
hcl
solut
mlhr
stomach
secret
min
w
gallbladd
contract
occur
intestin
perfus
mm
iphenylalanin
solut
releas
cck
contract
gallbladd
strongli
stimul
gastric
acid
weakli
next
studi
serum
gastrin
measur
made
gastric
secret
stimul
acid
perfus
thiryvella
loop
basal
serum
gastrin
pgml
h
output
zero
serum
gastrin
pg
ml
w
secret
min
stimul
rise
statist
insignific
could
account
observ
secret
anoth
studi
found
maxim
dose
histamin
dihydrochlorid
mgkghr
administ
continu
intraven
infus
perfus
jejun
loop
acid
increas
plateau
secret
gastric
fistula
meq
w
per
min
addit
histamin
increas
secret
histamin
probabl
acid
stimul
come
small
intestin
therefor
conclud
intestin
stimul
compound
distinct
cck
gastrin
histamin
radiologist
defin
sever
constant
reproducihl
landmark
distal
esophagu
experi
persever
possihl
correl
roentgenolog
event
distal
esophagu
actual
intralumen
contract
seen
endoscop
movi
film
repetit
sequenti
still
pictur
taken
esophagoscopi
may
match
centimeterhycentimet
barium
fill
esophagram
muscular
alevel
contract
entranc
vestihul
present
dynam
symmetr
contractil
ring
fix
level
esophagu
concentr
closur
ring
give
appear
rosett
near
distal
esophagu
esophag
vestihul
locat
distal
ring
contract
shorten
wrinkl
wall
second
rosett
previous
descrih
distal
esophag
rosett
appear
bottom
vestibul
wall
converg
pass
diaphragm
rosett
remain
close
time
distal
submerg
segment
visihl
mucos
junction
locat
within
tongu
gastric
mucosa
frequent
seen
posterior
aspect
esophag
side
distal
esophag
rosett
precis
correl
radiolog
fiber
optic
endoscop
studi
permit
use
studi
function
anatomi
distal
esophag
close
mechan
movi
still
photograph
anatom
correl
shown
relationship
stimul
intrins
nerv
esophagu
contract
smooth
muscl
studi
strip
opossum
esophagu
esophagi
taken
adult
anim
open
lengthwis
mucosa
remov
distal
cm
esophagu
cut
transvers
strip
cm
wide
strip
contain
manili
circular
muscl
place
tissu
bath
fill
krebsring
solut
one
end
strip
fix
end
attach
forc
displac
transduc
contract
elicit
transmur
stimul
second
train
electr
puls
millisecond
durat
interv
deliveri
train
puls
vari
second
strip
contract
second
period
stimul
afterward
interv
train
short
contract
occur
last
train
deliv
two
gradient
respons
strip
stimul
observ
first
strip
taken
orad
portion
esophagu
respond
faster
rate
stimul
strip
taken
distal
area
second
time
end
stimulu
begin
contract
increas
progress
strip
taken
distal
area
esophagu
measur
membran
electr
activ
contractil
respons
transmur
stimul
made
sucrosegap
apparatu
stimul
hyperpolar
membran
follow
gradual
depolar
level
spike
potenti
contract
occur
conclus
peristalt
sequnc
contract
esophagu
may
due
partli
gradient
delay
stimul
contract
circular
muscl
gradient
delay
may
reflect
differ
membran
electr
activ
along
esophagu
support
research
grant
use
tripl
lumen
tube
mea
ure
fat
absorpt
rate
intraduoden
perfus
man
lipid
mix
meal
contain
corn
oil
skim
milk
glucos
tracer
amount
triether
polyethylen
glycol
use
oil
aqueou
dilut
marker
respect
mea
l
perfus
midduodenum
minut
collect
jejun
content
made
everi
minut
portal
cm
distal
site
infus
rate
total
absorpt
distal
portal
steadi
state
condit
normal
sd
mgmincm
intestin
absorpt
rate
fat
correla
ted
posit
micellar
fat
concentra
tion
normal
biliari
deplet
state
chronic
pancreat
sprue
micella
r
fatti
acid
normal
r
ang
absorpt
rate
low
one
patient
chronic
pancreat
steatorrhea
absorpt
rate
per
cent
lipolysi
diminish
also
icellar
fatti
acid
concentr
low
despit
normal
level
bile
salt
wherea
subject
studi
micellar
fatti
acid
concentr
highli
correl
bile
salt
concentra
tion
observ
consist
idea
diminish
rate
step
fat
digest
may
lead
l
ower
absorpt
rate
furthermor
lower
absorpt
rate
result
diminish
micellar
fatti
acid
secondari
decreas
lipolysi
bile
salt
concentr
shown
one
may
examin
patient
malabsorpt
determin
factor
lipolyt
rate
micellar
solubil
fatti
acid
cellular
transfer
responsbil
measur
diminish
absorpt
rate
indi
vidual
suggest
basi
increas
occurr
hepatitisassoci
antigen
haa
patient
hepatoma
variou
part
world
may
reflect
etiolog
factor
asia
haa
hepatoma
report
patient
singapor
simon
et
al
lancet
high
patient
taiwan
tong
et
al
ann
intern
med
data
avail
south
vietnam
sinc
exposur
malaria
intestin
parasit
aspergillu
product
suggest
possibl
etiolog
factor
hepatoma
preliminari
studi
expand
provid
data
aspect
twentysix
patient
hepatoma
control
subject
hospit
patient
blood
donor
seen
saigon
month
period
form
basi
report
diagnosi
hepatoma
made
tissu
examin
case
clinic
ground
alphafetoprotein
hepatoma
men
women
vietnames
one
vietnamesechines
chines
haa
determin
immunoelectroosmophoresi
alphafetoprotein
afp
counterimmunoelectrophoresi
malaria
e
histolytica
titer
indirect
hemagglutin
presenc
antibodi
aspergillu
doubl
diffus
method
patient
hepatoma
afp
haa
posit
malaria
titer
posit
e
histolytica
titer
antibodi
aspergillu
control
subject
afp
haa
posit
malaria
titer
posit
e
histolytica
titer
antibodi
aspergillu
basi
preliminari
studi
patient
hepatoma
south
vietnam
higher
incid
haa
posit
malaria
e
histolytica
titer
antibodi
aspergillu
control
popul
review
case
pancreat
three
seattl
hospit
white
j
murat
depart
surgeri
univers
washington
seattl
washington
seven
hundr
thirtythre
case
acut
chronic
pancreat
found
search
record
year
univers
swedish
doctor
hospit
seattl
case
acut
pancreat
record
gallston
patient
alcohol
cholecystectomi
common
duct
drainag
dilat
duct
sphincteroplasti
splanchnicectomi
remaind
medic
therapi
patient
chronic
pancreat
alcohol
calcif
primari
treatment
consist
pancreaticojejunostomi
patient
dilat
duct
splanchnicectomi
small
hard
pancrea
without
ductal
dilat
resect
procedur
fail
case
relat
duoden
ulcer
postop
abdomin
trauma
relat
renal
failur
shock
hyperparathyroid
hyperlipemia
viral
diseas
author
impress
frequenc
unrecogn
gallston
duoden
ulcer
patient
recurr
acut
pancreat
part
play
shock
coronari
occlus
set
acut
attack
fact
good
gastrointestin
workup
usual
avail
averag
case
also
feel
surgeon
plan
oper
diseas
interv
stage
envis
anyon
number
oper
cholecystectomi
sphincteroplasti
choledochoduodenostomi
anastomosi
pancrea
intestin
oper
duoden
ulcer
rather
singl
one
effort
ascertain
effect
vagotomi
gallston
format
studi
bile
acid
pool
well
element
bile
seri
dog
anesthesia
alon
transthorac
truncal
vagotomi
chronic
gallbladd
fistula
construct
first
signific
chang
concentr
bile
acid
cholesterol
phospholipid
bile
salt
pool
follow
nembut
anesthesia
vagotomi
total
bile
acid
pool
increas
p
addit
daili
cholic
acid
product
drop
cholic
acid
rate
constant
decreas
signific
drop
connect
cholic
acid
half
life
increas
day
p
interest
find
ratio
cholic
acidto
cholesterol
decreas
sharpli
ratio
cholic
acid
phospholipid
addit
ratio
cholic
acid
chenodeoxychol
acid
reduc
signific
chang
increas
pool
size
probabl
secondaryto
stasi
enlarg
gallbladd
therefor
seem
unlik
cholesterol
stone
could
form
basi
vagotomi
alon
unless
stasi
import
factor
furthermor
concentr
cholic
acid
increas
greater
rate
volum
bile
chang
ratio
cholic
acid
two
bile
acid
suggest
latter
held
liver
cell
due
chang
membran
permeabl
abil
cell
extrud
acid
perhap
divid
vagu
reduc
secretin
hormon
output
lack
choleret
effect
hormon
might
account
chang
past
year
author
oper
person
patient
chronic
pancreat
acut
recurr
acut
pancreat
total
sphincterotomi
pancreaticojejunostomi
cholecystectomi
choledochoenterostomi
splanchnicectomi
lefttoright
resect
pancreaticoduodenectomi
perform
patient
patient
alcohol
develop
chronic
pancreat
second
trauma
second
unrecogn
retroperiton
sarcoma
due
congenit
obstruct
pancreat
duct
appar
connect
diseas
appar
instanc
hyperlipemia
author
feel
patient
chronic
pain
warrant
admiss
hospit
explor
idea
perform
pancreaticojejunostomi
patient
duct
dilat
rom
diamet
decompress
bile
duct
necessari
splanchnicectomi
pancreat
ductal
system
dilat
pancrea
small
hard
pain
resect
els
fail
sphincterotomi
effect
treat
patient
alcohol
chronic
pancreat
author
experi
approxim
patient
undergo
splanchnicectomi
reliev
pain
year
fgrtytwo
patient
dilat
duct
em
long
lon
er
pancreaticojejunostomi
carri
reliev
pain
postop
year
three
requir
subsequ
splanchnicectomi
requir
subsequ
resect
sphincterotomi
effect
patient
patient
calcifi
cyst
head
pancrea
adjac
sphincter
oddi
author
feel
patient
undergo
surgeri
chronic
pancreat
prepar
describ
oper
appropri
one
decid
upon
basi
clinic
find
singl
oper
appear
appropri
problem
one
combin
prefer
howev
reserv
pancreat
resect
case
splanchnicectomi
pancreaticojejunostomi
proven
ineffect
indic
specif
oper
discuss
studi
morpholog
cal
fun
ctional
statu
canin
jejun
allograft
suggest
multipl
sequenti
biopsi
histolog
c
evalu
best
method
monitor
reject
ion
process
graft
howev
sensit
method
would
use
provid
earlier
warn
j
e
ction
disaccharidas
activ
ugm
wet
wt
assay
biopsi
obtain
canin
jejun
allograft
determin
whether
chang
enzym
preced
histolog
abnorm
sequent
ial
assay
perform
control
dog
thiryvella
loop
construct
without
immunosuppress
dog
je
iunal
allograft
without
immunosuppress
sucras
maltas
lactas
activit
i
moder
stabl
control
anim
surgeri
allograft
show
decreas
activ
enzym
ie
ction
proceed
howev
ariabl
seen
among
specimen
tempor
singl
valu
unreli
decreas
trend
consist
lactas
chang
enzym
activ
usual
occur
morpholog
abnorm
lamina
propria
present
chang
enzym
ctiviti
usual
occur
villu
epitheli
cell
abnorm
seen
repres
studi
studi
demonstr
disaccharidas
activ
decreas
reject
usual
follow
morpholog
chang
earli
ject
ion
may
pre
cede
morpholog
indi
cator
advanc
reject
conclus
disaccharidas
assay
less
sensit
morpholog
cal
observ
monitor
reject
could
valu
supplement
morpholog
observat
on
mode
action
cholecystokinin
cck
octapeptid
fragment
cck
caerulein
pentagastrin
small
intestin
motor
activ
investig
rel
potenc
determin
isol
segment
guinea
pig
ileum
bath
aerat
chamber
contain
kreb
solut
maintain
isometr
mechan
respons
record
forc
transduc
connect
grass
polygraph
follow
result
obtain
muscl
develop
toler
initi
stimulu
even
test
minut
dose
singl
doserespons
studi
indic
respons
elicit
x
octacck
x
caerulein
x
cck
x
pentagastrin
similar
cholinerg
blockad
x
scopolamin
reduc
compar
respons
urecholin
x
peptid
x
octacck
x
caerulein
x
cck
x
pentagastrin
inhibit
greater
urecholin
respons
peptid
respons
differ
degre
inhibit
scopolamin
signific
p
tissu
age
cold
hour
experiment
studi
respons
peptid
data
show
progress
decreas
sensit
hormon
time
end
hour
respons
peptid
could
obtain
tissu
still
capabl
respond
urecholin
treatment
tissu
tetrodotoxin
x
complet
abolish
effect
four
peptid
respons
urecholin
remain
unchang
alpha
beta
blocker
fail
block
hormon
effect
intestin
conclud
four
peptid
capabl
contract
intestin
muscl
fact
effect
cck
relat
analogu
alter
scopolamin
suggest
possibl
oper
excitatori
cholinerg
compnent
tetrodotoxin
cold
trage
dta
support
view
seem
therefor
cck
feedback
control
intric
network
modul
neural
gut
motil
phenobarbit
induc
rise
nhydroxylas
activ
wistar
strain
rat
e
h
mosbach
daili
administr
phenobarbit
rhesu
monkey
increas
biliari
secret
bile
salt
bs
decreas
cholesterol
c
indic
increas
convers
hepat
cholesterol
bile
acid
reding
small
suggest
therefor
phenobarbit
induc
ahydroxylas
may
use
cholelithiasi
look
similar
effect
phenobarbit
mice
standard
method
determin
bile
salt
cholesterol
lecithin
adapt
permit
analysi
gallbladd
bile
singl
mous
male
mice
treat
phenobarbit
sodium
mgkg
ip
day
increas
bsc
ratio
gallbladd
bile
howev
chronic
administr
drug
diet
week
result
increas
level
cholesterol
bile
correspond
decreas
bsc
p
result
provid
indirect
evid
nhydroxylas
induc
phenobarbit
mous
evid
factor
come
play
chronic
drug
administr
revers
earli
effect
possibl
later
induct
enzym
involv
lipid
metabol
eg
hmgcoa
reductas
rais
doubt
ultim
use
full
gener
enzym
induc
cholelithiasi
hexos
absorpt
increas
alloxan
diabet
rat
sinc
hexos
disaccharid
transport
interrel
hexos
absorb
deriv
dietari
disaccharid
polysaccharid
studi
effect
diabet
intestin
disaccharidas
compar
match
control
c
day
diabet
rat
intestin
examin
mucos
underli
tissu
fraction
proxim
mid
distal
third
small
intestin
c
rat
three
quarter
disaccharidas
activ
mucos
scrape
total
intestin
activ
diabet
pmole
hydrolyzedmin
nearli
doubl
lactas
c
p
ool
maltas
c
p
ool
tripl
sucras
c
p
ool
sinc
intestin
growth
greater
diabet
control
group
increas
disaccharidas
chiefli
specif
activ
pmole
disaccharid
hydrolyzedmin
per
g
protein
lactas
specif
activ
increas
chiefli
proxim
segment
maltas
sucras
specif
activ
increas
three
segment
proport
activ
origin
present
thu
stimul
diabet
maintain
normal
longitudin
gradient
high
disaccharidas
activ
proxim
mid
intestin
also
normal
longitudin
gradient
rate
hexos
absorpt
thu
diabet
parallel
effect
hexos
absorpt
disaccharidas
degre
stimul
longitudin
pattern
disaccharidas
stimul
follow
normal
pattern
rate
hexos
absorpt
along
length
intestin
sinc
vitamin
calcium
ca
statu
anim
determin
pathway
metabol
boyl
et
al
proc
nat
acad
sci
statu
would
also
expect
influenc
effect
vitamin
intestin
ca
transport
studi
effect
ca
absorpt
deplet
rat
vitamin
convert
chiefli
deriv
metabolit
activ
intestin
frolik
et
al
arch
biochem
biophi
deplet
rat
found
increas
net
intestin
ca
absorpt
flux
effect
flux
ca
lumen
younoszai
et
al
gastroenterol
effect
vitamin
ca
transport
normal
rat
main
metabolit
deriv
examin
studi
intestin
plasmatolumen
flux
net
absorpt
ca
normal
control
c
normal
rat
inject
fortyeight
hr
studi
u
given
rat
match
group
twentyfour
hr
studi
rat
load
given
parenter
duodenum
duo
ileum
il
perfus
mm
calcium
rat
show
significantli
decreas
flux
ca
mole
hrg
mucosa
wet
wt
lumen
duo
p
il
cl
p
effect
net
ca
absorpt
mole
hrg
mucosa
wet
wt
duo
il
studi
demonstrateeffect
vttamin
intestin
ca
transport
appear
specif
metabol
state
anim
vitamin
decreas
flux
calcium
lumen
normal
rat
deplet
rat
major
action
increas
net
absorpt
effect
seen
normal
anim
may
reflect
differ
vitamin
metabol
esophag
manometri
frequent
employ
perfus
multicathet
assembl
pressur
measur
obtain
side
open
locat
cm
apart
often
great
variabl
pressur
measur
one
locat
differ
cathet
previou
investig
shown
pressur
measur
simultan
three
lumen
cathet
open
locat
ident
gastroenterolog
part
continu
studi
mechan
esophagu
methodolog
esophag
manometri
record
intralumin
pressur
bodi
esophagu
high
pressur
zone
mean
three
cathet
assembl
inner
rom
side
open
level
subject
studi
great
variabl
three
record
channel
averag
differ
highest
lowest
pressur
locat
time
mean
three
read
variabl
note
normal
subject
patient
alter
esophag
manometri
sinc
variabl
could
due
artifact
pressur
transmiss
along
cathet
assembl
systemat
studi
factor
perform
found
pressur
measur
depend
flow
rate
perfus
fluid
ie
perfus
rate
must
high
enough
record
rapid
pressur
chang
low
enough
alter
baselin
viscou
effect
perfus
rate
calcul
formula
relat
deform
system
rate
flow
f
perfus
fluid
maxim
intralumin
pressur
p
time
contract
formula
fdxp
determin
proper
rate
flow
cathet
system
rise
baselin
caus
viscou
effect
estim
poiseuil
equat
relat
length
diamet
cathet
cathet
system
pressur
record
transduc
within
rom
hg
pressur
open
conclud
differ
pressur
measur
cathet
assembl
side
open
level
due
artifact
pressur
transmiss
along
assembl
actual
differ
pressur
occur
side
open
proteolysi
estim
solid
substrat
digest
technic
cammarata
patient
ingest
two
steel
wire
mesh
capsul
contain
weight
quantiti
heat
coagul
albumin
attach
small
bore
tube
sampl
gastric
juic
aspir
proteolyt
activ
estim
hemoglobin
assay
three
hour
capsul
recov
wash
lyophil
reweigh
determin
quantiti
substrat
digest
proteolysi
express
percent
weight
substrat
digest
three
hour
second
capsul
expos
solut
sulfat
amylopectin
pepsin
inhibitor
wash
extens
prior
ingest
small
quantiti
pepsin
inhibitor
weight
remain
tightli
bound
solid
albumin
substrat
inhibitori
effect
substrat
bound
materi
studi
patient
endoscop
proven
activ
duoden
gastric
ulcer
studi
compar
hospit
patient
without
gastrointestin
tract
diseas
student
volunt
control
duoden
ulcer
patient
nll
significantli
greater
gastric
proteolysi
meansd
patient
control
nll
p
proteolysi
gastric
ulcer
patient
intermedi
rang
duoden
ulcer
control
patient
student
volunt
control
greater
proteolysi
nio
duoden
ulcer
patient
data
suggest
presenc
increas
gastric
proteolysi
activ
duoden
gastric
ulcer
patient
emphas
need
match
control
group
vivo
substrat
inhibit
proteolysi
sulfat
amylopectin
demonstr
mark
inhibit
proteolysi
ulcer
patient
inhibit
patient
control
inhibit
two
pernici
anemia
patient
achlorhydria
demonstr
gastric
proteolysi
inhibit
presum
nonpept
origin
comparison
solid
substrat
hemoglobin
method
measur
proteolysi
reveal
mark
underestim
proteolyt
activ
hemoglobin
method
appear
result
product
pepsin
inhibitor
vitro
proteolysi
autom
ascit
ultrafiltrationreinfus
zimmon
j
beckwith
f
iber
va
hospit
new
york
new
york
lemuel
shattuck
hospit
boston
massachusett
respons
cirrhot
patient
diuret
resist
ascit
continu
ascit
ultraflltratlonrelnfus
studi
use
new
autom
fallsaf
devic
constant
monitor
bodi
weight
urin
output
central
venou
pressur
abdomin
girth
ascit
continu
aspir
control
rate
mlhr
ultrafllt
modul
remov
crystalloid
concentr
protein
reinfus
intraven
volum
ascit
remov
rang
liter
per
procedur
protein
concentr
relnfus
could
increas
fold
vari
back
pressur
ultrafllt
modul
similarli
ultraflltraterelnfuslon
volum
ratio
vari
iii
volum
reinfus
rang
liter
rate
mlhr
intravascular
volum
load
gener
spontan
diuret
assist
diuresi
exampl
cirrhot
patient
bun
creatinin
initi
ascit
volum
measur
wi
th
albumin
liter
hou
r
ultraflltrationreinfuslon
remov
liter
ascit
liter
ultrafilt
liter
reinfus
respons
furosamld
urin
volum
increas
liter
net
weight
loss
lb
initi
experi
demonstr
mechan
safeti
effici
devic
clinic
use
obviat
compartment
izatlon
ascit
may
particular
valu
manag
tens
ascit
ascit
follow
abdomin
surgeri
ascit
high
protein
concentr
diuret
resist
ascit
